Tuesday, November 18, 2014
Print Entire 2014 Program:
|
|
SESSION 1 SCHEDULE | |
Tuesday
SESSION 1:
PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO ASCENDING AORTIC DISEASE
Moderators:Edward B. Diethrich, MD / Ali Khoynezhad, MD, PhD
|
|
x | |
6:49 AM - 6:53 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
View Abstract | |
6:53 AM - 6:58 AM | Cerebral Protection Techniques And Devices For Use In Transcatheter Aortic Valve Replacement (TAVR) And TEVAR: The Embrella And Claret Medical Sentinal Devices And Others: How Well Do They Work |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Abstract | |
6:59 AM - 7:04 AM | Status Of Left Atrial Appendage Occlusive Devices In 2014 |
Presenter(s):Ted Feldman, MD | |
View Abstract | |
7:05 AM - 7:10 AM | Trans-Carotid Access For TAVR: Value, Technique And Limitations |
Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
View Abstract | |
7:11 AM - 7:16 AM | Status Of Transcatheter Mitral Valve Repair: Where Is It Heading |
Presenter(s):Ted Feldman, MD | |
View Abstract | |
7:17 AM - 7:22 AM | Role And Value Of TAVR Today And In The Future |
Presenter(s):Allan Stewart, MD | |
View Abstract | |
ASCENDING AORTIC LESIONS | |
7:23 AM - 7:28 AM | New Simplified Concept For Constructing Branched Endografts From Standardized Components: How It Can Be Used For TAAAs, Arch Lesions And Hypogastric Revascularization |
Presenter(s):Patrick W. Kelly, MD | |
View Abstract | |
7:29 AM - 7:34 AM | Endovascular Approaches To The Ascending Aorta For Repair With A Branched Endograft: Techniques And When Is It Feasible And For What Lesions |
Presenter(s):Tilo Koelbel, MD, PhD | |
View Abstract | |
7:35 AM - 7:40 AM | Innovative Approaches And Future Horizons To Ascending Aortic Pathologies: What Can Be Done And What Problems Remain |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
7:41 AM - 7:46 AM | Tips, Tricks And Results With Endograft Repair Of Ascending Aortic Lesions |
Presenter(s):Grayson H. Wheatley, MD / Edward B. Diethrich, MD | |
View Abstract | |
7:47 AM - 7:52 AM | Hemodynamic And Anatomical Challenges To Overcome With Endovascular Grafts In The Ascending Aorta |
Presenter(s):Robert J. Hinchliffe, MD | |
View Abstract | |
7:53 AM - 7:58 AM | Experience With Ascending Aortic Endografts Using An FDA IDE Approved Device: What Has Been Done, What Lesions Can Be Treated And What Challenges Remain |
Presenter(s):Ali Khoynezhad, MD, PhD | |
View Abstract | |
7:59 AM - 8:05 AM | Panel Discussion |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Tuesday
SESSION 2:
NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC ARCH LESIONS AND DISSECTIONS
Moderators:Timothy A.M. Chuter, DM / Hazim J. Safi, MD
|
|
x | |
8:06 AM - 8:11 AM | For Arch Lesions In Situ Fenestration Is Still Viable: New Techniques Will Facilitate This Approach |
Presenter(s):Bjõrn Sonesson, MD, PhD | |
View Abstract | |
8:12 AM - 8:17 AM | Results Of Branched Endografts For Repair Of Aortic Arch Lesions: Based On A Chinese Multicenter Study |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Abstract | |
8:18 AM - 8:23 AM | Mid-Term Outcomes Of A Simplified Method Of Arch Aneurysm Treatment Using A Precurved Fenestrated Aortic Endograft: Technique And Results |
Presenter(s):Yoshihiko Yokoi, MD | |
View Abstract | |
MEGADEBATE | |
8:24 AM - 8:29 AM | DEBATE: Total Endovascular Aortic Arch Repair Is Feasible And Will Be The Best Method: Technique And Early Results |
Presenter(s):Stephan Haulon, MD | |
View Abstract | |
8:30 AM - 8:35 AM | DEBATE: Hybrid (Open And Endo) Repair Is The Best Treatment For Aortic Arch Lesions: Tips And Tricks |
Presenter(s):Germano Melissano, MD | |
View Abstract | |
8:36 AM - 8:41 AM | DEBATE: Value And Limitations Of Chimney Grafts To Treat Arch Lesions: When Are They Best: Based On An 11-Year Experience |
Presenter(s):Nicola Mangialardi, MD | |
View Abstract | |
8:42 AM - 8:47 AM | DEBATE: Total Endovascular Arch Replacement With Sandwich Grafts, And TEVAR Is Often The Simplest And Best Treatment For Arch Lesions |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
8:48 AM - 8:53 AM | DEBATE: Open Repair Is Still The Best Treatment For Most Arch Lesions |
Presenter(s):Joseph S. Coselli, MD | |
View Abstract | |
8:54 AM - 8:59 AM | Total Endovascular Arch Repair For Arch Aneurysms And Dissections: Comparison Of Bolton Double Branch Endograft vs. Hybrid Debranching With TEVAR |
Presenter(s):Toru Kuratani, MD, PhD | |
View Abstract | |
9:00 AM - 9:05 AM | A New Classification System For Type B Aortic Dissection (TBAD): It Will Help Predict The Probability Of Visceral Malperfusion And Reverse Aortic Remodeling After TEVAR |
Presenter(s):Ali Khoynezhad, MD, PhD | |
View Abstract | |
9:06 AM - 9:13 AM | Panel Discussion |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Tuesday
SESSION 3:
TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT
Moderators:Richard P. Cambria, MD / Juan C. Parodi, MD
|
|
x | |
9:13 AM - 9:18 AM | New MR Imaging Techniques (4D) To Measure Vascular Hemodynamics And Biomechanics: How Can They Help In Treating Patients With TBADs |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Abstract | |
9:19 AM - 9:24 AM | Tips And Tricks For Avoiding Pitfalls In The TEVAR Treatment Of TBADs: Based On Experience In More Than 1800 Patients |
Presenter(s):Wei Guo Fu, MD | |
View Abstract | |
FOUR-WAY DEBATE | |
9:25 AM - 9:30 AM | DEBATE: All “Uncomplicated” TBADs Should Be Treated Early By TEVAR Since All Are Or Will Become Complicated: INSTEAD XL And IRAD Prove It And We Don’t Need Further Trials |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Abstract | |
9:31 AM - 9:36 AM | DEBATE: Why We Still Need A Randomized Controlled Trial (RCT) Of Intensive Medical Therapy vs. Early TEVAR For Uncomplicated TBAD |
Presenter(s):Frank A. Lederle, MD | |
View Abstract | |
9:37 AM - 9:42 AM | DEBATE: Medical Therapy And Close Observation Is Best For Uncomplicated TBAD: When Complications Arise, Most Patients Are Best Treated With Open Operation: Long-Term Results (>20 Years) Justify It |
Presenter(s):Hazim J. Safi, MD / Ali Azizzadeh, MD | |
View Abstract | |
9:43 AM - 9:48 AM | DEBATE: With Patients Having Uncomplicated TBAD Medical Treatment With Delayed (2-3 Months) TEVAR Is The Best Treatment: It Will Lessen Complications Including Retrograde Type A Dissections |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
9:49 AM - 9:54 AM | Current Single Center Results Of Medically Treated TBAD Patients |
Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD | |
View Abstract | |
9:55 AM - 10:00 AM | Why We Need A New Classification System For Patients With TBAD: What Is It |
Presenter(s):Christoph A. Nienaber, MD, PhD / Michael D. Dake, MD | |
View Abstract | |
10:01 AM - 10:10 AM | Panel Discussion |
10:10 AM - 10:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Tuesday
SESSION 4:
NEW DEVELOPMENTS IN TEVAR AND THE MANAGEMENT OF TBAD PATIENTS
Moderators:Christoph A. Nienaber, MD, PhD / Michael D. Dake, MD
|
|
x | |
10:30 AM - 10:35 AM | Management Of Distal Re-entry Tears After TEVAR For TBAD: When Is It Necessary And How To Do It |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Abstract | |
10:36 AM - 10:41 AM | In Patients With Acute TBADs When Is TEVAR Closure Of Proximal Entry Tears Sufficient And When Is Adjunctive Treatment Necessary: What Adjunctive Procedures Can Be Used |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Abstract | |
10:42 AM - 10:47 AM | Endovascular Options To Obliterate The Patent False Lumen When Coverage Of The Primary Tear Does Not Do So: New Data On Safety And Efficacy Of These Options |
Presenter(s):Peter J. Mossop, MBBS | |
View Abstract | |
10:48 AM - 10:53 AM | Is The Petticoat Technique (Proximal Covered Stent And Distal Bare Stent) Effective In Treating Acute And Chronic TBADs: 3-Year Results Of The STABLE I And II Trials: Are Long-Term Outcomes Better |
Presenter(s):Joseph V. Lombardi, MD | |
View Abstract | |
10:54 AM - 10:59 AM | DEBATE: Value And Limitations Of Using Fenestrated And Branched Endografts (F/B EVAR) To Treat Chronic TBADs With Infradiaphragmatic AAAs: It Is The Way To Go |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Piotr M. Kasprzak, MD | |
View Abstract | |
11:00 AM - 11:05 AM | DEBATE: What Is Wrong With TEVAR To Treat Chronic TBADs |
Presenter(s):Nicholas J.W. Cheshire, MD / Richard G.J. Gibbs, FRCS | |
View Abstract | |
11:06 AM - 11:11 AM | When After An Acute TBAD Does The Dissection Flap Become Fixed: Based On Dynamic (4D) CTA And MRA |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Abstract | |
11:12 AM - 11:17 AM | Objective Assessment Of Current Endografts For TEVAR: Which Grafts For Which Lesion And Which Anatomy: It Makes A Difference |
Presenter(s):Ludovic Canaud, MD, PhD | |
View Abstract | |
11:18 AM - 11:25 AM | Panel Discussion |
Moderator(s): Kim J. Hodgson, MD / Jan S. Brunkwall, MD, PhD | |
11:25 AM - 11:30 AM | Pathophysiological Mechanism For False Lumen Enlargement To Form An Aneurysm After A TBAD: What Can Be Done To Prevent It |
Presenter(s):Ramon Berguer, MD, PhD | |
View Abstract | |
11:31 AM - 11:36 AM | Late Remodeling In Stented And Unstented Aortic Segments After TEVAR For Complex TBADs |
Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD | |
View Abstract | |
11:37 AM - 11:42 AM | Intensive Follow-up With CTA Imaging Surveillance Is Needed For TEVAR To Be Successful Treatment Of TBAD Patients |
Presenter(s):Götz M. Richter, MD, PhD | |
View Abstract | |
11:43 AM - 11:48 AM | Long-Term (20-Year) Results Of Open Repair Of Chronic TBADs With Aneurysm Formation Are Good: It Should Be The Gold Standard Of Care |
Presenter(s):Hazim J. Safi, MD | |
View Abstract | |
11:49 AM - 11:54 AM | Branched Endografts For Treating Chronic TBAD With Aneurysm Formation: Advantages And Limitations |
Presenter(s):Marcelo Ferreira, MD | |
View Abstract | |
11:55 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Tuesday
SESSION 5:
IN HONOR OF JAMES A. DEWEESE, MD: NEW DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Wesley S. Moore, MD / Frank J. Veith, MD
|
|
x | |
1:00 PM - 1:05 PM | Tips And Tricks To Make CAS Safer: Lessons Learned After More Than 3000 Procedures |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
1:06 PM - 1:11 PM | CAS Recanalization For Total ICA Occlusions: Long-Term Clinical And Image Follow-up: When Are The Procedures Worthwhile: A New Horizon |
Presenter(s):Paul H.L. Kao, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Diagnosis And Prophylactic Treatment Of Vulnerable Plaques: Can Their Vulnerability Be Decreased By Stenting |
Presenter(s):Gregg W. Stone, MD | |
View Abstract | |
1:18 PM - 1:23 PM | What Is The Current Evidence For Decreasing The Incidence Of Strokes On Medical Treatment Alone: Don’t Believe The NY Times – Statins Are Safe And Should Be Used More Widely |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Abstract | |
1:24 PM - 1:29 PM | What Constitutes Best Medical Treatment (BMRx) Currently In Asymptomatic Carotid Stenosis: What Happens To Carotid Plaques On BMRx |
Presenter(s):J. David Spence, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Long-Term Results Of SAMMPRIS Trial In Patients With Intracranial Stenoses: What Does It Tell Us About The Feasibility And Value Of BMRx |
Presenter(s):Colin P. Derdeyn, MD / Marc I. Chimowitz, MBChB | |
View Abstract | |
1:36 PM - 1:41 PM | Increased Cardiovascular Mortality In Patients With Asymptomatic Carotid Stenosis Who Are Not On Statins: What Should Optimal Medical Therapy Be And Can It Decrease Plaque Size And Danger |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD / | |
View Abstract | |
1:42 PM - 1:48 PM | Panel Discussion |
Moderator(s): Daniel G. Clair, MD / Jean-Pierre Becquemin, MD, FRCS | |
1:48 PM - 1:53 PM | Update On The ACT I Trial: A RCT Comparing CAS vs. CEA In Patients With Asymptomatic High-Grade Carotid Stenosis |
Presenter(s):Jon S. Matsumura, MD | |
View Abstract | |
1:54 PM - 1:59 PM | DEBATE: Medical Treatment Is Best For Patients With High-Grade Asymptomatic Carotid Stenosis (Asx CS) |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Abstract | |
2:00 PM - 2:05 PM | DEBATE: Carotid Endarterectomy (CEA) Is The Best Treatment For Most Patients With High-Grade Asx CS |
Presenter(s):Richard P. Cambria, MD | |
View Abstract | |
2:06 PM - 2:11 PM | DEBATE: Carotid Stenting (CAS) Is The Best Treatment For Most Patients With High-Grade Asx CS |
Presenter(s):William A. Gray, MD | |
View Abstract | |
2:12 PM - 2:17 PM | Early Results From The ACST-2 Trial: In >1500 Patients CAS And CEA Appear To Be Equivalent Treatments For Asx CS |
Presenter(s):Alison Halliday, MS, FRCS | |
View Abstract | |
2:18 PM - 2:23 PM | What Will CREST 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
2:24 PM - 2:29 PM | What Will SPACE 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Abstract | |
2:26 PM - 2:41 PM | DEBATE: Based On The CREST RCT And Other Data, CAS Is The Best Treatment For Most Patients With Sx CS If The Right Techniques Are Used In Experienced Centers |
Presenter(s):Horst Sievert, MD | |
View Abstract | |
2:30 PM - 2:35 PM | DEBATE: Based On The CREST RCT And Other Data, CEA Seems To Be The Best Treatment For Symptomatic Carotid Stenosis (Sx CS) In Most Patients |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
2:42 PM - 2:50 PM | Panel Discussion |
2:50 PM - 3:05 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Tuesday
SESSION 6:
MORE ON THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Glenn M. LaMuraglia, MD / Thomas S. Riles, MD
|
|
x | |
3:05 PM - 3:10 PM | Resolving The Differences Between Various CAS/CEA Guidelines – All Based On The Same Data: How Could They Be So Different |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Abstract | |
3:11 PM - 3:16 PM | How To Optimize Brain Safety With CAS And CEA: What Is The Significance Of Silent MRI Defects |
Presenter(s):Laura Capoccia, MD, PhD | |
View Abstract | |
3:17 PM - 3:22 PM | Microemboli And DW MRI Defects After Carotid Interventions: Do They Impair Cognitive Function |
Presenter(s):Wei Zhou, MD | |
View Abstract | |
3:23 PM - 3:28 PM | Can Asx CS Lead To Cognitive Impairment: Does Carotid Revascularization Produce Cognitive Improvement |
Presenter(s):Brajesh K. Lal, MD | |
View Abstract | |
3:29 PM - 3:34 PM | Proximal Brain Protection With Flow Reversal vs. Filter Protection For CAS: Which Is Better And How Best To Achieve Flow Reversal |
Presenter(s):Claudio J. Schonholz, MD | |
View Abstract | |
3:35 PM - 3:40 PM | Flow Reversal Brain Protection Can Be Achieved During CAS With A Modified Mo.Ma Device: How To Do It |
Presenter(s):Juan C. Parodi, MD | |
View Abstract | |
EARLY TREATMENT OF SX CS | |
3:41 PM - 3:46 PM | Is CEA Within 48 Hours Of Acute Symptom Onset Safe: The Evidence Is Mixed |
Presenter(s):Martin Bjorck, MD, PhD | |
View Abstract | |
3:47 PM - 3:52 PM | CEA Early After Symptom Onset Does Not Increase Risk: Not So With CAS |
Presenter(s):Gustav Fraedrich, MD | |
View Abstract | |
3:53 PM - 3:58 PM | DEBATE: Expedited CEA In Symptomatic CS Patients: How Long Post Symptom Onset Can Patients Safely Undergo CEA |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
3:59 PM - 4:04 PM | DEBATE: Early CAS After Symptom Onset Is Safe In Younger Patients Under Certain Conditions |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
4:05 PM - 4:12 PM | Panel Discussion |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Tuesday
SESSION 7:
MORE ON THORACIC AND THORACOABDOMINAL ANEURYSMS (TAAAs); PREVENTING SPINAL CORD ISCHEMIA (SCI)
Moderators:Larry H. Hollier, MD / Timothy A.M. Chuter, DM
|
|
x | |
4:12 PM - 4:17 PM | Paraplegia Following Fenestrated And Branched Aortic Endografts (F/B EVAR): Incidence, Severity And Ways To Prevent |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Abstract | |
4:18 PM - 4:23 PM | Incidence And Treatment Of SCI After TEVAR: Role Of Pressure Controlled Automatic Spinal Fluid Drainage (Liquo Guard System) |
Presenter(s):Germano Melissano, MD | |
View Abstract | |
4:24 PM - 4:29 PM | Value Of Neuromonitoring During Open And Endo TAAA Repairs: How To Do It |
Presenter(s):Michael J. Jacobs, MD | |
View Abstract | |
4:30 PM - 4:35 PM | Vascular Specialists Doing TEVAR May Be Underestimating The Paraplegia Risk: Pearls To Keep In Mind From A Senior TAAA Surgeon |
Presenter(s):Charles W. Acher, MD | |
View Abstract | |
4:36 PM - 4:41 PM | Incidence, Clinical Features Of SCI Associated With Endovascular Repair Of TAAAs: How To Treat And Prevent This Complication |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
4:42 PM - 4:47 PM | Best Approaches To Preventing SCI During TEVAR And Open Repair Of TAAAs: Pearls Regarding Etiology, Monitoring And Treating |
Presenter(s):Hamdy Awad, MD / Patrick Vaccaro, MD | |
View Abstract | |
4:48 PM - 4:53 PM | Panel Discussion |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Tuesday
SESSION 8:
MORE ON THORACIC AORTIC DISEASE, TEVAR AND TBADs
Moderators:Rodney A. White, MD / ShenMing Wang, MD, PhD
|
|
x | |
4:54 PM - 4:59 PM | Ascending Aortic Complications Following TEVAR: How Can They Be Diagnosed And Treated Successfully |
Presenter(s):Roberto Chiesa, MD | |
View Abstract | |
5:00 PM - 5:05 PM | Periscope Endografts To Revascularize The Left Subclavian Artery (LSA) During TEVARs Covering Its Origin: Technique And Advantages |
Presenter(s):Mario Lachat, MD | |
View Abstract | |
5:06 PM - 5:11 PM | Can PET-CT Help To Indicate Which Uncomplicated TBAD Will Become Complicated: Should This Be An Indication For TEVAR |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Abstract | |
5:12 PM - 5:17 PM | How To Manage Complications Of Malperfusion After Coverage Of The TBAD Primary Tear By TEVAR: Tips And Tricks |
Presenter(s):Ali Azizzadeh, MD / Mohammad H. Eslami, MD, RVT / Hazim J. Safi, MD | |
View Abstract | |
5:18 PM - 5:23 PM | Why The INSTEAD Trials Are Not Enough To Justify TEVAR For All Uncomplicated TBADs And Why We Need Additional Trials |
Presenter(s):Firas F. Mussa, MD | |
View Abstract | |
5:24 PM - 5:29 PM | Evaluation Of Dynamic Intimal Flap Movement In TBAD Patients: Effect Of TEVAR And How Important Is Time After Onset In Determining Flap Mobility |
Presenter(s):Frank R. Arko, MD | |
View Abstract | |
5:30 PM - 5:35 PM | Adjunctive False Lumen Techniques For Endovascular Repair Of Chronic TBADs: When Are They Needed |
Presenter(s):Eric E. Roselli, MD | |
View Abstract | |
5:36 PM - 5:41 PM | Relationship Between Aortic Morphology After TEVAR And Clinical Outcomes With TBADs |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
5:41 PM - 5:46 PM | Tricks And Pitfalls For Antegrade Endograft Delivery During Open Repair Of Acute Type A Aortic Dissections |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
View Abstract | |
5:47 PM - 5:55 PM | Panel Discussion End of Program A |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Tuesday
SESSION 9:
LOWER EXTREMITY OCCLUSIVE DISEASE MANAGEMENT HOT TOPICS – NEW TECHNIQUES AND NEW DEVICES
Moderators:Enrico Ascher, MD / Frank B. Pomposelli, MD
|
|
x | |
6:48 AM - 6:53 AM | Ultrasound Guidance To Decrease Access Site Complications: An Essential Tool Even For Experienced Interventionalists |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
6:54 AM - 6:59 AM | Role Of Directional Atherectomy For Treatment Of Lower Extremity Occlusive Disease: Is There A Gender Effect |
Presenter(s):Lawrence A. Garcia, MD | |
View Abstract | |
7:00 AM - 7:05 AM | Advantages And Limitations Of The Tack-It Device System For Minimizing Dissection After Plain Old Balloon Angioplasty (POBA) And Leaving Minimal Metal Behind: The TOBA Study |
Presenter(s):Marianne Brodmann, MD | |
View Abstract | |
7:06 AM - 7:11 AM | Technical Tips And Tricks To Optimize The Performance And Outcomes With The Supera Stent And Probably All Stents: Proper Sizing, Avoiding Elongation And Adequate Predilitation Matter In Producing Good 3-Year Results |
Presenter(s):D. Christopher Metzger, MD | |
View Abstract | |
7:12 AM - 7:17 AM | How To Use Drug Eluting Stents (DES) In Infrapopliteal Bifurcations |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Abstract | |
7:18 AM - 7:23 AM | Use Of Collaterals For Access And Retrograde Wire Passage: How To Do It |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Abstract | |
7:24 AM - 7:29 AM | When And How To Treat Below The Ankle Occlusive Disease: What Percent Of CLI Patients Will Require It |
Presenter(s):Roberto Ferraresi, MD | |
View Abstract | |
7:30 AM - 7:35 AM | With Below Knee (BK) Chronic Total Occlusions (CTOs), Success Depends On Choosing The Right Tools And Techniques: What New Tools And Techniques Exist To Help With Pedal And Tibial Access Like 3 French Sheaths And Systems |
Presenter(s):Andrej Schmidt, MD | |
View Abstract | |
7:36 AM - 7:42 AM | Panel Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Tuesday
SESSION 10:
LOWER EXTREMITY HOT TOPICS – MORE NEW TECHNOLOGIES AND THE IMPORTANCE OF TECHNIQUE; DEBATES
Moderators:Kenneth Ouriel, MD, MBA / Gregg S. Landis, MD
|
|
x | |
7:42 AM - 7:47 AM | DEBATE: For CLI: Endovascular Treatments Should Be Used First In 100% Of Patients |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
View Abstract | |
7:48 AM - 7:53 AM | DEBATE: For CLI: Open Surgery Should Be Used First In Some Patients: Which Ones |
Presenter(s):Firas F. Mussa, MD | |
View Abstract | |
7:54 AM - 7:59 AM | Value Of Ultrasound Guided Pedal Access To Treat CLI: How Can It Facilitate Use Of The Diamond Back Atherectomy Device: How Best To Close The Puncture Site |
Presenter(s):Jihad A. Mustapha, MD | |
View Abstract | |
8:00 AM - 8:05 AM | How Do Stent Characteristics/Details And Technical Details Of PTA Balloon Usage Affect Outcomes And Incidence Of Restenosis: Oversizing Matters And Is Bad |
Presenter(s):Dierk Scheinert, MD | |
View Abstract | |
8:06 AM - 8:11 AM | How To Optimize Outcomes With SFA Interventions: Details Of Stent Design And Deployment Techniques Are Important In Determining Restenosis And Failure As Is Predilatation With An Uncoated Balloon Before DEBs |
Presenter(s):Stefan Mueller-Hülsbeck, MD | |
View Abstract | |
8:12 AM - 8:17 AM | DEBATE: Why In Treating BK CTOs It Is Best To Stay Intraluminal |
Presenter(s):Marco G. Manzi, MD | |
View Abstract | |
8:18 AM - 8:23 AM | DEBATE: Subintimal Angioplasty Is Very Useful And Often Unavoidable In Treating BK CTOs |
Presenter(s):Amman Bolia, MD | |
View Abstract | |
8:24 AM - 8:29 AM | 15-Year Trends In CLI Treatment And Major Amputation: Better Care Is Making A Difference: Is It Due To Better Interventional And Bypass Treatment: Does Increased CLI Spending Increase Limb Salvage And Decrease Amputation Rates |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
8:30 AM - 8:37 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Tuesday
SESSION 11:
MORE LOWER EXTREMITY HOT TOPICS – NEW STENT AND DRUG ELUTING BALLOON (DEB) DATA; IMPACT AND COST ISSUES
Moderators:Joseph L. Mills, MD / Giancarlo Biamino, MD, PhD
|
|
x | |
8:38 AM - 8:43 AM | Is There A Negative Effect Of Endovascular Failure On Bypass Outcomes: Is It Reality Or A Myth |
Presenter(s):Michael S. Conte, MD | |
View Abstract | |
8:44 AM - 8:49 AM | What Is The Effect Of Extensive Lesion Calcification On The Outcome Of DEB Treatment |
Presenter(s):Gunnar Tepe, MD | |
View Abstract | |
8:50 AM - 8:55 AM | Why Are DEBs Cost Effective For Treating CLI Patients |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
8:56 AM - 9:01 AM | How To Align Financial Incentives For The Doctor, The Hospital And The Payer (Insurance Company) To Provide The Best And Most Effective Care In The Least Costly Manner: Impact Of Expensive New Technologies And Reintervention Rates |
Presenter(s):W. Charles Sternbergh III, MD | |
View Abstract | |
9:02 AM - 9:07 AM | Tips And Tricks For Tibial Interventions For CLI |
Presenter(s):Roberto Ferraresi, MD | |
View Abstract | |
9:08 AM - 9:13 AM | What’s New With US Approved Drug Eluting Stents (DESs) In The SFA And Below |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
9:14 AM - 9:19 AM | 5-Year Results And New Findings From The Zilver PTX RCT And Registry: Benefits Of DESs Are Durable And Value With In Stent Restenosis (ISR), Long Lesions And Diabetics |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
9:20 AM - 9:25 AM | 2-3-Year Results With EverFlex Helical Nitinol Stent In The SFA And The Popliteal Artery: Are The Benefits Durable |
Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD | |
View Abstract | |
9:25 AM - 9:33 AM | Panel Discussion |
9:33 AM - 9:48 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Tuesday
SESSION 12:
IN HONOR OF ROBERT B. RUTHERFORD, MD: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA; CLI, STENTS AND DEBs
Moderators:Ali F. AbuRahma, MD / Dierk Scheinert, MD
|
|
x | |
FOR SFA AND POPLITEAL LESIONS | |
9:48 AM - 9:53 AM | Update On The Efficacy Of DEBs For SFA And Popliteal Artery Lesions: Why Some Trials Are Positive And Some Negative: Are Good Results Holding Up: GLOBAL IN.PACT Registry Results In >1400 Patients |
Presenter(s):Gunnar Tepe, MD / Dierk Scheinert, MD | |
View Abstract | |
9:54 AM - 9:59 AM | POBA And “Vanella” Bare Metal Stents (BMS) Have Merit In Some AK And BK Occlusive Lesions Reserving The Fancy And Costly Stuff For Special Situations |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
10:00 AM - 10:05 AM | What Have We In The US Learned From Our European Colleagues About CLI Treatment That Can Be Used To Improve Patient Care In The US |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
10:06 AM - 10:11 AM | Stenting For Femoral And Popliteal Artery Lesions: Where Do We Currently Stand And What Problems Remain |
Presenter(s):Erich Minar, MD | |
View Abstract | |
10:12 AM - 10:17 AM | Role Of DEBs vs. DESs For SFA Lesions And Value Of Paclitaxel DEBs For Long SFA Lesions: Is There Level 1 Proof Of Benefit |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
10:18 AM - 10:23 AM | Paclitaxel Coated DEBs Are Better Than Uncoated Balloons In The SFA: 1-Year Results From The IN.PACT SFA I/II RCTs |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Gunnar Tepe, MD | |
View Abstract | |
10:24 AM - 10:29 AM | DEBs Are Effective For SFA Lesions: 1-Year Results From The LEVANT II RCT Show It To Be So With The Bard Lutonix DEB: Stents Were Rarely Needed |
Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD | |
View Abstract | |
10:30 AM - 10:35 AM | Durability Of Paclitaxel Coated DEBs In The SFA: Long-Term (3-Year) Results Of The PACIFIER Trial |
Presenter(s):Michael Werk, MD | |
View Abstract | |
10:36 AM - 10:41 AM | Mid-Term Results From The Belgian IN.PACT Trial Of Paclitaxel Coated DEBs vs. POBA: What Is Special About This Trial |
Presenter(s):Erik E. Debing, MD, PhD | |
View Abstract | |
10:42 AM - 10:50 AM | Panel Discussion |
FOR BK AND INFRAPOPLITEAL LESIONS | |
Moderator(s): Michael S. Conte, MD / George H. Meier III, MD | |
10:50 AM - 10:55 AM | How Often After Tibial Interventions For CLI Are Reinterventions Required: We Need Better Primary Treatments: What Are The Cost Implications |
Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD | |
View Abstract | |
10:56 AM - 11:01 AM | Single Center RCT Of IN.PACT Deep Paclitaxel Coated DEBs vs. Uncoated Balloons Shows Benefit For BK Lesions Causing CLI: 3-Year Results Of The DEBATE Trial |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:02 AM - 11:07 AM | Single Center Results With Paclitaxel Coated DEBs For Infrapopliteal Lesions Shows Benefits: What Are They |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
View Abstract | |
11:08 AM - 11:13 AM | A Multicenter RCT (IN.PACT DEEP) Comparing Paclitaxel Coated DEBs With Uncoated Balloons Fails To Show Benefit For The DEBs |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
11:14 AM - 11:19 AM | Why Do The SINGLE CENTER Trial And Other BK DEB Results Differ From The Multicenter Trial Results: All DEBs Are Not Equal Or Used Equally: A Critical Analysis Of All Data And Some 3-Year Results |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:20 AM - 11:25 AM | How To Explain Differing Results Of RCTs Of DEBs In BK And Infrapopliteal Lesions: When Will We Get DEBs For BK Lesions In The US |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Abstract | |
11:26 AM - 11:31 AM | DEBs: Are They A Breakthrough Technology Or Another Tool In The Box: Why Is There Still Uncertainty: Do The PACUBA Trial Results With SFA/POP In Stent Restenosis (ISR) Help |
Presenter(s):Johannes Lammer, MD | |
View Abstract | |
11:32 AM - 11:37 AM | How Long Is Restored Patency Needed In CLI Patients; What Leads To Increased Limb Salvage With Poor Patency: Importance Of Reintervention, DESs And DEBs |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
View Abstract | |
11:38 AM - 11:43 AM | How Important To Interventional Outcomes Is Leaving No Foreign Body Or Metal Behind In The Artery: How Can It Be Achieved |
Presenter(s):Giancarlo Biamino, MD, PhD / Dierk Scheinert, MD | |
View Abstract | |
11:44 AM - 11:49 AM | Variable And High Total Costs For Caring For CLI Patients: What Can Be Done To Cut Costs Without Impairing Patient Care |
Presenter(s):Timothy M. Sullivan, MD | |
View Abstract | |
11:50 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Tuesday
SESSION 13:
IN HONOR OF JOHN J. BERGAN, MD: MORE LOWER EXTREMITY ISCHEMIA TREATMENT – ROLE OF OPEN SURGERY; IN STENT RESTENOSIS (ISR) MANAGEMENT – DEBs, DESs, ATHERECTOMY
Moderators:Samuel R. Money, MD, MBA / Barry T. Katzen, MD
|
|
x | |
ROLE OF OPEN SURGERY | |
1:00 PM - 1:05 PM | Extreme Distal Vein Bypasses After Failed Endovascular Treatments |
Presenter(s):Giustino Marcucci, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Pedal Bypass With Deep Venous Arterialization: Long-Term Results And Hemodynamic Changes Are Surprisingly Good: Is It An Option After Failed Arterial Bypasses And Endovascular Treatments |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Abstract | |
1:12 PM - 1:17 PM | Endovascular vs. Open Treatments For Lower And Upper Extremity CLI: How To Avoid Failure And Bad Outcomes |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
1:18 PM - 1:23 PM | DEBATE: Endovascular Treatment First In All Patients With CLI Is Best |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
1:24 PM - 1:29 PM | DEBATE: Open Surgical Treatment First Is Best For Some CLI Patients: Which Ones And Why |
Presenter(s):Michael S. Conte, MD | |
View Abstract | |
1:30 PM - 1:35 PM | What Is The Best Treatment Strategy For CLI Patients In Terms Of Outcomes And Cost: When Open First, When Endo First |
Presenter(s):Timothy M. Sullivan, MD | |
View Abstract | |
1:36 PM - 1:42 PM | Panel Discussion |
DEBS AND TREATMENT OF ISR | |
Moderator(s): Giancarlo Biamino, MD, PhD / Michael B. Silva, Jr., MD | |
1:43 PM - 1:48 PM | Importance Of Technique In Avoiding Dissection With PTA Using DEBs And Standard Balloons: Does Good Flow Matter: How To Know: When Are Stents Really Necessary |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Abstract | |
1:49 PM - 1:54 PM | How To Cross And Recanalize Chronically Occluded Stents: Stent Puncture And The Radiofrequency PowerWire Can Be Helpful: Technical Tips |
Presenter(s):Marcelo Guimaraes, MD | |
View Abstract | |
1:55 PM - 2:00 PM | Treatment Of ISR: DEBs Are OK If The Lesion Is Just Intimal Hyperplasia: A Stent Is Required If The Lesion Is Severely Calcified |
Presenter(s):Dierk Scheinert, MD | |
View Abstract | |
2:01 PM - 2:06 PM | DEBATE: Laser Atherectomy And Stent Graft vs. Laser Atherectomy And DEB For ISR: Which Is Best And Why Debulking Is Essential |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Abstract | |
2:07 PM - 2:12 PM | DEBATE: For ISR, POBA vs. DEB vs. DES vs. Covered Stent: 1-Year Results Of The FAIR Trial With The IN.PACT Admiral DEB: Debulking Is Not Necessary |
Presenter(s):Hans Krankenberg, MD | |
View Abstract | |
2:13 PM - 2:18 PM | The Ocelot OCT Catheter For Crossing CTOs And The Next Generation Atherectomy Device (Phoenix): How Are They Better And In Which Arteries |
Presenter(s):James F. McKinsey, MD | |
View Abstract | |
2:19 PM - 2:24 PM | How Well Do Paclitaxel Coated DEBs Work For ISR In CLI Patients With Diabetes: 3-Year Results From The DEBATE RCT |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
2:25 PM - 2:30 PM | In Memoriam And Recognition Of 5 Giants In Vascular Surgery Who Are No Longer With Us: John Bergan, James DeWeese, Roy Greenberg, Robert Rutherford And David Sumner |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Abstract | |
2:31 PM - 2:38 PM | Panel Discussion |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Tuesday
SESSION 14:
NEW DEVELOPMENTS WITH STENT-GRAFTS FOR OCCLUSIVE DISEASE AND ISR
Moderators:Gary Giangola, MD
|
|
x | |
2:38 PM - 2:43 PM | Use Of Stent-Grafts To Avoid Rupture And Embolization In Endovascular Treatment Of Complex Iliac Artery Occlusive Disease |
Presenter(s):Maria Antonella Ruffino, MD | |
View Abstract | |
2:44 PM - 2:49 PM | DEBATE: For Long SFA Occlusions DEBs Or Viabahn Propaten Stent-Grafts Are The Best Treatment With The Best Outcomes: Will Drug Coating Tips To Stent-Grafts Improve Results: Will They Be Available |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
2:50 PM - 2:55 PM | DEBATE: For Long SFA Occlusions Zilver PTX DESs Are The Best Treatment With The Best Results |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
2:56 PM - 3:01 PM | Technical Considerations For Optimal Use Of Viabahn Covered Stents For Long SFA Occlusive Lesions: Lessons Learned From The VIPER And VIASTAR Trials |
Presenter(s):Dennis R. Gable, MD, FACS | |
View Abstract | |
3:02 PM - 3:07 PM | 2-Year Results Of The RELINE Trial Comparing Viabahn Stent-Grafts To POBA For ISR Show Durable Benefits To Endograft Treatment |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
View Abstract | |
3:08 PM - 3:13 PM | Interim Analysis Of The SUPER B Trial Comparing Heparin Bonded Viabahn Endografts To Vein Bypasses For SFA Occlusive Disease |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Abstract | |
3:14 PM - 3:19 PM | Covered Balloon Expandable Endovascular Graft Reconstruction Of The Aortic Bifurcation (CERAB Procedure) For Aorto-Iliac Occlusive Disease: 2-Year Results And Hemodynamic And Other Advantages |
Presenter(s):Peter C.J. Goverde, MD | |
View Abstract | |
3:20 PM - 3:26 PM | Panel Discussion |
3:26 PM - 3:38 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Tuesday
SESSION 15:
NEW DEVELOPMENTS IN THE TREATMENT OF ACUTE LOWER EXTREMITY ISCHEMIA (ALI) AND INTERMITTENT CLAUDICATION
Moderators:John B. Chang, MD / Patrick J. Lamparello, MD
|
|
x | |
ACUTE LOWER EXTREMITY ISCHEMIA | |
3:38 PM - 3:43 PM | How To Avoid Groin Incisions In Hostile Groins When Performing Femoral Embolectomy |
Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
View Abstract | |
3:44 PM - 3:49 PM | Percutaneous Endovascular Thrombosuction: Devices, Techniques, Indications And Results |
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
3:50 PM - 3:55 PM | Advantages To Indigo Mechanical Thrombectomy For ALI: Device And Technique |
Presenter(s):Claudio J. Schonholz, MD | |
View Abstract | |
3:56 PM - 4:01 PM | DEBATE: Endovascular Treatments Can Treat Almost All Patients With ALI |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
4:02 PM - 4:07 PM | DEBATE: Some Patients With ALI Require Open Surgical Treatment – Either A Bypass Or Open Thrombectomy: Which Patients |
Presenter(s):Joseph L. Mills, MD | |
View Abstract | |
4:08 PM - 4:13 PM | Young Athletes With ALI Should Have An Endovascular First Approach: What Are The Causes Of The ALI |
Presenter(s):Werner Lang, MD | |
View Abstract | |
4:14 PM - 4:19 PM | Cancer And ALI: A Deadly Combination: Why |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
4:20 PM - 4:25 PM | With ALI: When Endo; When Open: What Are The Mid-Term Outcomes |
Presenter(s):Rabih A. Chaer, MD | |
View Abstract | |
NEW DATA REGARDING INTERMITTENT CLAUDICATION AND ITS TREATMENT | |
4:26 PM - 4:31 PM | Current Drug And Non-Interventional Treatments For Intermittent Claudication: Are They Effective |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
4:32 PM - 4:37 PM | For Intermittent Claudication: Immediate Treatment vs. Delayed Treatment vs. No Treatment: Which Is Best |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
4:38 PM - 4:43 PM | Endovascular vs. Exercise Treatment For Intermittent Claudication: Which Is Best |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Abstract | |
4:44 PM - 4:50 PM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Tuesday
SESSION 16:
NEW DEVELOPMENTS IN CHRONIC CLI AND ITS TREATMENTS: THE ANGIOSOME CONCEPT – PROS AND CONS
Moderators:Keith D. Calligaro, MD / Peter F. Lawrence, MD
|
|
x | |
4:50 PM - 4:55 PM | Advantages Of New SVS Lower Extremity Threatened Limb Classification System For Risk Stratification Based On Wound, Ischemia And Foot Infection |
Presenter(s):Joseph L. Mills, MD / Michael S. Conte, MD | |
View Abstract | |
4:56 PM - 5:01 PM | Advantages Of And Indications For The Supera Stent – A Vascular Mimetic Implant With Special Properties: High Radial Strength, Low Chronic Outward Force: Tips And Tricks For Implanting And Using |
Presenter(s):Peter C.J. Goverde, MD | |
View Abstract | |
5:02 PM - 5:07 PM | 3-Year Results With The Supera Interwoven Biomimetic Stent For Femoro-Popliteal Lesions Based On The SUPER B Trial: Why Is This Stent Better Than Others |
Presenter(s):Lawrence A. Garcia, MD / Kenneth Rosenfield, MD / Dierk Scheinert, MD | |
View Abstract | |
5:08 PM - 5:13 PM | How To Measure Success And Failure With Interventional Treatments For Lower Extremity Ischemia: The Difference Between Thrombosis And Occlusion |
Presenter(s):Kenneth Ouriel, MD, MBA | |
View Abstract | |
5:14 PM - 5:19 PM | Lower Extremity Outcomes With Fancy Endovascular Devices: We Should Remain Skeptical And Look At The Data |
Presenter(s):Scott L. Stevens, MD | |
View Abstract | |
5:20 PM - 5:25 PM | Is Directional Atherectomy (Silverhawk Or Turbohawk) With DEB, Better Than DEB Alone: Based On The DEFINITIVE AR RCT: 1-Year Results |
Presenter(s):Gunnar Tepe, MD / Thomas Zeller, MD | |
View Abstract | |
PROS AND CONS OF THE ANGIOSOME CONCEPT | |
5:26 PM - 5:31 PM | DEBATE: The Angiosome Concept Is Necessary And Critical In Diabetic/CLI Patients |
Presenter(s):Richard F. Neville, MD / Anton N. Sidawy, MD, MPH | |
View Abstract | |
5:32 PM - 5:37 PM | DEBATE: The Angiosome Concept Need Not Be Followed In Diabetic Patients With CLI |
Presenter(s):Ignacio Escotto, MD | |
View Abstract | |
5:38 PM - 5:43 PM | Is The Angiosome Concept Real In Determining Limb Salvage: Results Of A 2-Center Study |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Abstract | |
5:44 PM - 5:49 PM | Perfusion Measurements Before And After Tibial PTA Do Not Support The Angiosome Concept |
Presenter(s):Werner Lang, MD | |
View Abstract | |
5:50 PM - 5:55 PM | Assessing Pedal Microcirculation With An Angiographic Wound Blush: Successful Revascularization And Wound Healing Can Occur Beyond Angiosomes And Beyond Pedal Loop Patency: Angiosomes Differ In Various Patients And Are Not The Holy Grail |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
View Abstract | |
5:56 PM - 6:01 PM | There Is Still A Role For Primary Major Amputation For CLI: When Is It Indicated |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Abstract | |
6:02 PM - 6:10 PM | Panel Discussion End of Program B |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Tuesday
SESSION 17:
NATURAL HISTORY, BEST MEDICAL TREATMENT, PREVENTION OF ARTERIOSCLEROSIS AND ITS COMPLICATIONS
Moderators:Bruce A. Perler, MD, MBA / Keith D. Calligaro, MD
|
|
x | |
6:43 AM - 6:48 AM | Can Medical Treatment Slow The Growth Of Small AAAs |
Presenter(s):Frank A. Lederle, MD | |
View Abstract | |
6:49 AM - 6:54 AM | Are There New Medical Techniques For Limiting AAA Growth With Drugs (Telmisartan) And Cell Therapy: How Can They Work |
Presenter(s):Ronald L. Dalman, MD | |
View Abstract | |
6:55 AM - 7:00 AM | Are Statins Decreasing The AAA Rupture Rate: Results From A Danish Nationwide Population-Based Study |
Presenter(s):Jes S. Lindholt, MD | |
View Abstract | |
7:01 AM - 7:06 AM | A New Agent PCSK9 To Lower LDL: How Low Can LDL Go And Is It Safe |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
7:07 AM - 7:12 AM | What Is The Association Between The A/B Index And MI And Stroke Risk: Can It Be Altered; What Is The Association Between Obesity And Vascular Disease In Various Vascular Beds: When Is Being Fat Good |
Presenter(s):Caron B. Rockman, MD | |
View Abstract | |
7:13 AM - 7:18 AM | DEBATE: Statins Have No Role To Play In Primary Prevention And Should Be Avoided In Most Patients |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Abstract | |
7:19 AM - 7:24 AM | DEBATE: Nonsense: Statins Are A Game Changer, A Miracle Drug: They Should Be Used More Widely In Primary Prevention: Optimal Dosage Of Which Drug |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
7:25 AM - 7:30 AM | Statins In Vascular Patients: Are There Non-Responders And Responders – How To Tell And What To Do With Non-Responders: What To Do When Patients Have “Apparent Toxicity”: How To Load Preop And Preprocedurally |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
7:31 AM - 7:36 AM | Optimal Beta Blocker Management In Patients Requiring Vascular Surgery Or Intervention: Current Facts And Optimal Dosing And Drug |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Abstract | |
7:35 AM - 7:45 AM | Panel Discussion |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Tuesday
SESSION 18:
INTERVENTIONAL TREATMENT OF HYPERTENSION AND OTHER MEDICAL DISEASES – RENAL DENERVATION
Moderators:Horst Sievert, MD / Frank J. Veith, MD
|
|
x | |
7:45 AM - 7:50 AM | Role Of Sympathetic Nervous System In Cardiovascular Function And Hypertension: How Does Renal Artery Denervation Produce A Drop In Blood Pressure |
Presenter(s):John W. Osborn, PhD | |
View Abstract | |
7:51 AM - 7:56 AM | Renal Denervation For Drug Resistant Hypertension: Does It Work: Many Trials Say It Does And Yet SIMPLICITY III Says It Does Not: Does The Emperor Have No Clothes |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
7:57 AM - 8:02 AM | Collateral Benefits Of Renal Denervation: Reasons Why SIMPLICITY III Did Not Meet Its Goals: Will Other Techniques To Decrease Sympathetic Tone And Blood Pressure Work: How About Barostimulation (Rheos Device) And A-V Fistula (With ROX Device) |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Abstract | |
8:03 AM - 8:08 AM | Unanswered Questions About Renal Denervation After SIMPLICITY III; What Other Devices Are Being Evaluated And Will They Be Effective (Northwind, Paradise, Ultrasound, Etc.) |
Presenter(s):Horst Sievert, MD | |
View Abstract | |
8:09 AM - 8:14 AM | Where Do We Go After SIMPLICITY III: Is There Evidence That Renal Denervation Will Work: Are There Other Devices And Technology And What Do They Offer |
Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD | |
View Abstract | |
8:15 AM - 8:20 AM | What Is Required To Support A Renal Denervation Practice For Resistant Hypertension And Other Devices: Should Vascular Surgeons Consider Setting Up Such A Program Before Everyone Else Jumps On The Bandwagon |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Abstract | |
8:21 AM - 8:26 AM | Defining Real Resistant Hypertension: Are There Responders And Non-Responders To Renal Denervation And Can RF (Radiofrequency) Treatment Injure The Renal Arteries |
Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP | |
View Abstract | |
8:27 AM - 8:32 AM | Failure Of SIMPLICITY III To Demonstrate Efficacy Of Renal Denervation By Endovascular RF Could Be Due To Nerve Distribution Far From The Renal Artery Lumen: Is Surgical Perirenal Neurolysis Possible And What Is Its Effect |
Presenter(s):Juan C. Parodi, MD | |
View Abstract | |
8:33 AM - 8:39 AM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Tuesday
SESSION 19:
TREATMENT AND AVOIDANCE OF COMPLICATIONS; ENDOLEAKS AND THEIR MANAGEMENT
Moderators:Timur P. Sarac, MD / Frans L. Moll, MD, PhD
|
|
x | |
MANAGEMENT OF COMPLICATIONS | |
8:39 AM - 8:44 AM | Access Site Complications After Non-Cardiac Interventions: Incidence, Predictive Factors, How To Prevent And Outcomes: Value Of Routine Ultrasound Guidance |
Presenter(s):Mark W. Mewissen, MD | |
View Abstract | |
8:45 AM - 8:50 AM | Endovascular Treatment Of Anastomotic Complications After Open Surgery – Including False Aneurysms And Infections |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Abstract | |
8:51 AM - 8:56 AM | Endovascular Treatment Of Tracheo-Innominate Artery Fistulas: How To Do It Successfully |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
8:57 AM - 9:02 AM | Successful Treatment Of An Innominate Artery-Tracheal Fistula With A Modified Endograft |
Presenter(s):Evan C. Lipsitz, MD | |
View Abstract | |
NEW DEVELOPMENTS IN ENDOLEAK MANAGEMENT | |
9:03 AM - 9:08 AM | What Is Currently The Best Information About The Significance Of TypeType 2 Endoleaks: How Are They Best Diagnosed And Treated |
Presenter(s):Kim J. Hodgson, MD | |
View Abstract | |
9:09 AM - 9:14 AM | Conservative (Observational) Management Is Appropriate For Some Primary Type 1A Endoleaks After EVAR And TEVAR Procedures: Which Ones |
Presenter(s):Frans L. Moll, MD, PhD | |
View Abstract | |
9:15 AM - 9:20 AM | What Are The Real Causes Of Endotension: Can A Hypervascular AAA Sac Wall Cause It: How To Diagnose And Treat It |
Presenter(s):Timur P. Sarac, MD | |
View Abstract | |
9:21 AM - 9:26 AM | Type 1 Endoleaks After EVAR: Role Of Onyx In Fixing Them: Tips And Tricks For Its Use And How To Diagnose And Treat Those That Masquerade As Type 2 Endoleaks |
Presenter(s):Robert A. Morgan, MD | |
View Abstract | |
9:27 AM - 9:32 AM | What Is The Real Long-Term Outcome Of Type 2 Endoleaks: Based On A Single Center And The OVER Trial Experience |
Presenter(s):Wei Zhou, MD | |
View Abstract | |
9:33 AM - 9:38 AM | Open Aortic Wrap For Persistent Type 1A Endoleak: Technical Tips And Results |
Presenter(s):Ross Milner, MD | |
View Abstract | |
9:39 AM - 9:44 AM | Accurate Endoleak Detection And Characterization Using Temporal Information From Contrast Enhanced Ultrasound |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Abstract | |
9:45 AM - 9:52 AM | Panel Discussion |
9:52 AM - 10:05 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Tuesday
SESSION 20:
OPTIMAL PERIPROCEDURAL MEDICAL MANAGEMENT IN VASCULAR PATIENTS; SOME INTERESTING HISTORY AND TECHNOLOGY; THE CCSVI FOR MULTIPLE SCLEROSIS (MS) CONTROVERSY
Moderators:Caron B. Rockman, MD / K. Craig Kent, MD
|
|
x | |
PERIPROCEDURAL MANAGEMENT, INTERESTING HISTORY AND TECHNOLOGY | |
10:05 AM - 10:10 AM | Periop And Periprocedural Care Is Key For Vascular Patients: What Is Optimal Antiplatelet Treatment; Statin Dosage, Drugs And Loading; And Beta Blockade |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
10:11 AM - 10:16 AM | Scandalous High Long-Term Mortality After EVAR: It Is Due To MD Ignorance Regarding Statins And Other Medical Treatment: The AAA Is Fixed But MIs Kill: Statins Should Be In The Drinking Water |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
10:17 AM - 10:22 AM | Heparin Management During Open AAA Repair: Is Heparin Necessary For Elective Or Ruptured AAA Repair |
Presenter(s):Arno M. Wiersema, MD | |
View Abstract | |
10:23 AM - 10:28 AM | How Do Statins Influence Long-Term Restenosis And Cardiovascular Events (Stroke And MI) After CEA And After CAS |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
10:29 AM - 10:34 AM | Tales From The Crypt: 5000-Year-Old History Of Atherosclerosis (ASO): What It Tells Us About ASO Today |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
10:35 AM - 10:40 AM | What Andreas Gruntzig Said 30 Years Ago And Its Relevance Today |
Presenter(s):Sigrid Nikol, MD | |
View Abstract | |
10:41 AM - 10:46 AM | Shock Wave Lithoplasty For Treating Severely Calcified Occlusive Lesions: Theory And 30-Day CE Mark Study Results |
Presenter(s):Andrew Holden, MBChB | |
View Abstract | |
10:47 AM - 10:53 AM | Panel Discussion |
THE CCSVI FOR MS CONTROVERSY | |
Moderator(s): Lindsay Machan, MD / Manish Mehta, MD, MPH | |
10:53 AM - 10:58 AM | What Is New In CCSVI For MS: The Positive Evidence Mounts: How To Select Patients: Can Brain Perfusion Be Improved: Is Open Vein Repair Ever Needed |
Presenter(s):Paolo Zamboni, MD | |
View Abstract | |
10:59 AM - 11:04 AM | Vein PTA Helps Selected MS Patients With CCSVI: There Is No Doubt: Stem Cell Therapy May Also Be Beneficial |
Presenter(s):Ivo Petrov, MD, PhD | |
View Abstract | |
11:05 AM - 11:10 AM | The Omohyoid Muscle Can Be A Cause Of Venous Compression Leading To CCSVI: Documentation And Relief By Resection |
Presenter(s):Alberto Lomeo, MD | |
View Abstract | |
11:11 AM - 11:16 AM | Regarding CCSVI And MS, A Skeptic’s View |
Presenter(s):J. David Spence, MD | |
View Abstract | |
11:17 AM - 11:22 AM | Despite Some Questions, There Is Still A Relationship Between CCSVI And MS And An Opportunity For A Positive Effect From Endovascular Treatment |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
11:23 AM - 11:28 AM | The Proper Technique For Venoplasty For CCSVI As A Contributory Cause Of MS: Variability In Technique May Account For Variable Results |
Presenter(s):Donald B. Reid, MD | |
View Abstract | |
11:29 AM - 11:34 AM | Is The CCSVI Concept In MS Valid: Results Of A Meta-analysis |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Abstract | |
11:35 AM - 11:40 AM | The Presence Of Extracranial Venous Narrowing Is The Same In MS Patients And Normal Controls |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
11:41 AM - 11:46 AM | Update On The RCT Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us |
Presenter(s):L. Nelson Hopkins, MD / Robert Zivadinov, MD, PhD, FAAN | |
View Abstract | |
11:47 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Tuesday
SESSION 21:
ISSUES: VARIABLE VASCULAR CARE, GOVERNMENT, FDA, HEALTH CARE REFORM, ETHICS
Moderators:Kenneth Ouriel, MD, MBA / Robert M. Zwolak, MD, PhD
|
|
x | |
1:00 PM - 1:05 PM | How To Increase Public Awareness Of Vascular Disease And The Role Of The Specialty Of Vascular Surgery |
Presenter(s):Robert B. McLafferty, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Disparity Of Vascular Care: Variations Of Index Vascular Procedures In Different Hospitals And Different Locations: Why |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
View Abstract | |
1:12 PM - 1:17 PM | DEBATE: The Changes In The FDA Process For Cardiovascular Device Evaluation And Approval Will Increase US Access To Safe And Effective Devices – And Make It More Like Other Civilized Countries |
Presenter(s):Dorothy B. Abel, BSBME / J. Pablo Morales, MD | |
View Abstract | |
1:18 PM - 1:23 PM | DEBATE: Are The FDA Changes Really Going To Facilitate New Device Evaluation And Availability In The US: The Difficulty Lies With Congress, Not The FDA |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Template For An IDE For Physician Modified Endografts |
Presenter(s):Patrick W. Kelly, MD / Rodney A. White, MD / Dorothy B. Abel, BSBME | |
View Abstract | |
1:30 PM - 1:35 PM | Perverse Incentives To Perform Vascular Procedures, And Pay For Performance Measurements Are Bad: How To Fix The Problems |
Presenter(s):Timothy F. Kresowik, MD | |
View Abstract | |
1:36 PM - 1:41 PM | Panel Discussion |
IMPACT OF OBAMACARE | |
1:42 PM - 1:47 PM | Impact Of Obamacare (ACA) On American Medicine And Our Country: I Thought It Was Bad But I Never Realized How Bad |
Presenter(s):Clifford J. Buckley, MD | |
View Abstract | |
1:48 PM - 1:53 PM | The Train Is Coming At You: What Will The Cost Of Obamacare Be To Vascular Patients And Vascular Surgeons |
Presenter(s):James H. Black III, MD | |
View Abstract | |
1:54 PM - 1:59 PM | Detrimental Effects Of The ACA And ACOs On The Work Environment Of Vascular Surgeons And Their Freedom To Provide The Best Care: Are Doctors-Unions A Legal And Inevitable Solution |
Presenter(s):Timothy M. Sullivan, MD | |
View Abstract | |
2:00 PM - 2:05 PM | The Impact Of The ACA On The Medical Device Industry: What Harm Or Benefit Will It Cause: How Are Things Working Out |
Presenter(s):Kem Hawkins, MBA | |
View Abstract | |
2:06 PM - 2:11 PM | Impact Of Obamacare On Vascular Surgery In 2014 And 2015 |
Presenter(s):Robert M. Zwolak, MD, PhD | |
View Abstract | |
2:12 PM - 2:17 PM | Heart And Vascular Care In The Era Of Health Reform And The ACA: Where Are We Headed And How To Survive |
Presenter(s):John H. Furtek, BS, RT(r) | |
View Abstract | |
2:18 PM - 2:23 PM | The ACA Says It's Willing To Pay For Disease Prevention: Why That Is Not True |
Presenter(s):Clifford M. Sales, MD, MBA / Patricia Davidson, RN | |
View Abstract | |
2:24 PM - 2:30 PM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Tuesday
SESSION 22:
ISSUES RELATED TO INDEPENDENCE FOR VASCULAR SURGERY, RESIDENCY TRAINING, BUSINESS, REIMBURSEMENT, COST/BENEFIT, CONFLICT OF INTEREST (COI)
Moderators:Michel Makaroun, MD / Karl A. Illig, MD
|
|
x | |
INDEPENDENCE AND GOVERNANCE ISSUES FOR VASCULAR SURGERY | |
2:30 PM - 2:35 PM | What Have Been The Beneficial Effects For Patients And Vascular Surgeons Of Vascular Surgery Being Recognized As An Independent Specialty In Switzerland |
Presenter(s):Jürg Schmidli, MD | |
View Abstract | |
2:36 PM - 2:41 PM | How Has Independence Helped Vascular Surgery And Its Patients In Sweden |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Abstract | |
2:42 PM - 2:47 PM | How Has Independence For Its Governing Bodies Helped Vascular Surgery And Its Patients In The UK |
Presenter(s):George Hamilton, MD; FRCS | |
View Abstract | |
2:48 PM - 2:53 PM | How Has The European Vascular Surgery FEBVS Exam Contributed To Vascular Surgery’s Independence In Europe And Improved Patient Care |
Presenter(s):David McLain, FEBVS | |
View Abstract | |
2:54 PM - 2:59 PM | The American Board of Vascular Surgery (ABVS) And The Vascular Surgery Board of The American Board of Surgery (VSB of ABS): Is There More |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
RESIDENCY TRAINING IN VASCULAR SURGERY | |
3:00 PM - 3:05 PM | Update On The Current Status Of 0+5 Vascular Surgery Residency Training |
Presenter(s):Murray L. Shames, MD / Karl A. Illig, MD | |
View Abstract | |
3:06 PM - 3:11 PM | The New Residency Review Committee-Surgery (RRC-S) Vascular Criteria For Training In General And Vascular Surgery: What Will The Case Requirements Be: Is It Good For Vascular Surgery |
Presenter(s):Ronald L. Dalman, MD | |
View Abstract | |
BUSINESS, REIMBURSEMENT AND COST ISSUES | |
3:12 PM - 3:17 PM | What Is Happening With Vascular Procedural Reimbursement In 2015: How Bad Will It Be |
Presenter(s):Sean P. Roddy, MD | |
View Abstract | |
3:18 PM - 3:23 PM | Current Business Considerations In Medicine And Reimbursement: How Can We Deal With Them |
Presenter(s):Glenn Jacobowitz, MD / Mark A. Adelman, MD | |
View Abstract | |
3:24 PM - 3:29 PM | What Vascular Specialists Can Do To Protect Their Assets From Frivolous Law Suits Related To Malpractice And Other Issues |
Presenter(s):Hillel Presser, Esq., MBA | |
View Abstract | |
3:30 PM - 3:35 PM | Heart And Vascular Institutes: Boons Or Busts For Vascular Surgeons: What Are The Dangers |
Presenter(s):Timur P. Sarac, MD | |
View Abstract | |
3:36 PM - 3:41 PM | The FAST Vascular Concept: A Method To Reduce Resource Utilization With EVAR And Open Repair Of AAAs |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
3:42 PM - 3:47 PM | What Are The Drivers Of Cost For Treating SFA Occlusive Disease And AAAs: How Can These Costs Be Decreased |
Presenter(s):Richard J. Powell, MD | |
View Abstract | |
3:48 PM - 3:53 PM | Setting Up A Functional Hybrid Room Involves More Than You Think: What Resources, Personnel And Costs Must Be Involved |
Presenter(s):Rodney A. White, MD | |
View Abstract | |
3:54 PM - 4:04 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 22 | |
SESSION 23 SCHEDULE | |
Tuesday
SESSION 23:
OUTPATIENT TREATMENT, IMPROVING CARE, RCTs, REGISTRIES
Moderators:Mark A. Adelman, MD / Jack L. Cronenwett, MD
|
|
x | |
4:04 PM - 4:09 PM | Advantages Of An Outpatient Endovascular Center To An Academic Vascular Surgery Department |
Presenter(s):Mark A. Adelman, MD | |
View Abstract | |
4:10 PM - 4:15 PM | What Organization(s) Should Set Standards, Accredit And Regulate Outpatient Vascular And Vein Diagnostic And Treatment Centers – Toward What Goals |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
4:16 PM - 4:21 PM | The Importance Of Patient Reported Outcome Measures (PROMs) To Vascular Surgeons |
Presenter(s):Mark J.W. Koelemay, MD, PhD | |
View Abstract | |
4:22 PM - 4:27 PM | Relationship Between Patient Satisfaction And Favorable Surgical Outcomes |
Presenter(s):K. Craig Kent, MD | |
View Abstract | |
4:28 PM - 4:33 PM | Income vs. Outcomes In Vascular Patients: Low Income Is An Independent Risk Factor For Outcomes: Why |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
4:34 PM - 4:39 PM | Access To Health Care Does Not Correlate With Limb Salvage In CLI: Race And Socioeconomic Status Do |
Presenter(s):Michael C. Stoner, MD | |
View Abstract | |
4:40 PM - 4:45 PM | LEAN Principles And Their Application To Vascular Surgery: What Can Toyota Teach Us About Providing Better Vascular Health Care |
Presenter(s):Tej M. Singh, MD, MBA | |
View Abstract | |
EVIDENCE BASED MEDICINE AND RCTS | |
4:46 PM - 4:51 PM | Commentary On Evidence Based Medicine And RCTs In Cardiovascular Surgery And Medicine; Not All RCTs Are Holy |
Presenter(s):Peter Samek, MD, PhD | |
View Abstract | |
4:52 PM - 4:56 PM | RCTs Can Be Underpowered And Futile To Detect Small Effects In Many Instances: Some Examples |
Presenter(s):Charles C. Miller, PhD | |
View Abstract | |
4:58 PM - 5:03 PM | In The Treatment Of Asymptomatic Carotid Stenosis: How Do RCTs Relate To The Real World: What Are The Pitfalls Of RCTs |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Abstract | |
IMPROVED TECHNOLOGY AND VASCULAR SPECIALISTS' PRACTICES | |
5:04 PM - 5:09 PM | How Can Social Media Help Vascular Specialists |
Presenter(s):Ido Weinberg, MD, MSc | |
View Abstract | |
5:10 PM - 5:15 PM | How A Smart Phone Can Change Your Practice For The Better: How A Computer Analysis Of EKGs Can Give You Ejection Fractions And Ventricular Wall Motion And Do Away With Many Cardiac Echo Studies |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
5:16 PM - 5:21 PM | Update On The Status Of The SVS VQI Registry And What It Can Offer Clinically And For Research |
Presenter(s):Larry W. Kraiss, MD / Jack L. Cronenwett, MD | |
View Abstract | |
5:22 PM - 5:27 PM | Are There Disadvantages To VQI Initiatives: Do They Give Rise To Conflicts |
Presenter(s):Kenneth Ouriel, MD, MBA | |
View Abstract | |
5:28 PM - 5:34 PM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Tuesday
SESSION 24:
ISSUES RELATING TO SIMULATION, TRAINING AND EDUCATION
Moderators:Jason T. Lee, MD / Mario Lachat, MD
|
|
x | |
SIMULATION, TRAINING AND EDUCATION | |
5:34 PM - 5:39 PM | Advantages And Limitations Of Patient Specific Simulator Rehearsal Prior To EVAR And Other Procedures |
Presenter(s):Isabelle van Herzeele, MD, PhD | |
View Abstract | |
5:40 PM - 5:45 PM | Simulator Training vs. Clinical Invasive Experience: A RCT Showing Benefits Of Case Specific Simulator Training Even With Experienced Operators |
Presenter(s):Lars B. Lonn, MD, PhD | |
5:46 PM - 5:51 PM | New Pathways And Technology To Improve Efficiency And Resource Use In Vascular Practice |
Presenter(s):Nicholas J.W. Cheshire, MD | |
View Abstract | |
5:52 PM - 5:57 PM | VESAP 3: Where Is It And How Can It Help In MOC And Review For The Vascular Surgery Board Exams |
Presenter(s):John F. Eidt, MD | |
View Abstract | |
5:58 PM - 6:03 PM | Advances In The Education Of Vascular Surgeons In Complex Endovascular Techniques: The Boot Camp Initiative And Regional Video Conferencing |
Presenter(s):Mark G. Davies, MD / Alan B. Lumsden, MD, FACS | |
View Abstract | |
6:04 PM - 6:10 PM | Panel Discussion End of Program C |
END OF SESSION 24 | |
Wednesday, November 19, 2014
Print Entire 2014 Program:
|
|
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
EXCITING NEW TECHNOLOGY AND TECHNIQUES
Moderators:Ronald L. Dalman, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
6:45 AM - 6:50 AM | 4 French Instrumentation For Lower Extremity Disease Treatment As An Outpatient: Experience In >2000 Patients Over 10 Years: How To Do It |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Abstract | |
6:51 AM - 6:56 AM | Role Of Endovascular Adventitial Drug Delivery To Prevent Restenosis: The Bullfrog Catheter System |
Presenter(s):Christopher D. Owens, MD | |
View Abstract | |
6:57 AM - 7:02 AM | A New Endovascular Balloon And A New Temporary Vascular Shunt To Help Treat Vascular Injury, Hemorrhage And Shock |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Abstract | |
7:03 AM - 7:08 AM | TAVR For Pure Aortic Insufficiency: How To Make It Work And What Is Left For Surgical Valve Repair |
Presenter(s):Dietmar H. Koschyk, MD | |
View Abstract | |
7:09 AM - 7:14 AM | Percussion Crossing Device For Calcified CTOs: How Does It Work And Early Results Of Piculet Hammer Device |
Presenter(s):Max Amor, MD | |
7:15 AM - 7:20 AM | Will Drug-Eluting Fully Bioabsorbable Scaffolds Prove Advantageous In The Coronary Arteries |
Presenter(s):Gregg W. Stone, MD | |
View Abstract | |
7:21 AM - 7:26 AM | Some Innovative New Devices From Tim Chuter: The Inch Worm Balloon; The Shapeshifter Catheter And Microstents |
Presenter(s):Timothy A.M. Chuter, DM | |
View Abstract | |
7:27 AM - 7:32 AM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW INFORMATION ABOUT PARALLEL GRAFTS – CHIMNEYS, PERISCOPES AND SANDWICH GRAFTS (CHIMPS) FOR TAAAs
Moderators:Timur P. Sarac, MD / Giovanni Torsello, MD
|
|
x | |
7:32 AM - 7:37 AM | Current Role Of Chimneys And Parallel Grafts For The Treatment Of Complex Aortic Aneurysms |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Abstract | |
7:38 AM - 7:43 AM | Value And Limitations Of Periscope Grafts For Distal TAAAs |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
7:44 AM - 7:49 AM | Brazilian Registry Of Sandwich Technique Repairs For TAAAs: Mid-Term Results And How Do They Compare With Results Of Fenestrated And Branched Repairs |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
7:50 AM - 7:55 AM | The Eye Of The Tiger Technique To Eliminate Gutter Endoleaks With Parallel Grafts |
Presenter(s):David J. Minion, MD | |
View Abstract | |
7:56 AM - 8:01 AM | Late Outcomes Of Thoracic And Visceral Chimney Grafts: Are They Durable |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
8:02 AM - 8:07 AM | DEBATE: Mid-Term Results Of Sandwich Grafts For TAAAs Equal Those Of Branched Endografts |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:08 AM - 8:13 AM | DEBATE: Branched Endografts Are Better Treatment For TAAAs Than Sandwich Grafts Or Other Parallel Grafts |
Presenter(s):Stephan Haulon, MD | |
View Abstract | |
8:14 AM - 8:20 AM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
IN HONOR OF ROY K. GREENBERG, MD: MORE ABOUT TAAAs: OPEN SURGERY, CHIMPS, FENESTRATED AND BRANCHED (F/B) ENDOGRAFTS
Moderators:Frank J. Veith, MD / Piergiorgio Cao, MD, FRCS
|
|
x | |
8:20 AM - 8:25 AM | New Strategies For Open Treatment Of TAAAs Including Sutureless Revascularization Of Renal Arteries Using A Novel Hybrid Graft And Other Techniques |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
8:26 AM - 8:31 AM | Why Do TAAAs In Young Patients With Connective Tissue Disorders Still Require Open Surgery And Are There Differences Between Degenerative And Post Dissection TAAAs That Should Influence Treatment |
Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
8:32 AM - 8:37 AM | DEBATE: Fenestrated And Branched F/B EVAR Is The Best And Most Durable Treatment For Pararenal And Thoracoabdominal Aneurysms |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
8:38 AM - 8:43 AM | DEBATE: Outcomes Of Multiple Chimney And Periscope Grafts For Pararenal And Thoracoabdominal Aneurysms Are Equal To F/B Endografts And More Versatile |
Presenter(s):Mario Lachat, MD | |
View Abstract | |
8:44 AM - 8:49 AM | Mid-Term Outcomes And Technical Tips For Sandwich Endografts To Repair Pararenal And TAAAs: Are They Competitive With F/B Endografts |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
8:50 AM - 8:55 AM | 2-Year Experience With An Off-The-Shelf Multibranched Endograft (T-Branched Graft From Cook) For TAAAs: Advantages And Limitations |
Presenter(s):Martin J. Austermann, MD / Theodosios Bisdas, MD / Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
View Abstract | |
8:56 AM - 9:01 AM | DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Up To The Job |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Abstract | |
9:02 AM - 9:07 AM | DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Not Ready For Wide Usage |
Presenter(s):Colin D. Bicknell, MD, FRCS | |
View Abstract | |
9:08 AM - 9:13 AM | Why I No Longer Use Surgeon-Modified Endografts For Complex AAAs And TAAAs: Advantages Of Industry-Made Endografts |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Abstract | |
9:14 AM - 9:19 AM | Advantages And Limitations Of Internally Branched Endografts For Complex AAAs And TAAAs |
Presenter(s):Marcelo Ferreira, MD | |
View Abstract | |
9:20 AM - 9:28 AM | Panel Discussion |
9:28 AM - 9:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
MORE ABOUT PARALLEL GRAFTS AND F/B GRAFTS FOR AAAs, TAAAs AND COMPLICATIONS OF TBADs
Moderators:Matthew J. Eagleton, MD / James F. McKinsey, MD
|
|
x | |
9:40 AM - 9:45 AM | The Geppetto Technique To Avoid Brachial Access In Complex Endovascular Interventions Requiring Revascularization Of Multiple Branches |
Presenter(s):David J. Minion, MD | |
View Abstract | |
9:46 AM - 9:51 AM | The Nellix Endovascular Device Can Be Used With Multiple Chimneys For Juxta And Suprarenal AAAs And Ruptured AAAs: How To Do It |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
9:52 AM - 9:57 AM | The Nellix Device Can Be Used To Treat Juxtarenal Elective And Ruptured AAAs By Employing Parallel Grafts To The Renal Arteries |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Abstract | |
9:58 AM - 10:03 AM | Gore Hybrid Grafts To Facilitate Visceral Debranching In Complex Hybrid Aortic Aneurysm Repairs |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
10:04 AM - 10:09 AM | The Gutter Killer: A New Catheter For Embolization Of Gutter Endoleaks In Parallel Grafts |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
10:10 AM - 10:15 AM | What Are Frequently Encountered Problems With F/B Endografts: How Can They Be Prevented And Corrected |
Presenter(s):Tara M. Mastracci, MD | |
View Abstract | |
10:16 AM - 10:23 AM | Panel Discussion |
Moderator(s): Jerry Goldstone, MD, FACS, FRCSEd / Mario Lachat, MD | |
10:24 AM - 10:29 AM | Mid-Term Outcomes Of Sandwich Grafts For Revascularizing Hypogastric Arteries With Common Iliac Aneurysms |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
10:30 AM - 10:35 AM | Parallel Grafts (Chimney Or Periscope Grafts) Can Be Used To Revascularize A Critical IMA During EVAR Treatment Of AAAs |
Presenter(s):Ross Milner, MD | |
View Abstract | |
10:36 AM - 10:41 AM | Technique For Placing Guiding Sheaths, Stents And Stent-Grafts Into Visceral Arteries For Parallel Graft Procedures Complicated By Extreme Tortuosity Or Previous Hardware: How An Aortic Balloon Can Help |
Presenter(s):Jeffrey Y. Wang, MD | |
View Abstract | |
10:42 AM - 10:47 AM | Parallel Grafts (CHIMPS) For Revascularizing Vital Aortic Branches At All Levels Are Effective: What Is Their Value And Their Limitation |
Presenter(s):Chang Shu, MD | |
View Abstract | |
10:48 AM - 10:53 AM | Mid And Long-Term Results With Parallel Grafts (CHIMPS) In Complex AAA Repairs: How Good Are They |
Presenter(s):Alan M. Graham, MD | |
View Abstract | |
10:54 AM - 10:59 AM | A Side-By-Side Computational Flow Dynamic Analysis Of The Various Devices Used For Thoracoabdominal Aneurysm |
Presenter(s):Patrick W. Kelly, MD / Tyler Remund, PhD / Stephen Gent, PhD | |
View Abstract | |
11:00 AM - 11:06 AM | Panel Discussion |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
A TRIBUTE TO OUR MILITARY (8 AND 9-MINUTE TALKS)
Moderators:Eric Elster, MD / Todd E. Rasmussen, MD, FACS
|
|
x | |
11:07 AM - 11:16 AM | The Doolittle Raiders And 30 Seconds Over Tokyo: What Did Their Skill And Courage Do For The US In World War II |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
11:17 AM - 11:25 AM | Lessons Learned From Treating Combat Casualties In Our Operations In Iraq And Afghanistan |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Abstract | |
11:26 AM - 11:34 AM | Early Treatment Of Pediatric Vascular Injuries And Mass Casualties: Experience During Humanitarian Surgical Care During US Military Operations In Iraq And Afghanistan |
Presenter(s):Charles J. Fox, MD, FACS | |
View Abstract | |
11:35 AM - 11:43 AM | Recent Progress In Treating Major Vascular War Wounds |
Presenter(s):Eric Elster, MD | |
View Abstract | |
11:44 AM - 11:53 AM | What Biomedical Research That Is Important To All Of Us Is Being Conducted Aboard The International Space Station |
Presenter(s):Lee M. Morin, MD, PhD | |
View Abstract | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW CONCEPTS, DIFFERING VIEWPOINTS, CONTROVERSIES IN VASCULAR DISEASE AND ITS TREATMENT
Moderators:Enrico Ascher, MD / Herbert Dardik, MD
|
|
x | |
1:00 PM - 1:05 PM | Appropriate Genome-Based Antiplatelet Treatment Should Be A Prerequisite For All Interventional Treatments |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Combined Anatomic-Functional Testing With Coronary CT Angiography And Functional Flow Dynamics Is A Game Changer In Evaluating Cardiac Status In Vascular Patients: It Will Replace All Other Diagnostic Tests |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Value Of Biomarkers For Arteriosclerosis In Predicting Cardiac Risk In Vascular Patients |
Presenter(s):Peter Henke, MD | |
View Abstract | |
1:18 PM - 1:23 PM | Monocyte Phenotyping: A Sensitive Biomarker For Predicting Adverse Vascular Events |
Presenter(s):John P. Fletcher, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Update On The RCT Of Venous Balloon Angioplasty Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
1:30 PM - 1:35 PM | What Is SPY Technology And How Can It Help Vascular Specialists And Vascular Patients |
Presenter(s):Wei Zhou, MD | |
View Abstract | |
1:36 PM - 1:41 PM | DEBATE: Off Label Use Of EVAR Devices Leads To Higher Failure Rates |
Presenter(s):Andres Schanzer, MD | |
View Abstract | |
1:42 PM - 1:47 PM | DEBATE: Not So! Off-Label Use Of Newer EVAR Devices Does Not Lead To Higher Failure Rates: Why The Discrepancy |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Abstract | |
1:48 PM - 1:53 PM | Saccular AAAs Behave Differently From Fusiform AAAs Of The Same Diameter: How Should It Influence Our Treatment: Is There Proof |
Presenter(s):Jacques Busquet, MD | |
View Abstract | |
1:54 PM - 1:59 PM | DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Interventionalist’s Point Of View |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
2:00 PM - 2:05 PM | DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Endocompetent Vascular Surgeon’s View |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
2:06 PM - 2:13 PM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
NEW DATA ON MULTILAYER FLOW MODULATING (MLFM) BARE STENTS IN THE TREATMENT OF ANEURYSMS AND DISSECTIONS
Moderators:Frank J. Veith, MD / Edward B. Diethrich, MD
|
|
x | |
2:13 PM - 2:18 PM | Update On The Value Of MLFM Uncovered Stents In The Treatment Of Visceral And Popliteal Aneurysms: Do They Shrink: Have Any Ruptured |
Presenter(s):Claudio Rabbia, MD / Maria Antonella Ruffino, MD | |
View Abstract | |
2:19 PM - 2:24 PM | Endovascular Treatment Of Complex Thoracic Aortic Aneurysm With Multiple Overlapping Bare Stents Can Decrease Spinal Cord Ischemia (SCI) And Result In Decreased Aneurysm Size: When Is This Treatment Appropriate |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Abstract | |
2:25 PM - 2:30 PM | Continuing Impressions Of The Value Of MLFM Bare Stents In Treating Complex Aortic Aneurysms |
Presenter(s):Edward B. Diethrich, MD | |
View Abstract | |
2:31 PM - 2:36 PM | Mechanisms Whereby MLFM Bare Stents Could Prevent Aneurysm Rupture: Do They Work |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Abstract | |
2:37 PM - 2:42 PM | Brazilian Experience With MLFM Stents In The Treatment Of Aortic Aneurysms |
Presenter(s):Daniel Benitti, MD | |
View Abstract | |
2:43 PM - 2:48 PM | 3-Year Results Of The French Registry Of MLFM Stents In The Treatment Of Thoracic And Abdominal Complex Aortic Aneurysms |
Presenter(s):Claude D. Vaislic, MD | |
View Abstract | |
2:49 PM - 2:54 PM | Value And Limitations Of The MLFM Stent In Treating Arch Aneurysms And Dissections |
Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
View Abstract | |
2:55 PM - 3:00 PM | Pros And Cons Of MLFM Stents For The Treatment Of Complex Aortic Aneurysms: A Balanced View And Is Sac Thrombosis Good Or Bad For Aneurysm Wall Integrity And Rupture: What Is The Mechanism |
Presenter(s):Frans L. Moll, MD, PhD | |
View Abstract | |
3:01 PM - 3:06 PM | Advantages And Limitations Of MLFM Stents For Aortic Aneurysm Treatment: When Do They Work And When Don’t They: Results Of The German Registry |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
3:07 PM - 3:12 PM | DEBATE: The MLFM Device Is A Disruptive Technology For Aortic Aneurysm And Dissection Based On The Results Of A Global Registry |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Abstract | |
3:13 PM - 3:18 PM | DEBATE: MLFM Stents Are Not An Effective Treatment For Complex Aortic Aneurysm And Do Not Prevent Sac Growth And Rupture |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
3:19 PM - 3:29 PM | Panel Discussion |
3:30 PM - 3:40 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
NEW DEVELOPMENTS IN ROBOTICS, ENDOVASCULAR GUIDANCE, ENDOSCOPY ACCESS AND OTHER IMPROVED TECHNOLOGY
Moderators:Alan B. Lumsden, MD, FACS / Nicholas J.W. Cheshire, MD
|
|
x | |
IMPROVED ROBOTIC GUIDANCE | |
3:40 PM - 3:45 PM | Experience With Improved Lower Profile Robotic Catheter Techniques: They Facilitate Many Endovascular Procedures Including Complex Embolizations |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
3:46 PM - 3:51 PM | How Can Robotic Navigation Be Combined With 3D Imaging To Make Complex Endovascular Procedures Easier, Quicker And More Predictable With Complex Anatomy: How Does the 6 French System Help |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Abstract | |
3:52 PM - 3:57 PM | How Can Robotic Assistance And Guidance Be Helpful With Complex Anatomy For CAS And F/B EVAR: What About Radiation Exposure |
Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD | |
View Abstract | |
3:58 PM - 4:03 PM | What Does The ROVER Registry Tell Us About Advantages Of Robotic Catheter Based Procedures: Faster, Less Arterial Wall Trauma, Decreased Radiation Exposure, Improved Crossing Of Difficult CTOs |
Presenter(s):Jean Bismuth, MD | |
View Abstract | |
4:04 PM - 4:09 PM | Minimally Invasive Treatment Of Paget-Schroetter Disease With EKOS Ultrasound Assisted Thrombolysis And Robot Assisted First Rib Resection: How The Robot Helps |
Presenter(s):Hans M.E. Coveliers, MD, MBA | |
View Abstract | |
4:10 PM - 4:15 PM | The Truth About Endoscopic Vein Harvest: Is It Worthwhile: Based On VQI Observations |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
4:16 PM - 4:21 PM | Tips And Tricks For Radial Access For Lower Extremity And Other Remote Lesion Treatments: Equipment Required |
Presenter(s):Marcelo Guimaraes, MD | |
View Abstract | |
4:22 PM - 4:27 PM | Update With New Simplified Aortic Occlusion Balloon For Ruptured AAAs And Other Hemorrhagic Emergencies: Advantages, Limitations And Clinical Experience: Scoring System To Help Tell Us Which Ruptured AAAs Should Not Be Treated |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
4:28 PM - 4:33 PM | When Can Improved Duplex Ultrasound Replace Contrast CTA For Post-EVAR Surveillance And Detecting Failing Lower Extremity Stent-Grafts |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
4:34 PM - 4:40 PM | Panel Discussion |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAs
Moderators:Benjamin W. Starnes, MD / Matt M. Thompson, MD
|
|
x | |
4:40 PM - 4:45 PM | 100% Of Ruptured AAAs (RAAAs) Can Be Treated Endovascularly If Chimney, Periscopes And Other Adjuncts Are Used: Turn-Down Rates Are Low And Early Mortality Is Low |
Presenter(s):Dieter O. Mayer, MD / Thomas Larzon, MD, PhD / Mario Lachat, MD | |
View Abstract | |
THE RECENT RCTS OF RAAAS: FACTS AND FLAWS – A MEGA DEBATE | |
4:46 PM - 4:51 PM | Results From The French ECAR RCT Results Comparing EVAR With Open Repair For RAAAs |
Presenter(s):Pascal Desgranges, MD, PhD | |
View Abstract | |
4:52 PM - 4:57 PM | Results From The Dutch AJAX RCT Comparing EVAR With Open Repair For RAAAs |
Presenter(s):Willem Wisselink, MD | |
View Abstract | |
4:58 PM - 5:03 PM | Early Results From The UK IMPROVE Trial Comparing An EVAR Strategy With Open Repair For RAAAs: It Shows That The EVAR Strategy Has No Lower Early Mortality Than Open Repair |
Presenter(s):Janet T. Powell, MD, PhD | |
View Abstract | |
WHY THE RCTS ARE MISLEADING | |
5:04 PM - 5:09 PM | IMPROVE Trial Is A Laudable Study, But Its Conclusion Is Flawed: EVAR Is Better Than Open Repair For RAAAs |
Presenter(s):Frank J. Veith, MD | |
View Abstract | |
5:10 PM - 5:15 PM | The 3 Recent RAAA RCTs Are Flawed And Misleading: What Are These Flaws |
Presenter(s):Nicholas J.W. Cheshire, MD | |
View Abstract | |
5:16 PM - 5:21 PM | EVAR Is Clearly Better Than Open Repair And We Do Not Need An RCT To Prove It |
Presenter(s):Mario Lachat, MD | |
View Abstract | |
5:22 PM - 5:27 PM | The Recent RCTs Comparing EVAR To Open Repair For RAAAs Are Misleading And We Do Not Need More RCTs To Prove EVAR Is Better |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
OTHER OPINIONS AND DATA | |
5:28 PM - 5:33 PM | EVAR Clearly Should Be The First Treatment Choice For RAAAs: We Don’t Need More Trials To Prove It |
Presenter(s):Edward B. Diethrich, MD / Julio A. Rodriguez-Lopez, MD | |
View Abstract | |
5:34 PM - 5:39 PM | Does A Fixed Protocol For Treating Ruptured AAAs By EVAR Improve Outcomes: Based On A Prospective Multicenter Registry Results |
Presenter(s):Kim J. Hodgson, MD | |
View Abstract | |
5:40 PM - 5:45 PM | Meta-Analysis Of Recent RCTs Comparing EVAR With Open Repair For Ruptured AAAs: It Is Level 1A Evidence, But It May Be Misleading |
Presenter(s):Ron Balm, MD, PhD | |
View Abstract | |
5:46 PM - 5:51 PM | Long-Term Survival Of Ruptured AAAs Is Better After EVAR Than After Open Repair: The Early Survival Benefit Of EVAR Persists Beyond 5 Years |
Presenter(s):Dieter O. Mayer, MD / Mario Lachat, MD / Frank J. Veith, MD / Zoran Rancic, MD, PhD | |
View Abstract | |
5:52 PM - 5:57 PM | Why Are Treatment Outcomes For RAAAs Better In The US Than In The UK: Hints For Improving Results And Support For The Position That EVAR Is Better Than Open Repair |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
5:58 PM - 6:08 PM | Panel Discussion End of Program D |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
NEW FINDINGS AND INFORMATION ON THE TREATMENT OF POPLITEAL ANEURYSM
Moderators:Enrico Ascher, MD / Barry T. Katzen, MD
|
|
x | |
6:45 AM - 6:50 AM | What Are The Real Results Of Endovascular Popliteal Aneurysm Repair: When Is It Indicated And When Contraindicated |
Presenter(s):Sonia Ronchey, MD, PhD | |
View Abstract | |
6:51 AM - 6:56 AM | Anatomic Features That Predict Complications Of Endovascular Aneurysm Repair And When It Is Contraindicated |
Presenter(s):Thomas L. Forbes, MD | |
View Abstract | |
6:57 AM - 7:02 AM | The Modern Treatment Of Popliteal Aneurysms Varies Widely: Why Is This So: Value Of Thrombolysis: What Is The Best Surgical Approach |
Presenter(s):Martin Bjorck, MD, PhD | |
View Abstract | |
7:03 AM - 7:08 AM | Long-Term Outcomes And Sac Shrinkage After Endovascular Popliteal Aneurysm Repair: What Are The Implications |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
View Abstract | |
7:09 AM - 7:14 AM | Avoidance And Treatment Of Complications After Endografting For Popliteal Aneurysm |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
7:15 AM - 7:20 AM | Popliteal Aneurysm Treatment: When Endo, When Open: Technical Tips: Primary And Secondary Patency Results; Reintervention Is Not Always Required For Graft Failure |
Presenter(s):Neal S. Cayne, MD | |
View Abstract | |
THREE-PART DEBATE | |
7:21 AM - 7:26 AM | DEBATE: Endovascular Treatment Is Inferior For Popliteal Aneurysms Needing Treatment |
Presenter(s):Werner Lang, MD | |
View Abstract | |
7:27 AM - 7:32 AM | DEBATE: Some Popliteal Aneurysms Should Be Treated Endo; Some Open |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Abstract | |
7:33 AM - 7:38 AM | DEBATE: Almost All Popliteal Aneurysms Can Be Treated Endovascularly: Technical Considerations And Outcomes: What Was The Outcome Of The Former Vice President's Large Popliteal Aneurysm Repairs In 2004 |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
7:39 AM - 7:44 AM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
NEW DEVELOPMENTS IN THE TREATMENT OF INFECTED AORTIC GRAFTS AND ENDOGRAFTS; VALUE OF EVAR FOR MYCOTIC ANEURYSMS
Moderators:Dennis F. Bandyk, MD / Keith D. Calligaro, MD
|
|
x | |
7:45 AM - 7:50 AM | Update On Silver/Triclosan Synergy Prosthesis For In Situ Replacement Of Infected Aortic Prostheses: They Really Work Based On The SATIGI Registry And Other Data |
Presenter(s):Max Zegelman, MD | |
View Abstract | |
7:51 AM - 7:56 AM | Endovascular Treatment Of Mycotic AAAs: When Does It Work And For How Long: Based On 132 Cases With Long Follow-up |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Abstract | |
7:57 AM - 8:02 AM | When Are Endografts The Best Treatment For Aortic Infection And When Are They Not |
Presenter(s):Francesco Setacci, MD | |
View Abstract | |
8:03 AM - 8:08 AM | Conservative Treatment Of Endograft Infection After EVAR With CT Guided Drainage And Graft Preservation: When Can It Work And When Can It Not |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
8:09 AM - 8:14 AM | Treatment Of Para And Suprarenal Aortic Graft Infection: Do Endografts Play A Role |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
8:15 AM - 8:20 AM | Technical Tips For Removing An Infected Endograft: It Is Not Simple |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
8:21 AM - 8:26 AM | EVAR Can Be Effective Treatment For Infected Aneurysms In All Parts Of The Aorta With Both Simple And Complex Anatomies: Chimney Grafts May Be Needed: How To Do It Successfully And Get Long-Term Survival |
Presenter(s):Boonprasit Kritpracha, MD | |
View Abstract | |
8:27 AM - 8:32 AM | DEBATE: Management Of Mycotic Aneurysms And Infected Stent-Grafts After EVAR And TEVAR: Infected Endografts Must Come Out |
Presenter(s):Piotr M. Kasprzak, MD | |
View Abstract | |
8:33 AM - 8:38 AM | DEBATE: Not So: A New Treatment Paradigm For Treating Infected Endografts After EVAR And Mycotic Aneuryms May Allow Endograft Preservation |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
8:39 AM - 8:44 AM | How To Treat Mycotic Thoracic Aneurysms |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
8:45 AM - 8:52 AM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
EXCITING NEW DEVELOPMENTS IN THE MEDICAL TREATMENT OF VASCULAR DISEASE
Moderators:Russell H. Samson, MD, RVT, FACS / Frans L. Moll, MD, PhD
|
|
x | |
8:52 AM - 8:57 AM | Do Atherosclerotic Plaques Regress: How And Why: What Are The Implications For Treatment |
Presenter(s):Ralph G. DePalma, MD | |
View Abstract | |
8:58 AM - 9:03 AM | How Can The Medical Treatment Of Arteriosclerosis Be Improved: Should More Patients Receive Statins: Do HDL Levels Matter: Does Elevating A Low HDL Level Help In Any Way: What Is On The Horizon For Improving Drug Or Medical Treatment For Arteriosclerosis |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
9:04 AM - 9:09 AM | What Do The New AHA Cholesterol Guidelines And The New Information About Beta Blockers Mean To Vascular Surgeons |
Presenter(s):Peter Henke, MD | |
View Abstract | |
9:10 AM - 9:15 AM | Medical Therapy In Peripheral Artery Disease: Anything New On The Horizon: What Is The Value Of Chronic PA Pressure Monitoring With The CardioMEMS Implantable Pressure Sensor |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
9:16 AM - 9:21 AM | Why All Vascular Patients Should Have Perioperative Or Periprocedural Troponins: How Do They Help In Patient Treatment |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
9:22 AM - 9:27 AM | How Long Should Dual Antiplatelet Treatment Be Continued After Patients Receive A Coronary Stent (BMS Or DES): When Is It Safe To Stop Clopidogrel And Perform Non-Cardiac Surgery – An AAA, A Leg Bypass Or CEA: What To Do If Surgery Cannot Be Delayed: Based On New Findings From The OPTIMIZE Trial |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
9:28 AM - 9:33 AM | Vitamin D Supplementation And Tight Blood Glucose Control In Diabetics Do Not Have A Major Impact On The Progression Of Vascular Disease: Other Factors Are More Important |
Presenter(s):Erich Minar, MD | |
View Abstract | |
9:34 AM - 9:39 AM | How To Prevent And Treat Postoperative Delirium After Vascular Surgery |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Abstract | |
9:40 AM - 9:47 AM | Panel Discussion |
9:48 AM - 10:00 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
NEW DEVELOPMENTS IN ENDOVASCULAR TECHNOLOGY, TECHNIQUES AND THE MEDICAL TREATMENT OF VASCULAR DISEASE
Moderators:Alan B. Lumsden, MD, FACS / Richard J. Powell, MD
|
|
x | |
10:00 AM - 10:05 AM | Imaging With Lower Radiation Exposure Using A Novel Fixed C-Arm System During Endovascular Procedures: The Philips Allura Clarity Hybrid OR |
Presenter(s):Olivier H.J. Koning, MD | |
View Abstract | |
10:06 AM - 10:11 AM | Unusual Uses Of Re-entry Devices: They Are An Essential Tool |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Abstract | |
10:12 AM - 10:17 AM | DEBATE: Be Skeptical About The Need For Atherectomy Systems: The New Ones May Be No Better Than The Old Ones |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Abstract | |
10:18 AM - 10:23 AM | DEBATE: Not So Fast, Leaving Nothing Behind Trumps Any Permanent Device In The SFA: Current Evidence And Clinical Utility Of Atherectomy Systems |
Presenter(s):Lawrence A. Garcia, MD | |
View Abstract | |
10:24 AM - 10:29 AM | Endovenous Or Perivascular Routes For Internal Prosthetic Bypasses In The SFA And Popliteal Arteries: How Can IVUS And Robotics Help: A New Treatment Concept |
Presenter(s):Alan B. Lumsden, MD, FACS / Tony S. Das, MD | |
View Abstract | |
10:30 AM - 10:35 AM | Where Do We Stand With Cell Therapy For Ischemia In The Legs; In The Heart |
Presenter(s):Alan Dardik, MD, PhD | |
View Abstract | |
10:36 AM - 10:41 AM | Tips And Tricks For Endovascular Interventions In Pediatric Patients |
Presenter(s):Furuzan Numan, MD | |
View Abstract | |
10:42 AM - 10:47 AM | Manifestations And Treatment Of Spontaneous Renal Artery Dissections |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
10:48 AM - 10:57 AM | Panel Discussion |
NEW DEVELOPMENTS IN MEDICAL TREATMENT AND RISK MODIFICATION | |
Moderator(s): Ron Waksman, MD / Jack L. Cronenwett, MD | |
10:57 AM - 11:02 AM | How To Improve 5-Year Survival After Vascular Surgery By 25% Or More: Give Proper Doses Of Statins And Antiplatelet Agents |
Presenter(s):Jack L. Cronenwett, MD | |
View Abstract | |
11:03 AM - 11:08 AM | Preoperative Statin Administration Decreases The Incidence Of Contrast Induced Kidney Injury |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
View Abstract | |
11:09 AM - 11:14 AM | A Frailty Index And What It Can Mean For Vascular Specialists Or Surgeons Interested In Vascular Disease Patients: Is It Better Than The Eyeball Test |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
11:15 AM - 11:20 AM | Differential Effect Of Arteriosclerotic Risk Factors In Men And Women: Why Does It Matter |
Presenter(s):Caron B. Rockman, MD | |
View Abstract | |
11:21 AM - 11:26 AM | Cilostazol Is Associated With Improved Outcomes After Vascular Interventions: Should Vascular Specialists Use It And How |
Presenter(s):Richard J. Powell, MD | |
View Abstract | |
11:27 AM - 11:32 AM | What Test Should We Use To Evaluate Antiplatelet Drugs In Vascular Patients – Especially Those Undergoing A Procedure |
Presenter(s):Frans L. Moll, MD, PhD | |
View Abstract | |
11:33 AM - 11:38 AM | Importance Of Smoking Cessation Prior To Lower Extremity Bypasses: It Decreases The Failure Rate |
Presenter(s):Christopher J. Abularrage, MD / James H. Black III, MD | |
View Abstract | |
11:39 AM - 11:44 AM | How To Prevent Cardiovascular Death In Diabetic Patients With CLI And Arteriosclerosis: It Is As Important As Saving The Limb |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:45 AM - 11:50 AM | Characteristics Of Patients Who Currently Develop Acute Limb Ischemia And What Is Their Long-Term Prognosis |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Abstract | |
11:51 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
ADVANCES IN IMAGING
Moderators:Barry T. Katzen, MD / Henrik Sillesen, MD, DMSc
|
|
x | |
1:00 PM - 1:05 PM | Selective Intra-Arterial CTA For Lower Extremity Occlusive Disease In Patients With Renal Insufficiency: It Decreases Contrast Dose And Is Safe |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | Advantages Of An Integrated 3-D Imaging Solution For Planning, Fusion And Assessment Of Complex Aortic Procedures |
Presenter(s):Stephan Haulon, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Aortic Procedures Of The Future Will Mandate 3D Imaging For Planning And Preparation, And For Performing |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
1:18 PM - 1:23 PM | The Use Of A Computerized Patient Specific Model And MRA Data To Predict Pressure Drops Across Equivocal Stenoses |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
1:24 PM - 1:29 PM | Precannulation Of Visceral And Renal Arteries Using Fusion Software On The Artis Zeego System During F/B EVAR Is Fast, Simple, And Valuable: How To Do It |
Presenter(s):Neal S. Cayne, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Value And Implementation Of 3D Ultrasound Scans For All AAA Evaluations: What Can And Should Be Measured: What Equipment Is Needed |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
1:36 PM - 1:41 PM | 3D Ultrasound Is The CT Scan Of The Future And Eliminates Radiation Exposure |
Presenter(s):Brajesh K. Lal, MD | |
View Abstract | |
1:42 PM - 1:47 PM | What New Information Can Be Learned From 3D Ultrasound Of AAAs: How Can It Provide Finite Element Analysis |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Abstract | |
1:48 PM - 1:53 PM | Panel Discussion |
1:54 PM - 1:59 PM | What Important Information Can Be Obtained From Transcranial Doppler (TCD) If You Know How To Get It: Wider Use Of TCD Is Justified |
Presenter(s):Zsolt Garami, MD | |
2:00 PM - 2:05 PM | 3D Holography To Guide Endovascular Interventions: How Does It Work: Can CTA Be Avoided And MRI And 3D Ultrasound Take Its Place |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Abstract | |
2:06 PM - 2:11 PM | A Complete Mobile Hybrid Room With Ziehm Vision RFD Hybrid C-Arm And Stille Imagiq2 Floating Table For Complex Endovascular Procedures: Advantages And Limitations Compared To A Fixed Hybrid Room |
Presenter(s):Peter C.J. Goverde, MD | |
View Abstract | |
2:12 PM - 2:17 PM | DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: YES, In Most Cases |
Presenter(s):Michel Makaroun, MD | |
View Abstract | |
2:18 PM - 2:23 PM | DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: NO, In Most Cases |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Abstract | |
2:24 PM - 2:29 PM | Panel Discussion |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
ADVANCES AND UPDATES IN THE TREATMENT OF THORACIC OUTLET SYNDROMES, AN HISTORICAL VIGNETTE AND NEW DEVICES AND CONCEPTS
Moderators:R. Clement Darling III, MD / Julie Ann Freischlag, MD
|
|
x | |
2:29 PM - 2:34 PM | New Thoracic Outlet Syndrome (TOS) SVS Reporting Standards: What Is New |
Presenter(s):Karl A. Illig, MD | |
View Abstract | |
2:35 PM - 2:40 PM | Treatment Of TOS And Popliteal Entrapment In High Performance Athletes: What Is The Role Of Exercise, Physiotherapy And Surgery |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
2:41 PM - 2:46 PM | Some Patients With Presumed Neurogenic TOS Really Have Jugular And Subclavian Venous Stenosis: Balloon Angioplasty Can Provide Symptom Relief |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Abstract | |
2:47 PM - 2:52 PM | Current Optimal Treatment For Arterial Compression At The Thoracic Outlet |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:53 PM - 2:58 PM | Historical Vignette: The First Endoleak And The First AAA Repair By Norman Freeman – Before Charles Dubost’s |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
2:59 PM - 3:04 PM | Infrared IVUS: A New Technique For Detecting Vulnerable Plaque |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
3:05 PM - 3:10 PM | Early Experience With A New Improved Digital Mobile C-Arm: The Cios Alpha System From Siemens: Advantages And Limitations |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
3:11 PM - 3:16 PM | Panel Discussion |
3:17 PM - 3:30 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
NEW CONCEPTS, TECHNIQUES, UPDATES
Moderators:Christopher K. Zarins, MD / Amman Bolia, MD
|
|
x | |
3:30 PM - 3:35 PM | Value And Limitations Of Optical Coherence Tomography For Use In Lower Extremity Vascular Assessment And Treatments |
Presenter(s):Vikram S. Kashyap, MD | |
View Abstract | |
3:36 PM - 3:41 PM | Sensible And Extreme Approach To Limb Preservation (The SEAL Approach): Who And What Is Involved And What Are The Benefits: Should There Be SEAL Centers |
Presenter(s):Niten Singh, MD | |
View Abstract | |
3:42 PM - 3:47 PM | The Chocolate Balloon: A New Better Less Traumatic Drug Coated Balloon For Dilating Arterial Lesions With Less Dissection: Mode Of Action, Advantages And Clinical Experience |
Presenter(s):Jihad A. Mustapha, MD | |
View Abstract | |
3:48 PM - 3:53 PM | Does Prostate Endovascular Embolization Work: For What Conditions: Advantages And Limitations |
Presenter(s):Jörn O. Balzer, MD, PhD | |
View Abstract | |
3:54 PM - 3:59 PM | Pathophysiology Of Hand And Finger Ischemia In Hemodialysis Patients And How It Can Best Be Treated |
Presenter(s):Roberto Ferraresi, MD | |
View Abstract | |
4:00 PM - 4:05 PM | Update On Tissue Engineered Arterial Prostheses: Progress And Remaining Challenges |
Presenter(s):Elliot L. Chaikof, MD, PhD | |
View Abstract | |
4:06 PM - 4:11 PM | For Recanalizing Lower Extremity CTOs Above And Below The Knee, Simpler And Cheaper Devices Are Better: It Does Not Matter Whether The Route Is Intraluminal Or Subintimal |
Presenter(s):Amman Bolia, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Will DEBs Become The Gold Standard For Dilating Bare Metal Stents (BMSs) In The SFA: Will This Strategy Be Cost Effective |
Presenter(s):Stefan Mueller-Hülsbeck, MD | |
View Abstract | |
4:18 PM - 4:23 PM | Current Optimal Techniques For Minimizing Contrast Induced Nephropathy After Angiographic Procedures |
Presenter(s):Jonathan R. Boyle, MD, FRCS | |
View Abstract | |
4:24 PM - 4:29 PM | Quantitative Determination Of Respiratory Movement Of Aorta And Side Branches In Image Fusion Guidance: How Can It Improve Branch Origin Location Accuracy And Minimize Errors |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
4:30 PM - 4:35 PM | Underutilization Of Statins In CLI Patients: Statins Keep The Patient Alive Longer And Decrease Amputation Rates After Open And Endo Revascularization Procedures |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Abstract | |
4:36 PM - 4:41 PM | Diagnosis And Management Of Vascular Complications In Athletes |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Abstract | |
4:42 PM - 4:50 PM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
NEW CONCEPTS IN ENDOVASCULAR TREATMENT AND MANAGEMENT OF COMPLICATONS; MORE INFORMATION ABOUT RENAL DENERVATION AND OTHER WAYS TO TREAT RESISTANT HYPERTENSION; AMPUTATIONS
Moderators:Mark H. Wholey, MD / Krishna J. Rocha-Singh, MD
|
|
x | |
4:50 PM - 4:55 PM | We Don’t Need More Endovascular Treatments: Just Better Use Of The Ones We Have |
Presenter(s):Manj S. Gohel, MD, FRCS | |
View Abstract | |
4:56 PM - 5:01 PM | AAA Wall Microvasculature: How Does It Relate To Thrombus Formation And AAA Growth |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
5:02 PM - 5:07 PM | Hypercoagulable Testing Is Far Overused In Vascular Patients Whose Revascularizations Fail Repeatedly: What Should We Do To Evaluate Such Patients And When Is Such Testing Helpful |
Presenter(s):Elna M. Masuda, MD | |
View Abstract | |
5:08 PM - 5:13 PM | A New Simple Technique For Perfusing The Lower Limb To Prevent Ischemia During Prolonged Sheath Obstruction Of The Femoral Arteries During F/B EVAR |
Presenter(s):Johannes Kalder, MD | |
View Abstract | |
5:14 PM - 5:19 PM | Total Percutaneous Axillary Artery Access In Complex Endovascular Aortic Repair: Technical Tips And Precautions |
Presenter(s):Barend M.E. Mees, MD, PhD | |
View Abstract | |
MORE TOPICS ON RESISTANT HYPERTENSION | |
5:20 PM - 5:25 PM | With Respect To Renal Denervation, Where Do The Renal Sympathetic Nerves Lie With Respect To The Renal Artery: Can Radiofrequency (RF) And Ultrasound Inactivate Them And What Effect Do These Modalities Have On The Renal Artery |
Presenter(s):Renu Virmani, MD | |
View Abstract | |
5:26 PM - 5:31 PM | Is An Arteriovenous Anastomosis The Way To Cure Resistant Hypertension: How Does It Work And Results Of The ROX Arteriovenous Coupler Trial |
Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP | |
View Abstract | |
5:32 PM - 5:37 PM | Percutaneous Creation Of An A-V Fistula With The ROX Device: Can It Treat Resistant Hypertension And Other Conditions |
Presenter(s):David H. Deaton, MD | |
View Abstract | |
5:38 PM - 5:43 PM | Is There A Role For Chemoablation For Renal Denervation |
Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA | |
View Abstract | |
5:44 PM - 5:49 PM | Why The Negative Results Of SIMPLICITY III Are No Surprise: It Does Not Mean The Field Is Dead: Predictions For The Future |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
5:50 PM - 6:00 PM | Panel Discussion End of Program E |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES – DRUGS, DEVICES AND SURGERY – PART 1
Moderators:Michael R. Jaff, DO
|
|
x | |
7:00 AM - 7:05 AM | Introduction To The Symposium |
Presenter(s):Frank J. Veith, MD | |
7:05 AM - 7:15 AM | Welcome And Introduction |
Presenter(s):Michael R. Jaff, DO | |
7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers |
Presenter(s):Ido Weinberg, MD, MSc | |
View Abstract | |
7:25 AM - 7:35 AM | The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary |
Presenter(s):David M. Dudzinski, MD | |
View Abstract | |
7:35 AM - 7:50 AM | What Is State-of-the-Art Medical Therapy For PE |
Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
View Abstract | |
7:50 AM - 8:00 AM | Intravenous Thrombolytic Therapy For PE: Do We Know More In 2014 |
Presenter(s):Christopher Kabrhel, MD, MPH | |
View Abstract | |
8:00 AM - 8:10 AM | Catheter-Directed Thrombolysis For PE: A Better Lytic Alternative? |
Presenter(s):Jason T. Salsamendi, MD | |
View Abstract | |
8:10 AM - 8:25 AM | Percutaneous Pharmacomechanical Intervention For PE: What Does The Data Say, And Where Must We Go From Here |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
8:25 AM - 8:35 AM | Lysis For PE: What About The Nuts And Bolts – Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done |
Presenter(s):Raghu Kolluri, MD | |
View Abstract | |
8:35 AM - 8:45 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It? |
Presenter(s):Jeffrey Y. Wang, MD | |
View Abstract | |
Moderator(s): Michael R. Jaff, DO | |
8:45 AM - 9:15 AM | Case Presentations / Panel Discussion / Questions And Answers |
Panelist(s): Christopher Kabrhel, MD, MPH / Iris Baumgartner, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jason T. Salsamendi, MD / Jeffrey Y. Wang, MD | |
View Abstract | |
9:15 AM - 9:45 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES – DRUGS, DEVICES AND SURGERY – PART 2
Moderators:Michael R. Jaff, DO
|
|
x | |
9:45 AM - 10:00 AM | The SEATTLE Trial: A Breakthrough For PE Treatment? |
Presenter(s):Gregory Piazza, MD, MS | |
View Abstract | |
10:00 AM - 10:10 AM | What Did The SEATTLE Trial Fail To Answer? |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
10:10 AM - 10:20 AM | Vortex Strategy For Massive PE |
Presenter(s):Christopher J. Kwolek, MD | |
View Abstract | |
10:20 AM - 10:35 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why? |
Presenter(s):Thoralf Sundt, MD | |
View Abstract | |
10:35 AM - 10:45 AM | What Is The Modern Algorithm For Management Of Massive And Submassive PE |
Presenter(s):Tod C. Engelhardt, MD | |
View Abstract | |
10:45 AM - 11:00 AM | Iliac Venous Stenosis: When To Look And When To Stent |
Presenter(s):John A. Kaufman, MD | |
View Abstract | |
11:00 AM - 11:15 AM | The Team Approach To PE Management: The Emergence Of National PERT Centers |
Presenter(s):Kenneth Rosenfield, MD | |
View Abstract | |
11:15 AM - 11:45 AM | Challenging Cases And “PERT” Decisions |
Panelist(s): Tod C. Engelhardt, MD / John A. Kaufman, MD / Christopher J. Kwolek, MD / Gregory Piazza, MD, MS / Kenneth Rosenfield, MD / Thoralf Sundt, MD | |
View Abstract | |
11:45 AM - 12:00 PM | Questions And Answers |
12:00 PM - 1:00 PM | Lunch Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
OCCLUSION OF THE DEEP VEINS OF THE LEG: CAUSES, RISKS TO THE PATIENT, AND OPPORTUNITIES FOR TREATMENT
Moderators:Kenneth Ouriel, MD, MBA / Alan Dardik, MD, PhD
|
|
x | |
1:00 PM - 1:05 PM | Large Vein Occlusive Disease: The Magnitude Of The Problem In The Population |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Physiology Of Large Vein Occlusion: A Hemodynamic Explanation For The Post-Thrombotic Syndrome |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Predictors Of Post-Thrombotic Syndrome After DVT: Which Patients Will Have Problems |
Presenter(s):Susan R. Kahn, MD, MSc | |
View Abstract | |
1:18 PM - 1:23 PM | DVT In The Leg: New Modalities For Managing A Lifelong Problem For The Patient |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Venous Thrombosis: Can We Determine The Age Of The Thrombus And Does It Matter Anyway |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Chronic Femoral DVT Should Not Be Treated With Aggressive Interventions |
Presenter(s):John Blebea, MD, MBA | |
View Abstract | |
1:36 PM - 1:41 PM | DEBATE: Endovascular Interventions Work For Chronic Femoral Occlusions And Should Be Considered In Most Patients |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
1:42 PM - 1:47 PM | 2014: The Forefront Of New Anticoagulants For DVT |
Presenter(s):Jeffrey W. Olin, DO | |
View Abstract | |
1:48 PM - 1:53 PM | Femoral Vein Excision For Vascular Reconstruction: Techniques To Minimize Post-Thrombotic Symptoms |
Presenter(s):Timur P. Sarac, MD | |
View Abstract | |
1:54 PM - 1:59 PM | Panel Discussion |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
ACUTE LOWER EXTREMITY DVT: AVOIDING EARLY AND LATE ADVERSE OUTCOMES
Moderators:Samuel R. Money, MD, MBA / Jean-Paul de Vries, MD, PhD
|
|
x | |
2:00 PM - 2:05 PM | Risk Of Pulmonary Embolism With DVT: Which Clots, Who And When |
Presenter(s):Michael R. Jaff, DO | |
View Abstract | |
2:06 PM - 2:11 PM | The Bull’s Eye Sign: A New Iliac Vein Marker To Avert The Need For IVUS |
Presenter(s):Enrico Ascher, MD | |
View Abstract | |
2:12 PM - 2:17 PM | Thrombolysis For Acute Deep Venous Thrombosis: Is It Safe, Is It Effective: Lessons From The 2014 Cochrane Update |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
2:18 PM - 2:23 PM | The EKOS System For Treatment Of Acute DVT: Theory And Practice |
Presenter(s):Anil P. Hingorani, MD | |
View Abstract | |
2:24 PM - 2:29 PM | Newer Methods For Treating Acute DVT: Thrombolysis, Ultrasound, And Mechanical Thrombectomy Devices |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
View Abstract | |
2:30 PM - 2:35 PM | Update On The ATTRACT Study Of rt-PA For Acute DVT |
Presenter(s):Suresh Vedantham, MD | |
View Abstract | |
2:36 PM - 2:41 PM | DEBATE: Early Intervention Is Best For Acute Iliofemoral DVT And Prevents Post-Thrombotic Complications |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
2:42 PM - 2:47 PM | DEBATE: Antithrombotic Therapy Alone For Acute DVT: Lack Of High Level Evidence For Endovenous Interventions |
Presenter(s):Jeffrey W. Olin, DO | |
View Abstract | |
2:48 PM - 2:56 PM | Panel Discussion |
2:56 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
NOVEL BALLOONS, STENTS, THROMBOLYSIS, ULTRASOUND, AND MECHANICAL THROMBECTOMY DEVICES FOR LARGE VEIN OCCLUSIONS
Moderators:Timur P. Sarac, MD / Cees H.A. Wittens, MD, PhD
|
|
x | |
3:16 PM - 3:21 PM | Dedicated Stents For The Venous System: Requirements And Status Of Devices In Clinical Development |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
3:22 PM - 3:27 PM | DEBATE: Currently Marketed Stents Are Suboptimal In The Venous System: The Need For New Devices Engineered For The Veins |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
3:28 PM - 3:33 PM | DEBATE: New Devices Are Encouraged But Stent Malfunctions Are Rare In The Venous System, Even With Older Devices |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
3:34 PM - 3:39 PM | Should Drug-Eluting Balloons Be Considered For Large Vein Stenoses: Theory And Predictions For The Future |
Presenter(s):William A. Gray, MD | |
View Abstract | |
3:40 PM - 3:45 PM | Iliofemoral DVT In Pregnancy: Thrombus Removal Is Safe And Avoids Long-Term Morbidity |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
3:46 PM - 3:51 PM | Long-Term Outcomes After Trellis Thrombectomy For DVT |
Presenter(s):Rabih A. Chaer, MD | |
View Abstract | |
3:52 PM - 3:57 PM | Tips And Tricks For Recanalization Of Occluded Large Veins: The Role Of The Ekosonic System |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
3:58 PM - 4:03 PM | DEBATE: Ultrasound-Enhanced Thrombolysis Yields No Benefit Over Thrombolysis Alone |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
4:04 PM - 4:09 PM | DEBATE: Nonsense; EKOS Thrombolysis For Acute DVT Is A Game Changer |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
4:10 PM - 4:15 PM | Panel Discussion |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Wednesday
SESSION 47:
TREATMENT OF INFERIOR VENA CAVA THROMBUS, MALIGNANCY, INJURY AND OCCLUSION
|
|
x | |
4:16 PM - 4:21 PM | Treatment Of Chronic IVC Occlusion With Stents: Which Patients, Which Stents, And Results |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
4:22 PM - 4:27 PM | IVC Resection And Reconstruction For Malignancy: Tips And Tricks |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
4:28 PM - 4:33 PM | Aggressive Management Of Acute Thrombosis Of The Inferior Vena Cava |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
4:34 PM - 4:39 PM | Robotic Removal Of Malfunctioning IVC Filters: A Case And Potential For The Future |
Presenter(s):Samuel R. Money, MD, MBA | |
View Abstract | |
4:40 PM - 4:45 PM | Exsanguinating Hemorrhage From Iatrogenic IVC Injury: Presentation, Management And Outcome |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
4:46 PM - 4:51 PM | Getting Paid For Inferior Vena Caval Procedures: Newer CPT Codes And When To Use Them |
Presenter(s):Sean P. Roddy, MD | |
View Abstract | |
4:52 PM - 5:00 PM | Panel Discussion |
END OF SESSION 47 | |
Thursday, November 20, 2014
Print Entire 2014 Program:
|
|
SESSION 48 SCHEDULE | |
Thursday
SESSION 48:
NEW DEVELOPMENTS IN AAAs AND EVAR
Moderators:Juan C. Parodi, MD / Frank A. Lederle, MD
|
|
x | |
6:45 AM - 6:50 AM | Thick Layer Of Thrombus In The Aortic Neck Should Not Be A Contraindication To EVAR: How To Size Neck Diameter With Thrombus: The Thrombus Resorbs With Time |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
6:51 AM - 6:56 AM | How Does Aortic Neck Morphology And Thrombus Burden Influence AAA Sac Behavior After EVAR |
Presenter(s):Thomas S. Maldonado, MD | |
View Abstract | |
6:57 AM - 7:02 AM | How Does Treatment Delay Increase The Risk Of AAA Repair With Open Surgery: With EVAR |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Abstract | |
7:03 AM - 7:08 AM | What Is The Post EVAR Syndrome: How Should It Be Treated |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Abstract | |
7:09 AM - 7:14 AM | Preoperative Prednisone Enhances Recovery After EVAR In A RCT: What Is The Mechanism And Optimal Dosage |
Presenter(s):Torben V. Schroeder, MD, DMSc / Lars B. Lonn, MD, PhD | |
View Abstract | |
7:15 AM - 7:20 AM | DEBATE: Small AAAs (4.0-5.4 cm) Should Not Be Fixed |
Presenter(s):Frank A. Lederle, MD | |
View Abstract | |
7:21 AM - 7:26 AM | DEBATE: Despite The Level I Evidence, Many Small AAAs (4.0-5.4 cm) Should Be Fixed |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
7:27 AM - 7:32 AM | Causes And Consequences Of Delay In Treatment Of AAAs And Why Unfit Patients With Large AAAs Should Be Treated: Without Treatment They Die Of Rupture: With Treatment They Can Survive |
Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD | |
View Abstract | |
7:33 AM - 7:38 AM | In Women, Indexing AAA Diameter To Body Surface Area Is A Better Predictor Of Rupture Than Diameter Alone: Not So In Men: Why And What Are The Implications |
Presenter(s):Marc L. Schermerhorn, MD | |
View Abstract | |
7:39 AM - 7:44 AM | How Often Is Fenestrated EVAR Indicated In Today’s EVAR Population And Can It Be Done Safely By Percutaneous Access |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
7:45 AM - 7:54 AM | Panel Discussion |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Thursday
SESSION 49:
NEW DEVELOPMENTS IN THE TREATMENT OF LESIONS OF THE AORTIC RANCHES AND THE VISCERAL SEGMENT OF THE AORTA
Moderators:Marc L. Schermerhorn, MD / Thomas A. Sos, MD
|
|
x | |
RENAL ARTERY LESIONS | |
7:54 AM - 7:59 AM | What Is The Role Of Renal Artery Stenting After The CORAL And ASTRAL Trials |
Presenter(s):Thomas A. Sos, MD | |
View Abstract | |
8:00 AM - 8:05 AM | How Can We Predict The Success Of Renal Artery Stenting: It Is Not Just Looking At An Arteriogram |
Presenter(s):Monika L. Gloviczki, MD, PhD | |
View Abstract | |
8:06 AM - 8:11 AM | Endovascular Treatment Of Renovascular Disease In Pediatric Patients Is Dangerous And Ineffective |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
8:12 AM - 8:17 AM | What Is The Current Data On The Natural History Of Renal Artery Aneurysms: How Should Traditional Treatment Criteria Be Changed |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
8:18 AM - 8:23 AM | Optimal Techniques For Endovascular Treatment Of Renal And Visceral Artery Aneurysms: Is Open Surgery Ever Best |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
8:24 AM - 8:29 AM | Panel Discussion |
MESENTERIC ARTERIES | |
Moderator(s): Edward Y. Woo, MD / Gustavo S. Oderich, MD, FACS | |
8:30 AM - 8:35 AM | DEBATE: Chronic Mesenteric Ischemia Is Best Treated Endovascularly |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
8:36 AM - 8:41 AM | DEBATE: Not So; Chronic Mesenteric Ischemia Is Best Treated By Open Surgery |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
8:42 AM - 8:47 AM | Are Improved Early And Mid-Term Results With Covered Stents For Chronic Mesenteric Ischemia Durable: Technical Tips To Place Them |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Abstract | |
8:48 AM - 8:53 AM | Endovascular Treatment Of All 3 Mesenteric Arteries (CA, SMA, IMA): When Is It Necessary And Technical Tips |
Presenter(s):Furuzan Numan, MD | |
View Abstract | |
VISCERAL SEGMENT OF AORTA | |
8:54 AM - 8:59 AM | Middle Aortic Syndrome: When Is Treatment Indicated; When Not: Is PTA Ever Of Value |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
9:00 AM - 9:05 AM | Endovascular Treatment Of Penetrating Ulcers Of The Aorta In The Infrarenal Segment; In The Visceral Segment |
Presenter(s):Afshin Assadian, MD | |
View Abstract | |
9:06 AM - 9:11 AM | Endovascular Treatment Of Isolated Abdominal Aortic Dissections: When Is It Necessary And How To Do It |
Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
View Abstract | |
9:12 AM - 9:20 AM | Panel Discussion |
9:20 AM - 9:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Thursday
SESSION 50:
NEW DEVELOPMENTS IN LAPAROSCOPIC VASCULAR SURGERY, PRESERVATION OF OPEN SURGICAL SKILLS, AND THE NATURAL HISTORY OF AAAs WITHOUT TREATMENT AND AFTER EVAR
Moderators:Roger M. Greenhalgh, MD / Jean-Baptiste Ricco, MD, PhD
|
|
x | |
LAPAROSCOPIC VASCULAR SURGERY | |
9:30 AM - 9:35 AM | Decline Of Laparoscopic And Robotic Vascular Surgery: Will The Trend Be Reversed |
Presenter(s):Willem Wisselink, MD | |
View Abstract | |
9:36 AM - 9:41 AM | Short And Long-Term Results Of Laparoscopic Vascular Surgery: Will It Survive In The Endovascular Era |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Abstract | |
9:42 AM - 9:47 AM | Why Laparoscopic Surgery For Aorto-Iliac Occlusive Disease Still Has A Future |
Presenter(s):Bernard J. Segers, MD | |
View Abstract | |
AAA NATURAL HISTORY WITH AND WITHOUT TREATMENT | |
9:48 AM - 9:53 AM | EVAR 1, DREAM, ACE And OVER Trials Show That Secondary Aortic Sac Rupture After EVAR Remains A Problem |
Presenter(s):Roger M. Greenhalgh, MD | |
View Abstract | |
9:54 AM - 9:59 AM | The Incidence Of AAAs Is Decreasing: Why Is This So And What Does It Mean For Screening |
Presenter(s):Frank A. Lederle, MD | |
View Abstract | |
10:00 AM - 10:05 AM | Better Long-Term Durability Results Can Be Achieved With EVAR Than In The EVAR, DREAM Or OVER Trials: Based On The Use Of A Third Generation Endograft Used In >200,000 Patients |
Presenter(s):Scott L. Stevens, MD | |
View Abstract | |
10:06 AM - 10:11 AM | Long-Term Results With EVAR Beyond 5 Years: Why Are They Better Than In The 3 Landmark EVAR vs. Open Repair RCTs (EVAR 1, DREAM AND OVER) |
Presenter(s):Timur P. Sarac, MD | |
View Abstract | |
10:12 AM - 10:17 AM | Why Should All High Risk AAAs Be Treated In A High Volume Center: Will It Happen |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Abstract | |
10:18 AM - 10:24 AM | Panel Discussion |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Thursday
SESSION 51:
HOT TOPICS IN THE TREATMENT OF JUXTARENAL AND PARARENAL AAAs, TAAAs AND RAAAs
Moderators:Jean-Pierre Becquemin, MD, FRCS / Frank J. Veith, MD
|
|
x | |
10:24 AM - 10:29 AM | Comparison Of FEVAR And Open Surgery For Juxtarenal AAAs: Why Open Surgery Is Still An Important Option |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Abstract | |
10:30 AM - 10:35 AM | DEBATE: Fenestrated EVAR (FEVAR) Is A Better Option Than Open Repair For Most Juxtarenal AAAs |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
10:36 AM - 10:41 AM | DEBATE: Open Repair Is Better Than FEVAR For Most Juxtarenal AAAs |
Presenter(s):Richard G.J. Gibbs, FRCS / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
10:42 AM - 10:47 AM | FEVAR Is The Treatment Of Choice For Pararenal And Paravisceral AAAs In Patients >80 Years Of Age: Based On A NSQIP Study |
Presenter(s):Anton N. Sidawy, MD, MPH | |
View Abstract | |
10:48 AM - 10:53 AM | G-I Complications From FEVAR Procedures Involving The Celiac And Superior Mesenteric Arteries: Causes And Prevention: Dangers Of CO2 Arteriography |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
10:54 AM - 10:59 AM | DEBATE: For Juxta And Pararenal AAAs Off-The-Shelf Devices Are Best For Most Patients |
Presenter(s):Mark A. Farber, MD | |
View Abstract | |
11:00 AM - 11:05 AM | DEBATE: For Juxta And Pararenal AAAs Custom-Made Fenestrated Branched Endografts Are Best For Most Patients |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
11:06 AM - 11:11 AM | DEBATE: For Juxta And Pararenal AAAs Standard Endovascular Devices With Parallel Graft Adjuncts Are Best For Most Patients |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
11:12 AM - 11:17 AM | DEBATE: For Juxta And Pararenal AAAs All Types Of Endografts Are Necessary To Treat Patients Well |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
11:18 AM - 11:24 AM | Panel Discussion |
Moderator(s): Mark A. Farber, MD / Martin Malina, MD, PhD | |
11:24 AM - 11:29 AM | There Is Still A Place For AUI Endografts For Complex AAAs (Including Juxta And Pararenal) Although Parallel Graft And Adjuncts May Be Required |
Presenter(s):Martin R. Back, MD | |
View Abstract | |
11:30 AM - 11:35 AM | Outcomes Of Ruptured AAAs (Both Endo And Open) Are Better If Treated By Vascular Surgeons Than If Treated By General Surgeons: A NSQIP Study |
Presenter(s):Amy B. Reed, MD | |
View Abstract | |
11:36 AM - 11:41 AM | How Accurate Is The Diagnosis Of Rupture In AAA Patients Dying Without Treatment: An Important Parameter In Evaluating Natural History Studies |
Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD | |
View Abstract | |
11:42 AM - 11:47 AM | For Short Necked Juxtarenal AAA What Is The Best Treatment: Standard EVAR, FEVAR, Standard EVAR With Chimneys Or Open Repair: What Is The Current Role Of Open Repair |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Abstract | |
11:48 AM - 11:53 AM | Anatomic Scoring As A Predictor For The Outcome Of FEVAR For Juxtarenal AAA Repairs: How Useful Is It |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 51 | |
SESSION 52 SCHEDULE | |
Thursday
SESSION 52:
SOME ISSUES WITH MALPRACTICE, OFF-LABEL USE, OUTPATIENT PRACTICE, CENTRALIZATION AND TRAINING, UPDATES
Moderators:Enrico Ascher, MD / Michael L. Marin, MD
|
|
x | |
1:00 PM - 1:05 PM | In A Malpractice Case, How Can One Resolve A Problem With A Bad Or Biased Expert Witness Or An Interventional Expert Who Considers Any Open Procedure With A Poor Result Malpractice |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
1:06 PM - 1:11 PM | DEBATE: Should We Treat Patients Outside IFUs: Yes, There Are Real Benefits And Upsides |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
1:12 PM - 1:17 PM | DEBATE: Should We Treat Patients Outside IFUs: No, There Are Many Downsides And Risks Including Malpractice |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
OUTPATIENT ISSUES | |
1:18 PM - 1:23 PM | Tips And Tricks For Use Of CO2 Arteriography And Venography In An Outpatient Facility: Advantages And Limitations |
Presenter(s):Kyung Cho, MD | |
View Abstract | |
1:24 PM - 1:29 PM | High Quality Digital Fluoroscopy With A Motorized C-Arm Can Facilitate Complex Endovascular Procedures In An Outpatient Setting |
Presenter(s):Enrico Ascher, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Outpatient Fast Track EVAR: When Is It Feasible And Safe And Tips On How To Do It: Advantages And Risks |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Abstract | |
TRAINING ISSUES | |
1:36 PM - 1:41 PM | Operator Training For Fenestrated Devices: Is The Technique Broadly Applicable |
Presenter(s):Luis A. Sanchez, MD | |
View Abstract | |
1:42 PM - 1:47 PM | How To Retrain And Train In The Open Surgical Skills That Vascular Surgeons Will Need In The Future |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Abstract | |
1:48 PM - 1:54 PM | Panel Discussion |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Thursday
SESSION 53:
NEW TECHNOLOGIES, TECHNIQUES, UPDATES AND MORE ON MLFM STENTS
Moderators:Timur P. Sarac, MD / Ali F. AbuRahma, MD
|
|
x | |
1:54 PM - 1:59 PM | Value And Technique For Aortic Balloon Control In Vascular Trauma Patients |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
2:00 PM - 2:05 PM | Almost All Aorto-Iliac Occlusions Can Be Treated Endovascularly: Tips And Tricks For Doing So Safely |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Abstract | |
2:06 PM - 2:11 PM | Outcomes Of Percutaneous EVAR: When Is It Contraindicated: Tips And Tricks For Doing It Safely |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
2:12 PM - 2:17 PM | Advantages Of Microbubbles To Reduce Dose Of Thrombolytics For Clot Lysis: Bleeding Risk Is Decreased: How Does It Work |
Presenter(s):Kak Khee Yeung, MD, PhD / Willem Wisselink, MD | |
View Abstract | |
2:18 PM - 2:23 PM | New Approaches To Developing Better Arterial Grafts |
Presenter(s):George Hamilton, MD; FRCS | |
View Abstract | |
2:24 PM - 2:29 PM | US Population Based Survey Shows Surveillance After EVAR Falls Short In >50% Of Patients: What Can And Should Be Done About It |
Presenter(s):Andres Schanzer, MD | |
View Abstract | |
MORE ABOUT MLFM STENTS | |
2:30 PM - 2:35 PM | Moroccan Results Of The MLFM Stent Experience For Treating Complex Aortic Aneurysms And Type B Dissections |
Presenter(s):Amira Benjelloun, MD | |
View Abstract | |
2:36 PM - 2:41 PM | How The MLFM Bare Stent Can Change The Natural History And Behavior Of Aortic Aneurysms: Theoretical Considerations |
Presenter(s):Mark F. Fillinger, MD | |
View Abstract | |
2:42 PM - 2:47 PM | The Phantom MLFM Aorto Bi-Iliac Device: A Fresh Perspective On The Treatment Of Aortic And Iliac Aneurysms |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Abstract | |
2:48 PM - 2:56 PM | Panel Discussion |
2:56 PM - 3:06 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Thursday
SESSION 54:
OPEN SURGERY AND AORTIC COARCTATION RELATED TOPICS
Moderators:Larry H. Hollier, MD / Hans-Henning Eckstein, MD, PhD
|
|
x | |
3:06 PM - 3:11 PM | The Value Of Open Surgery Simulators In Training Of Vascular Surgeons: How Do They Work And Can They Help |
Presenter(s):Afshin Assadian, MD | |
View Abstract | |
3:12 PM - 3:17 PM | Is There A Role For Open Surgical Treatment Of Renal Artery Stenosis For Renovascular Hypertension After The ASTRAL And CORAL Trials |
Presenter(s):George Hamilton, MD; FRCS | |
View Abstract | |
3:18 PM - 3:23 PM | Why Is Axillo-Bifemoral Bypass The New Gold Standard – Replacing Aorto-Bifemoral Bypass When Open Surgery Is Required For Aorto-Iliac Occlusive Disease: What Are The Current Indications For Not Using Endovascular Treatments |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Abstract | |
3:24 PM - 3:29 PM | 10-Year Results Of Open Repair Of Juxtarenal AAAs: How Durable Is The Procedure And Is It A Better Treatment Than FEVAR Or Chimney Grafts With EVAR |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
3:30 PM - 3:35 PM | How To Perform Open Conversion Safely After Failed EVAR: Tips And Tricks |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
3:36 PM - 3:41 PM | When Is Open Surgical Repair Of AAAs Indicated In The Endovascular Era: In What Percentage Of Cases Will It Be Necessary |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
3:42 PM - 3:47 PM | When Is Open Surgical Repair Required And The Best Treatment For Complex Vascular Injuries In The Endovascular Era |
Presenter(s):Samy S. Nitecki, MD | |
View Abstract | |
3:48 PM - 3:53 PM | How To Make Carotid Body Tumor Excision Almost Bloodless |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
AORTIC COARCTATION TOPICS | |
3:54 PM - 3:59 PM | DEBATE: Covered Balloon Expandable Stents (Advanta V12) Are The Best And Most Durable Way To Treat Aortic Coarctations: When Are They Not |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Abstract | |
4:00 PM - 4:05 PM | DEBATE: Bare Metal Balloon Expandable Stents Are The Best Most Durable Way To Treat Most Aortic Coarctations: When Are They Not |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Abstract | |
4:06 PM - 4:11 PM | Endovascular Treatment Of Late Complications (Recurrent Stenosis And/Or Aneurysm) Of Surgically Repaired Aortic Coarctations |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
4:12 PM - 4:19 PM | Panel Discussion |
END OF SESSION 54 | |
SESSION 55 SCHEDULE | |
Thursday
SESSION 55:
VISCERAL, RENAL AND HYPOGASTRIC ARTERY ISSUES
Moderators:Ronald M. Fairman, MD / Fabio Verzini, MD, PhD
|
|
x | |
MESENTERIC ISCHEMIA | |
4:19 PM - 4:24 PM | Endovascular Treatment Of Acute Mesenteric Ischemia: Value Of First Look Laparoscopy Or Laparotomy |
Presenter(s):Joseph S. Giglia, MD / George H. Meier III, MD | |
View Abstract | |
4:25 PM - 4:30 PM | Treatment Of Isolated SMA Dissection Producing Acute Mesenteric Ischemia |
Presenter(s):Robert B. McLafferty, MD | |
View Abstract | |
VISCERAL ARTERY ANEURYSMS | |
4:31 PM - 4:36 PM | Endovascular Treatment Of Celiac Artery Branch Pseudoaneurysms With Life Threatening Hemorrhage: When To Use Covered Stents; When To Use Coil Embolization; Is Open Surgery Ever The Best Treatment |
Presenter(s):Kyung Cho, MD | |
View Abstract | |
4:37 PM - 4:42 PM | When Is Endovascular Repair Indicated With Ruptured Visceral Artery Aneurysms: What Are The Outcomes Of Endovascular And Open Treatments |
Presenter(s):Rabih A. Chaer, MD | |
View Abstract | |
4:43 PM - 4:48 PM | Inferior Pancreatico-Duodenal Artery Aneurysms Are Commonly Associated With Celiac Artery Occlusions: What Is The Best Option For Treatment |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
4:49 PM - 4:54 PM | Should All Splenic Artery Aneurysms Be Managed Endovascularly: When Should They Not Be |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Abstract | |
RENAL ARTERY ANEURYSMS | |
4:55 PM - 5:00 PM | Natural History Of Renal Artery Aneurysms: Which Treatment (Endo vs. Open) Option Is Best And When |
Presenter(s):Neal S. Cayne, MD | |
View Abstract | |
5:01 PM - 5:06 PM | Coiling vs. Covered Stenting For Renal Artery Aneurysms: When Is Open Surgery The Best Treatment |
Presenter(s):Furuzan Numan, MD | |
View Abstract | |
HYPOGASTRIC ARTERY AND LONG-TERM FEVAR TOPICS | |
5:07 PM - 5:12 PM | How Should Isolated Iliac Artery Aneurysms Be Treated: Management Of The Hypogastric Especially When It Is Aneurysmal |
Presenter(s):Lars B. Lonn, MD, PhD | |
View Abstract | |
5:13 PM - 5:18 PM | Hypogastric Artery Revascularization With EVAR: When Is Coil Or Occluder Use Acceptable: Which Branch Device Is Best: What About Sandwich Grafts |
Presenter(s):Piergiorgio Cao, MD, FRCS / Fabio Verzini, MD, PhD | |
View Abstract | |
5:19 PM - 5:24 PM | Clinical Trial Results With The Gore Branched Device For Hypogastric Revascularization: Are There Limitations |
Presenter(s):Darren B. Schneider, MD | |
View Abstract | |
5:25 PM - 5:30 PM | Hypogastric Artery Revascularization During EVAR Using 2 Commercially Available Devices (Gore C3 And Endologix AFX) Without Need For Brachial Access: How To Do It |
Presenter(s):Brian G. DeRubertis, MD | |
View Abstract | |
5:31 PM - 5:36 PM | 10-Year Experience With Iliac Branched Devices (IBDs) For Hypogastric Artery Revascularization During EVAR: Durability And Pitfalls To Avoid |
Presenter(s):Martin J. Austermann, MD / Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
View Abstract | |
5:37 PM - 5:42 PM | 14-Year Experience With FEVAR: The Procedure Is Durable But Reinterventions May Be Required |
Presenter(s):Michael J. Denton, FRACS / Domenic Robinson, MD | |
View Abstract | |
5:43 PM - 5:48 PM | Different Techniques To Preserve The Hypogastric Arteries During EVAR: Tips And Tricks |
Presenter(s):Claudio J. Schonholz, MD | |
View Abstract | |
5:49 PM - 5:57 PM | Panel Discussion End of Program G |
END OF SESSION 55 | |
SESSION 56 SCHEDULE | |
Thursday
SESSION 56:
NEW AND UPDATED ENDOVASCULAR GRAFTS AND DEVICES FOR USE IN ABDOMINAL AORTIC DISEASE
Moderators:Daniel G. Clair, MD / Vicente Riambau, MD, PhD
|
|
x | |
6:45 AM - 6:50 AM | Are The Outcomes And Costs Different With Current Endovascular Graft Systems For EVAR: Based On Data From The OVER Trial |
Presenter(s):Jon S. Matsumura, MD | |
View Abstract | |
6:51 AM - 6:56 AM | Next Generation Endografts For AAAs: Are They Iterative Or Transformative |
Presenter(s):Robert M. Bersin, MD | |
View Abstract | |
6:57 AM - 7:02 AM | Trouble In Paradise: How EVAR Advances And Pushing The Endo Envelope Can Lead To Disaster And Harm Patients |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Abstract | |
7:03 AM - 7:08 AM | A Better Gore Excluder C3 Device That Is Not Only Repositionable But Also Has A Modifiable Body Angle That Can Adapt The Proximal Fixation And Sealing Zone With Difficult AAA Neck Anatomy |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
7:09 AM - 7:14 AM | World Experience With The Bolton Treovance Device For EVAR: The RATIONALE Registry: What Are The Device’s Advantages And Results |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
7:15 AM - 7:20 AM | Use Of The Anaconda Fenestrated Endograft For EVAR In Challenging Or Hostile Anatomy: Advantages And Results |
Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Abstract | |
7:21 AM - 7:26 AM | How Well Does The Vascutek Anaconda Fenestrated Cuff Work To Treat Complications Of Standard EVAR: Advantages And Experience To Date |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS / Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR | |
View Abstract | |
7:27 AM - 7:32 AM | Results With The Nellix Device For Endovascular AAA Sealing (EVAS) In Europe: Advantages And Tips To Avoid Complications |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
7:33 AM - 7:38 AM | The NELLIX EVAS FORWARD Global Registry: Early Results In 250 Patients: Nellix (EVAS) Device To Treat AAAs With Adverse Features: What Has Been The Need For Reinterventions And How Is It Better Than Conventional EVAR Devices |
Presenter(s):Andrew Holden, MBChB | |
View Abstract | |
7:39 AM - 7:44 AM | Experience With The Nellix Device For AAAs: When Should It Be Used Preferentially And Can It Be Used To Treat Complications Of Other AAA Repairs Like Endoleaks, Anastomotic Breakdown And Ruptures |
Presenter(s):Ian Loftus, MD / Matt M. Thompson, MD | |
View Abstract | |
7:45 AM - 7:49 AM | Expanding The Applicability Of EVAR Safely With The TriVascular Ovation Device |
Presenter(s):Sean P. Lyden, MD | |
View Abstract | |
7:50 AM - 7:58 AM | Panel Discussion |
END OF SESSION 56 | |
SESSION 57 SCHEDULE | |
Thursday
SESSION 57:
MORE ABOUT NEW AND UPDATED ENDOVASCULAR GRAFTS, DEVICES AND TECHNOLOGIES FOR TREATING ABDOMINAL AORTIC DISEASE,COMPLEX AAAs AND INFECTIONS
Moderators:Michel Makaroun, MD / Michael L. Marin, MD
|
|
x | |
7:58 AM - 8:03 AM | 2-Year Results With The Ovation Graft From TriVascular For EVAR: Advantages Of This Low Profile Device |
Presenter(s):Dierk Scheinert, MD | |
View Abstract | |
8:04 AM - 8:09 AM | How To Maximize The Benefits Of The Sealing Zone In The Ovation Endograft: Tips And Tricks |
Presenter(s):David J. Minion, MD | |
View Abstract | |
8:10 AM - 8:15 AM | The Altura Endograft For EVAR: Advantages And 2-Year Results |
Presenter(s):Albrecht H. Kramer, MD | |
View Abstract | |
8:16 AM - 8:21 AM | 3-Year European Results With A Lower Profile Device For EVAR: Advantages Of The Incraft From Cordis: The INNOVATION Trial |
Presenter(s):Giovanni Pratesi, MD / Giovanni Torsello, MD | |
View Abstract | |
8:22 AM - 8:27 AM | US Experience With The New Cordis Incraft For EVAR: Advantages And Limitations |
Presenter(s):Michel Makaroun, MD | |
View Abstract | |
8:28 AM - 8:33 AM | Results With The Aorfix EVAR Device From Lombard Are Good: How Iliac Morphology And Changes In Morphology Affect Outcomes |
Presenter(s):Brian R. Hopkinson, ChM, FRCS | |
View Abstract | |
8:34 AM - 8:39 AM | Good Mid-Term Outcomes With The Aorfix Endograft In The PYTHAGORAS PMA Trial: Advantages And Limitations |
Presenter(s):Mark F. Fillinger, MD | |
View Abstract | |
8:40 AM - 8:45 AM | When Is A Chimney Graft Procedure Better Than A Fenestrated Graft: How To Design A Better Aortic Endograft To Conform To Chimney Or Other Parallel Grafts |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
8:46 AM - 8:51 AM | Update On The Ventana Fenestrated Graft From Endologix: What Are Its Advantages And What Is Its Current Status |
Presenter(s):Daniel G. Clair, MD | |
View Abstract | |
8:52 AM - 8:57 AM | Results With A New Concept And Endograft For EVAR And TEVAR: The Horizon Endograft: The Concept Can Be Used To Construct Branched Grafts In Any Location |
Presenter(s):Gioachino Coppi, MD | |
View Abstract | |
8:58 AM - 9:03 AM | How Does The Endologix AFX Endograft Achieve A Seal In Irregular AAA Necks: Why Is It Better Than Other Aortic Endografts: Proof On A Dynamic CT Scan |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
9:04 AM - 9:09 AM | Advantages Of The Vela AFX Endograft System From Endologix: How Does It Make EVAR Better Or Easier – Particularly With Challenging AAA Necks |
Presenter(s):Julio A. Rodriguez-Lopez, MD | |
View Abstract | |
9:10 AM - 9:15 AM | 1-Year Results With A New Iliac Side Branched Device From Jotec For Revascularizing Hypogasric Arteries: Advantages And Limitations |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
View Abstract | |
9:16 AM - 9:21 AM | Updated Experience With Treatment Of Infected Aortic Grafts Using A Neo-Aorta Constructed With Spiral Greater Saphenous Vein: Why Is It Better Than Using Deep Lower Extremity Veins Or Other Techniques |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Abstract | |
9:22 AM - 9:29 AM | Panel Discussion |
9:29 AM - 9:40 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 57 | |
SESSION 58 SCHEDULE | |
Thursday
SESSION 58:
NEW OR IMPROVED ENDOGRAFTS, DEVICES, TECHNOLOGIES AND INFORMATION FOR TREATING THORACIC AORTIC DISEASE AND COMPLEX ANEURYSMS
Moderators:Eric L.G. Verhoeven, MD, PhD / Matt M. Thompson, MD
|
|
x | |
9:40 AM - 9:45 AM | In The UK Does TEVAR For Descending Thoracic Aortic Aneurysms Win Over Open Repair And Should We Be Looking For Asymptomatic Thoracic Aneurysms |
Presenter(s):Janet T. Powell, MD, PhD | |
View Abstract | |
9:46 AM - 9:51 AM | IVUS Is A Necessary Adjunctive Technology For Adequate TEVAR Treatment Of Complicated TBADs |
Presenter(s):Ali Azizzadeh, MD | |
View Abstract | |
9:52 AM - 9:57 AM | Early Experience With Newer Lower Profile Zenith Alpha Endografts For TEVAR And EVAR From Cook: How Well Do They Work |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
9:58 AM - 10:03 AM | Conformability Matters With TEVAR In Or Near The Aortic Arch: Modifications Of The C-TAG Device To Deal With Radial Fit Issues Of The Proximal Endograft: Redeployability And The Ability To Modify Proximal Graft Angles Are Also Helpful |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Abstract | |
10:04 AM - 10:09 AM | Early Results With A New Off-The-Shelf Branched Gore Endograft For TAAA Repairs: Advantages And Limitations |
Presenter(s):Pierre Galvagni Silveira, MD, PhD | |
View Abstract | |
10:10 AM - 10:15 AM | The GREAT Registry Confirms That The Gore Conformable C-TAG Endograft Is Working Well Near The Aortic Arch |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
10:16 AM - 10:21 AM | A Modified Relay Endograft With A Proximal Scalloped Or Fenestrated Opening (From Bolton) To Preserve Left Subclavian Flow: A Branched Graft Is Unnecessary: How Well Does This Bolton Graft Work |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Abstract | |
10:22 AM - 10:27 AM | Advantages, Limitations And Early Results With The JOTEC Device For F/B EVAR Repair Of TAAAs And Iliac Aneurysms |
Presenter(s):Burkhart Zipfel, MD, PhD | |
View Abstract | |
10:28 AM - 10:33 AM | Another Novel Potentially Off-The-Shelf Modular Branched Endovascular Graft From JOTEC For TAAAs: The Way It Works And Early Clinical Experience |
Presenter(s):Mario Lachat, MD / Giovanni Torsello, MD / Nicola Mangialardi, MD | |
View Abstract | |
10:34 AM - 10:44 AM | Panel Discussion |
END OF SESSION 58 | |
SESSION 59 SCHEDULE | |
Thursday
SESSION 59:
MORE NEW OR IMPROVED ENDOGRAFTS, DEVICES, TECHNOLOGIES AND INFORMATION FOR TREATING THORACIC AORTIC DISEASE AND COMPLEX ANEURYSMS
Moderators:Edward B. Diethrich, MD / Vicente Riambau, MD, PhD
|
|
x | |
10:44 AM - 10:49 AM | The Left Subclavian Artery (LSA) Can Be Covered In Most TEVAR Cases Without Revascularization: When Is Revascularization Necessary: Based On Data From The C-TAG Trial And The GREAT Registry |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
10:50 AM - 10:55 AM | LSA Origin Coverage During TEVAR Is Safe And Can Be Performed Without Complications Except In Specific Circumstances: What Are They |
Presenter(s):Gustav Fraedrich, MD | |
View Abstract | |
10:56 AM - 11:01 AM | LSA Flow Should Be Maintained During TEVAR: This Can Be Achieved With A Novel New Branched Device: The MONA LSA Device From Medtronic: How Does It Work And Early Results |
Presenter(s):Frank R. Arko, MD | |
View Abstract | |
11:02 AM - 11:07 AM | Clinical Experience With The MONA LSA Branched Device From Medtronic To Revascularize The Left Subclavian Artery During TEVAR |
Presenter(s):Eric E. Roselli, MD | |
View Abstract | |
11:08 AM - 11:13 AM | A Single Branched Endograft For TEVAR With Subclavian Revascularization From Gore: How Does It Work And Early Results: It Can Be Used To Treat All Arch Lesions Without Thoracotomy |
Presenter(s):Michael D. Dake, MD | |
View Abstract | |
11:14 AM - 11:19 AM | Laser Fenestration For LSA Revascularization During TEVAR: Technique And 4-Year CT Documented Durability |
Presenter(s):Jean M. Panneton, MD | |
View Abstract | |
11:20 AM - 11:25 AM | Advantages And Mid-Term Results With The Bolton Relay Endograft For TEVAR Extending Into Or Near The Arch |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
11:26 AM - 11:31 AM | Why Low Profile Devices Are Important For TEVAR: They Are Available With The Cook Zenith Alpha System |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
11:32 AM - 11:37 AM | A New Low Profile Endovascular Device From Cook To Treat Traumatic Aortic Injuries In Young Patients: Advantages And Limitations |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
11:38 AM - 11:43 AM | Advantages Of New Zenith Alpha System For TEVAR And EVAR: Are There Limitations |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Abstract | |
11:44 AM - 11:49 AM | New Endografts From Gore For F/B EVAR: Concepts For Easier Treatment Of Juxta, Para And Thoracoabdominal Aortic Aneurysm Repairs |
Presenter(s):Wayne W. Zhang, MD | |
View Abstract | |
11:50 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 59 | |
SESSION 60 SCHEDULE | |
Thursday
SESSION 60:
NEW OR IMPROVED ENDOVASCULAR DEVICES AND TECHNIQUES, STENTS, BIOABSORBABLE STENTS AND STENT-GRAFTS FOR TREATING LOWER EXTREMITY DISEASE AND ISCHEMIA
Moderators:Kenneth Rosenfield, MD / Giancarlo Biamino, MD, PhD
|
|
x | |
1:00 PM - 1:05 PM | 3-Year Results Of The STROLL Trial With Smart Stents In The SFA: Patency And Quality Of Life Are Maintained |
Presenter(s):Michael R. Jaff, DO | |
View Abstract | |
1:06 PM - 1:11 PM | What Will Be the Standard Of Care for Treating Primary Lesions In The SFA And Below: Update On The BIOLUX P-I And BIOLUX P-II Trial Results |
Presenter(s):Patrick Peeters, MD / Thomas Zeller, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Unique Properties Of A New Dual Component (Nitinol And PTFE) Stent: The Gore Tigris Conformable Stent: Early Results And When Should It Be Used |
Presenter(s):John R. Laird, MD | |
View Abstract | |
1:18 PM - 1:23 PM | An Improved Helical 3D Stent (The Biomimics Stent) May Resist Kinking, Lead To Swirling Blood Flow, Decreased ISR And Improved Patency At 2 Years |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
BIOABSORBABLE STENTS | |
1:24 PM - 1:29 PM | The Only Good Solution For Treatment Of Peripheral Artery Occlusive Lesions Must Avoid Permanent Implants: Bioabsorbable Scaffold Will Be The Future |
Presenter(s):Renu Virmani, MD | |
View Abstract | |
1:30 PM - 1:35 PM | A Bioabsorbable Vascular Scaffolding Stent With Drug Elution: The BVM Stent With Good 1-Year Results In The SFA: The ESPRIT Trial |
Presenter(s):Johannes Lammer, MD | |
View Abstract | |
1:36 PM - 1:41 PM | A Bioabsorbable Stent From Elixir Medical: How Does It Work And How Good Is It |
Presenter(s):Dierk Scheinert, MD | |
View Abstract | |
1:42 PM - 1:47 PM | Third Generation Bioabsorbable Self-Expanding DES Will Improve Results In Lower Extremity Occlusive Disease: Results With The Stanza DR Stent |
Presenter(s):Andrew Holden, MBChB | |
View Abstract | |
1:48 PM - 1:53 PM | Early And Mid-Term Results Of An Absorbable Stent For SFA Lesions |
Presenter(s):Gioachino Coppi, MD | |
View Abstract | |
1:54 PM - 1:59 PM | The Belgian REMEDY Registry Of Experience With The Bioabsorbable Remedy Stent In The SFA: 1-Year Results |
Presenter(s):Peter C.J. Goverde, MD | |
View Abstract | |
STENT-GRAFTS | |
2:00 PM - 2:05 PM | Endovascular Reconstruction Of Complex Aorto-Iliac Lesions: Stents vs. Covered Stents: Indications For Which And Why |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Abstract | |
2:06 PM - 2:11 PM | Uses For The Gore Hybrid Partially Stented PTFE Graft To Facilitate Arterial Bypasses In Multiple Locations |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
2:12 PM - 2:20 PM | Panel Discussion |
END OF SESSION 60 | |
SESSION 61 SCHEDULE | |
Thursday
SESSION 61:
NEW AND IMPROVED TECHNIQUES, STENTS, STENT-GRAFTS AND PROSTHETIC (PTFE) VASCULAR GRAFTS FOR TREATING LOWER EXTREMITY DISEASE AND ISCHEMIA
Moderators:Michael S. Conte, MD / Edward Y. Woo, MD
|
|
x | |
2:20 PM - 2:25 PM | How To Deal With Flush SFA Occlusions Endovascularly And Preserve Profunda Flow: Tips And Tricks |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
2:26 PM - 2:31 PM | A New More Conformable Covered Stent From Gore: Advantages, Limitations And Clinical Results |
Presenter(s):Andrew Holden, MBChB | |
View Abstract | |
IMPROVED PROSTHETIC VASCULAR GRAFTS | |
2:32 PM - 2:37 PM | Is There A Role For Prosthetic Bypasses Below The Knee And To Tibial Arteries And How To Make Them Work |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
2:38 PM - 2:43 PM | PTFE Tibial And Peroneal Bypasses When Vein Is Unavailable: They Yield Better Results Than Generally Acknowledged: An Update Based On A 30-Year Experience |
Presenter(s):Gregg S. Landis, MD / Frank J. Veith, MD | |
View Abstract | |
2:44 PM - 2:49 PM | Status Of The Propaten Heparin Bonded PTFE Graft: How Do We Know That It Is Better Than Standard PTFE Grafts |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
2:50 PM - 2:55 PM | Final 5-Year Results Of RCT Comparing Heparin Bonded PTFE (Propaten) Grafts vs. Standard PTFE Grafts In Fem-Pop And Fem-Fem Bypasses: How Durable Are The Benefits |
Presenter(s):Jes S. Lindholt, MD | |
View Abstract | |
2:56 PM - 3:01 PM | DEBATE: 5-Year Results With Heparin Bonded PTFE (Propaten) Grafts Are Better Than Standard PTFE And May Be As Good As ASV |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Abstract | |
3:02 PM - 3:07 PM | DEBATE: I Don’t Believe It: Good ASV Has To Be Better Than Any Prosthetic Graft |
Presenter(s):Michael S. Conte, MD | |
View Abstract | |
3:08 PM - 3:13 PM | When Are Prosthetic PTFE Grafts In The Lower Extremity As Good As Vein Grafts: Does Warfarin Help |
Presenter(s):Jack L. Cronenwett, MD | |
View Abstract | |
3:14 PM - 3:19 PM | PTFE Grafts With Heparin Bonding (Propaten) Can Have Good Patency Results Even When BK Popliteal And Crural Arteries Are Used For Outflow: Their Bad Reputation Is Undeserved |
Presenter(s):Walter Dorigo, MD | |
View Abstract | |
3:20 PM - 3:25 PM | Advantages Of The Fusion Bioline 2-Element Heparin Bonded PTFE Graft: Based On The FINEST Multicenter RCT |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Abstract | |
3:26 PM - 3:40 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 61 | |
SESSION 62 SCHEDULE | |
Thursday
SESSION 62:
ADDITIONAL NEW INFORMATION RELATED TO LOWER EXTREMITY ISCHEMIA AND POPLITEAL ANEURYSM MANAGEMENT
Moderators:Darren B. Schneider, MD / Palma M. Shaw, MD
|
|
x | |
3:40 PM - 3:45 PM | Tips And Tricks To Make Endovascular Treatment Of Acute Limb Ischemia Effective 100% Of The Time: Are Open Procedures Ever Required |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
3:46 PM - 3:51 PM | Ultrasound Enhanced Thrombolysis (EKOS) For The Treatment Of Infrainguinal Arterial Thrombosis: The Duet I And II Trial |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
3:52 PM - 3:57 PM | In Dialysis Patients With CLI How Much Can Be Achieved With Endovascular Treatments: Is Open Bypass Ever Needed |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
3:58 PM - 4:03 PM | Lower Extremity Revascularization In Dialysis Patients With CLI: Is It Of Value: When Endo; When Open; When A Primary Amputation |
Presenter(s):Rabih A. Chaer, MD | |
View Abstract | |
4:04 PM - 4:09 PM | What Is The Importance Of Patency After PTA-Stenting Or Bypass For Intermittent Claudication; For CLI: What Is The Mechanism For Exercise Improvement With Intermittent Claudication |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
4:10 PM - 4:15 PM | Endovascular Treatment Of Extensive Aorto-Iliac Occlusive Disease With A Bifurcated Endograft: A Potential Alternative To Kissing Stents Or Stent-Grafts |
Presenter(s):Thomas S. Maldonado, MD | |
View Abstract | |
4:16 PM - 4:21 PM | Evolving Treatment For Popliteal Aneurysms: When At Present Is Endovascular Treatment Contraindicated |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
4:22 PM - 4:27 PM | Elective And Emergent Treatment Of Popliteal Aneurysms: Can They All Be Treated Endovascularly And How Often Is Open Repair Indicated |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Abstract | |
4:28 PM - 4:34 PM | Panel Discussion |
END OF SESSION 62 | |
SESSION 63 SCHEDULE | |
Thursday
SESSION 63:
NEW AND IMPROVED DEVICES FOR ENDOSTAPLING OR ENDOANCHORING FOR EVAR AND TEVAR
Moderators:William D. Jordan, Jr., MD / Jean M. Panneton, MD
|
|
x | |
FOR AAA ENDOGRAFT PROCEDURES | |
4:34 PM - 4:39 PM | Do Aptus Heli-Fx EndoAnchors Provide Long-Term (5 Years) Fixation Of Endografts In AAA Necks After EVAR: Do They Decrease The Need For Surveillance: Do They Fix Endoleaks: Are They Worth Their Cost |
Presenter(s):David H. Deaton, MD | |
View Abstract | |
4:40 PM - 4:45 PM | Can Heli-Fx EndoAnchors Resolve Type I Endoleaks And Improve Long-Term Endograft Fixation: In Short Necked AAAs Are They Equal Or Superior To FEVARs Or Chimneys: Based On The ANCHOR Registry |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
4:46 PM - 4:51 PM | Mid-Term Results Of The Global And Dutch EndoAnchor Registries Of The Heli-Fx Endograft Stapling Devices: Can It Fix Type I Endoleaks And Graft Migration: Can It Be Proven |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
4:52 PM - 4:57 PM | Large Palmaz Stents vs. EndoAnchors To Fix Type I Endoleaks: Which Is Better And When |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
4:58 PM - 5:03 PM | Do EndoAnchors Improve Sac Regression After EVAR |
Presenter(s):Bart E. Muhs, MD, PhD | |
View Abstract | |
5:04 PM - 5:09 PM | Active Aortic Endograft Fixations With A Novel New Endostapling System By Vestech/Jotec: Description and Advantages |
Presenter(s):Thierry Richard, MD | |
View Abstract | |
FOR THORACIC PROCEDURES | |
5:10 PM - 5:15 PM | Value And Limitations Of Aptus Heli-Fx EndoAnchors In TEVAR Procedures: Can They Prevent Or Fix Type I Endoleaks From Difficult Neck Anatomy |
Presenter(s):Piotr M. Kasprzak, MD | |
View Abstract | |
5:16 PM - 5:21 PM | Can Delayed Type I Endoleaks After TEVAR Be Treated Successfully With Heli-Fx EndoAnchors |
Presenter(s):Manish Mehta, MD, MPH | |
View Abstract | |
5:22 PM - 5:27 PM | Value Of Heli-Fx EndoAnchors During Or After TEVAR Procedures |
Presenter(s):Jean M. Panneton, MD | |
View Abstract | |
5:28 PM - 5:38 PM | Panel Discussion End of Program H |
END OF SESSION 63 | |
SESSION 64 SCHEDULE | |
Thursday
SESSION 64:
VENOUS CLINICAL EXAMINATION AND SELECTING PATIENTS APPROPRIATELY
|
|
x | |
6:49 AM - 6:54 AM | CEAP & VCSS: Establishing The Treatment Plan Based On Clinical Findings |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
6:55 AM - 7:00 AM | What Duplex Ultrasound Mapping Adds To The Exam |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
7:01 AM - 7:06 AM | Quantifying Saphenous Reflux |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
7:07 AM - 7:12 AM | Value Of A Diagnostic Score Ascribing Leg Symptoms To Chronic Venous Disorders In Patients Undergoing Surgery For Varicose Veins |
Presenter(s):Paul Pittaluga, MD | |
View Abstract | |
7:13 AM - 7:18 AM | What Do The Quality Measures (QM) Measure: A Critical Analysis Of PQRS (Physician Quality Reporting System) Measures For Venous Disease |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
7:19 AM - 7:24 AM | The LET Score As A Standardized DVT Classification |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
7:25 AM - 7:30 AM | Hemodynamic Approach On Superficial Venous Reflux (ASVAL): Does It Work |
Presenter(s):Sylvain Chastanet, MD | |
View Abstract | |
7:31 AM - 7:36 AM | A New Look At Venous Hemodynamics: The Importance Of Measuring Both Reflux And Venous Ouflow Obstruction |
Presenter(s):Andrew N. Nicolaides, MS | |
View Abstract | |
7:37 AM - 7:42 AM | Hemodynamic Approach On Superficial Venous Reflux (CHIVA): Does It Work |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
7:43 AM - 7:48 AM | Why Is Individual Risk Assessment For Thrombosis Important To Vascular Surgeons Since They Already Use Heparin For Their Procedures |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
7:49 AM - 7:54 AM | Vein Diameter Is Not The Key For Stratifying Interventional Strategies For Superficial Venous Disease |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
7:55 AM - 8:00 AM | Panel Discussion |
END OF SESSION 64 | |
SESSION 65 SCHEDULE | |
Thursday
SESSION 65:
FIRST-LINE VENOUS IMAGING TECHNIQUES AND PHYSIOLOGIC TESTING
|
|
x | |
8:01 AM - 8:06 AM | Duplex Mapping Done Correctly |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
8:07 AM - 8:12 AM | What Information From Duplex Is Useful To Help Form A Treatment Plan? What Information Is Bogus But I’ve Seen Others Use Often |
Presenter(s):Neil M. Khilnani, MD | |
View Abstract | |
8:13 AM - 8:18 AM | Duplex Scanning Sourcing For Origin Of Reflux In Venous Ulcerations |
Presenter(s):Alfred M. Obermayer, MD | |
View Abstract | |
8:19 AM - 8:24 AM | Physiological Evaluation Of Venous Obstruction |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
8:25 AM - 8:30 AM | The Role Of IVUS In Stenting Of The Venous System |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
8:31 AM - 8:36 AM | How To Measure Iliac Vein Stenosis |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
8:37 AM - 8:42 AM | Shifting Paradigm Of Diagnosis And Treatment Of Suspected DVT (Role Of Non-Invasive Testing And Availability Of New Anticoagulants) |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
8:43 AM - 8:48 AM | Panel Discussion |
END OF SESSION 65 | |
SESSION 66 SCHEDULE | |
Thursday
SESSION 66:
SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
|
|
x | |
8:49 AM - 8:54 AM | Endovenous Thermal Ablation RCTs: Do We Know Enough |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
8:55 AM - 9:00 AM | Concomitant Treatment Of Truncal Reflux And Varicosed Tributaries Is The Gold Standard |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
9:01 AM - 9:06 AM | The Argument Against Mandatory Duplex Scanning Following Vein Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
9:07 AM - 9:12 AM | Clarivein Versus Radiofrequency Ablation: The Results Of A RCT |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
9:13 AM - 9:18 AM | Go Green: Avoid Synthetic Venous Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
9:19 AM - 9:24 AM | Reducing The Anxiety And Discomfort Of Patients Having Local Anesthetic Vein Treatments With Distraction Techniques And Hand Reflexology |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
9:25 AM - 9:30 AM | How Real Are Venous Thromboembolic Complications With Endovenous Thermal Ablation (The Paradox Between Data From Randomized Controlled Trials, Large Observational Case Series, And Registry Data) |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
9:31 AM - 9:36 AM | Different Options For Saphenous Vein Preservation |
Presenter(s):Paul Pittaluga, MD | |
View Abstract | |
9:37 AM - 9:42 AM | Does Superficial Venous Treatment (Open Or Endovenous) Help Venous Ulcer Healing |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) | |
View Abstract | |
9:43 AM - 9:48 AM | Perforator Ablation: What Are The Indications |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
9:49 AM - 9:54 AM | Incidence Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
9:55 AM - 10:00 AM | Value Of Postoperative Compression After Mini-Invasive Surgical Treatment Of Varicose Veins |
Presenter(s):Paul Pittaluga, MD | |
View Abstract | |
10:01 AM - 10:06 AM | Is 1920 Nanometer Wavelength The Future Of Venous Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
10:07 AM - 10:12 AM | Panel Discussion |
END OF SESSION 66 | |
SESSION 67 SCHEDULE | |
Thursday
SESSION 67:
WOUNDS, COMPRESSION, NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
Moderators:Thomas F. O'Donnell, Jr., MD / Fedor Lurie, MD, PhD
|
|
x | |
10:13 AM - 10:18 AM | Definition Of Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention |
Presenter(s):Marc A. Passman, MD | |
View Abstract | |
10:19 AM - 10:24 AM | Deep Venous Valve: When And Why |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
10:25 AM - 10:30 AM | DOMINATE The Wounds System |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
10:31 AM - 10:36 AM | Sulodexide For Advanced Venous Disease |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
10:37 AM - 10:42 AM | Venous Hemodynamic Revised – Valve Function And The Role Of Gravity |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
10:43 AM - 10:48 AM | The Importance Of Hemodynamics When Considering ASVAL |
Presenter(s):Sylvain Chastanet, MD | |
View Abstract | |
10:49 AM - 10:54 AM | What’s On The Horizon In Venous Thrombosis Research |
Presenter(s):Peter Henke, MD | |
View Abstract | |
10:55 AM - 11:00 AM | Panel Discussion |
END OF SESSION 67 | |
SESSION 68 SCHEDULE | |
Thursday
SESSION 68:
VENOUS SOCIETAL AND GOVERNANCE ISSUES
|
|
x | |
11:01 AM - 11:06 AM | A One Stop Vein Clinic: The Ideal Option? |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) | |
View Abstract | |
11:07 AM - 11:12 AM | IAC Vein Center: Importance And Update |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
11:13 AM - 11:18 AM | Comparison Of The New SVS/AVF Venous Ulcer Guidelines To Other Venous Ulcer Guidelines |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
11:19 AM - 11:24 AM | Who Will Treat The Varicose Veins And Who Will Pay For It In The Future |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
11:25 AM - 11:30 AM | Update On The SVS-PSO VQI Venous Registry |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
11:31 AM - 11:36 AM | What Is The Future Of Venous Reimbursement |
Presenter(s):Glenn Jacobowitz, MD | |
View Abstract | |
11:37 AM - 11:42 AM | A National Coverage Determination Policy Is Needed |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
11:43 AM - 11:48 AM | Primary CVD: Which Patients Should You Intervene On Early (GSV Ablation, Correct Hemodynamics) And If You Intervene Will It Reduce Or Prevent The Progression To Higher Clinical Class |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
11:49 AM - 11:54 AM | Why Standardization Is Needed With Endovenous Therapy |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Abstract | |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 68 | |
SESSION 69 SCHEDULE | |
Thursday
SESSION 69:
MEDICAL AND INTERVENTIONAL STRATEGIES FOR THROMBOEMBOLIC DISEASE
Moderators:Thomas W. Wakefield, MD / Bo G. Eklof, MD, PhD
|
|
x | |
INTERVENTIONAL STRATEGIES | |
1:00 PM - 1:05 PM | Benefit Of Early Thrombus Removal In DVT: How Should It Be Done; Endo Or Open |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | How Many Patients Will Be Suitable For Pharmaco-Mechanical Thrombolysis For Ilio- Femoral DVT |
Presenter(s):Stephen A. Black , MD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
1:12 PM - 1:17 PM | Ward Based Catheter Directed Lysis |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
1:18 PM - 1:23 PM | Early Thrombus Removal For Acute DVT: Does Tibial Access Help |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
1:24 PM - 1:29 PM | Aspirational Thrombectomy For DVT: Role Of Angiovac And How It Will Change Practice |
Presenter(s):Firas F. Mussa, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Catheter Directed Pulmonary Thrombolysis |
Presenter(s):Jason T. Salsamendi, MD | |
View Abstract | |
1:36 PM - 1:41 PM | Experience With 15 Consecutive Massive Pulmonary Embolism Patients And The Use Of The EKOS System |
Presenter(s):Luis R. Leon, MD, RVT, FACS | |
View Abstract | |
1:42 PM - 1:48 PM | Overview Of Current Role Of Lysis, Mechanical Thrombectomy And Stents For Acute And Subacute Iliofemoral And Caval DVT: What Is The Evidence In Support |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
1:49 PM - 1:54 PM | Panel Discussion |
MEDICAL STRATEGIES | |
1:55 PM - 2:00 PM | P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution And Prevents Vein Wall Fibrosis Better Than Enoxaparin And An Inhibitor To Von Willebrand Factor |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
2:01 PM - 2:06 PM | How To Use The Newer Oral Anticoagulants: New Data Using Aspirin For Recurrent Venous Thromboprophylaxis |
Presenter(s):Timothy K. Liem, MD | |
View Abstract | |
2:07 PM - 2:12 PM | New Drugs For DVT Will Likely Replace Coumadin Derivatives |
Presenter(s):John Blebea, MD, MBA | |
View Abstract | |
2:13 PM - 2:18 PM | To Bridge Or Not To Bridge: That Is The Question |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
2:19 PM - 2:24 PM | The Role Of Metabolomics In DVT |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
2:25 PM - 2:30 PM | DVT And PE In Infants And Children: Etiology, Diagnosis, Treatment And Prognosis |
Presenter(s):J. Leonel Villavicencio, MD | |
View Abstract | |
2:31 PM - 2:36 PM | D-Dimer And/Or Duplex Findings To Manage DVT |
Presenter(s):Timothy K. Liem, MD | |
View Abstract | |
2:37 PM - 2:42 PM | Panel Discussion |
END OF SESSION 69 | |
SESSION 70 SCHEDULE | |
Thursday
SESSION 70:
CROSS-SECTIONAL VENOUS IMAGING TO CLARIFY DIFFICULT CLINICAL SCENARIOS
Moderators:Cees H.A. Wittens, MD, PhD / Barry Stein, MD, FSIR, FACR
|
|
x | |
2:43 PM - 2:48 PM | Dutch Approach To Magnetic Resonance Venography And Computed Tomographic Venography In Lower Extremity Chronic Venous Disease |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
2:49 PM - 2:54 PM | American Approach To Magnetic Resonance Venography And Computed Tomographic Venography In Lower Extremity Chronic Venous Disease |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
View Abstract | |
2:55 PM - 3:00 PM | MR Venography And Cone Beam CT, Compared To IVUS And Conventional Venography For Deep Venous Intervention |
Presenter(s):Rick De Graaf, MD, PhD | |
View Abstract | |
3:01 PM - 3:06 PM | Current Practice For MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Pathologies And Syndromes: Which Is Better And Why |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
View Abstract | |
3:07 PM - 3:12 PM | A New Tool To Study The 3D Venous Anatomy Of The Human Embryo: The Computer Assisted Anatomical Dissection |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
View Abstract | |
3:13 PM - 3:18 PM | Image Fusion With MRV For 3D Guidance Of Deep Venous Interventions |
Presenter(s):Rick De Graaf, MD, PhD | |
View Abstract | |
3:19 PM - 3:24 PM | The Use Of IVUS To Document May Thurner Anatomy |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
3:25 PM - 3:30 PM | Panel Discussion |
END OF SESSION 70 | |
SESSION 71 SCHEDULE | |
Thursday
SESSION 71:
FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
Moderators:Jose I. Almeida, MD, RPVI, RVT, FACS / Seshadri Raju, MD
|
|
x | |
3:31 PM - 3:36 PM | Medical Treatment For Post-Thrombotic Syndrome |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
3:37 PM - 3:42 PM | Good, Bad, Ugly Of The New Dedicated Venous Stents |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
3:43 PM - 3:48 PM | Which Is More Important: Iliac Or Femoral Vein Stenosis |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
3:49 PM - 3:54 PM | Management Of In-Stent Restenosis |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
3:55 PM - 4:00 PM | How Knowledge Of Venous Embryology Can Help Establish Venous Outflow In Patients With Uncrossable Iliac Vein Obstruction |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
4:01 PM - 4:06 PM | DEBATE: Common Femoral Endovenectomy, A/V Fistula, And Endoluminal Iliac Vein Recanalization Is Best For Establishing Inflow |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
4:07 PM - 4:12 PM | DEBATE: Femoral Vein Recanalization Via Popliteal Access Establishes Better Inflow Than Common Femoral Vein Endovenectomy |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
4:13 PM - 4:18 PM | IVC Recanalization In The Presence Of A Thrombosed IVC Filter |
Presenter(s):David M. Williams, MD | |
View Abstract | |
4:19 PM - 4:24 PM | Managing The Iliocaval Confluence With Interdigitating Z-Stents: Another Technique From The Mississippi Group One Must Learn |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
4:25 PM - 4:30 PM | Value Of The Cutting Balloon In The Endovascular Treatment Of Post-Thrombotic Syndrome |
Presenter(s):David M. Williams, MD | |
View Abstract | |
4:31 PM - 4:36 PM | Update On EKOS “ACCESS DVT” Trial For Post-Thrombotic Syndrome |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
4:37 PM - 4:42 PM | Achieving Inflow When The Femoral Vein And Profunda Femoris Vein Are Occluded |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
4:43 PM - 4:48 PM | Crossing Femoro-Iliocaval Chronic Total Occlusions: Graduated Support And Tinkering |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
4:49 PM - 4:54 PM | Re-Opening Occluded Femoro-Iliocaval Stents Using Aggressive Sharp Devices, Exploding Occluded Stents, Then Relining With New Stent |
Presenter(s):E. Brooke Spencer, MD | |
View Abstract | |
4:55 PM - 5:00 PM | Off Label Use Of Arterial CTO Devices For Crossing Venous CTOs |
Presenter(s):Constantino Pena, MD | |
View Abstract | |
5:01 PM - 5:06 PM | When Should I Stop Trying To Cross A Total Venous Occlusion |
Presenter(s):E. Brooke Spencer, MD | |
View Abstract | |
5:07 PM - 5:12 PM | Deep Venous Reconstruction |
Presenter(s):Marzia Lugli, MD | |
View Abstract | |
5:13 PM - 5:18 PM | What Conduit(s) And Why, Do I Chose For Deep System Reconstruction From Vena Cava To Iliac Veins? |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
5:19 PM - 5:24 PM | Does Endovascular Treatment Work For Budd-Chiari Syndrome? |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
5:25 PM - 5:30 PM | Panel Discussion End of Program I |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Thursday
SESSION 72:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
Moderators:Joshua A. Hirsch, MD / Allan L. Brook, MD
|
|
x | |
72-A: 21ST CENTURY STROKE THERAPY PERSPECTIVES | |
8:00 AM - 8:09 AM | Emergency Room Stroke Triage Issues And Solutions |
Presenter(s):Edward C. Jauch, MD, MS | |
View Abstract | |
8:10 AM - 8:19 AM | IV vs. IA Is Not The Argument: Revascularization Needs To Occur Early! How To Make It Happen |
Presenter(s):Mayank Goyal, MD, FRCPC | |
View Abstract | |
8:20 AM - 8:29 AM | 3 Trials Failed To Validate Acute Stroke Intra-Arterial Treatment: Why? |
Presenter(s):Don Frei, MD | |
View Abstract | |
8:30 AM - 8:39 AM | Update And Relevance Of Certification Of Comprehensive Stroke Centers |
Presenter(s):Steven H. Rudolph, MD | |
View Abstract | |
8:40 AM - 8:49 AM | Clinical Trials Update In Stroke Intervention |
Presenter(s):Michael D. Hill, MD | |
View Abstract | |
8:50 AM - 8:59 AM | Healthcare Policy Impact On Your Practice |
Presenter(s):Joshua A. Hirsch, MD | |
View Abstract | |
9:00 AM - 9:10 AM | Panel Discussion |
72-B: STATE-OF-THE-ART IMAGING FOR STROKE | |
Moderator(s): Howard A. Rowley, MD / R. Gilberto Gonzalez, MD, PhD | |
9:10 AM - 9:19 AM | Magnetic Resonance Stroke Imaging Protocol Fast And Efficient |
Presenter(s):Howard A. Rowley, MD | |
View Abstract | |
9:20 AM - 9:29 AM | CT And CTA Best Imaging Triage: The Calgary Way |
Presenter(s):Mayank Goyal, MD, FRCPC | |
View Abstract | |
9:30 AM - 9:39 AM | Penumbra, Collaterals, And New Data: Let’s Talk! |
Presenter(s): R. Gilberto Gonzalez, MD, PhD | |
View Abstract | |
9:40 AM - 9:49 AM | Imaging And Treatment Of Patients With Acute Stroke: An Evidence Based Review |
Presenter(s):Pina C. Sanelli, MD, MPH, FACR | |
View Abstract | |
9:50 AM - 9:59 AM | Pial Collaterals And The Capillary Index: Implications |
Presenter(s):Colin P. Derdeyn, MD | |
View Abstract | |
10:00 AM - 10:09 AM | Collaterals, Not Clots! CT Angiography Predictors Of Recanalization, And Clinical Outcomes After Thrombectomy |
Presenter(s):David S. Liebeskind, MD | |
View Abstract | |
10:10 AM - 10:20 AM | Panel Discussion |
10:20 AM - 10:35 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
72-C: CLINICAL SCENARIOS OF THE POSTERIOR CIRCULATION OF INTEREST | |
Moderator(s): Eugene S. Flamm, MD / Lou R. Caplan, MD | |
10:35 AM - 10:44 AM | The 5-Minute Neurological Exam |
Presenter(s):Daniel L. Labovitz, MD | |
View Abstract | |
10:45 AM - 10:54 AM | Posterior Circulation Stroke Syndromes And Territories |
Presenter(s):Lou R. Caplan, MD | |
View Abstract | |
10:55 AM - 11:04 AM | Dissections Of The Vertebral And Carotid Arteries: When To Treat And Why |
Presenter(s):Philip M. Meyers, MD | |
View Abstract | |
11:05 AM - 11:14 AM | TIAs: Diagnosis And When To Treat Aggressively |
Presenter(s):David S. Liebeskind, MD | |
View Abstract | |
11:15 AM - 11:24 AM | Basilar Artery Aneurysms: Endovascular Approaches |
Presenter(s):David Fiorella, MD | |
11:25 AM - 11:34 AM | Posterior Fossa Aneurysms: Surgical Options |
Presenter(s):David J. Langer, MD | |
11:35 AM - 11:44 AM | Panel Discussion |
11:45 AM - 12:45 PM | Luncheon Session - Lunch Available In The South Corridor Exhibit Area, 2nd Floor |
72-D: LUNCHEON SESSION: INTRACRANIAL HEMORRHAGE: NOVEL TECHNIQUES AND THE STANDARD OF CARE IN 2014 | |
Moderator(s): Aman B. Patel, MD / Eugene S. Flamm, MD / TBD | |
12:00 PM - 12:10 PM | Standard Algorithm For Neurosurgical Management Of Intracranial Hemorrhage |
Presenter(s):David Gordon, MD | |
12:10 PM - 12:20 PM | A Less Invasive Percutaneous Image Guided System: What Are The Possible Advantages/Disadvantages? |
Presenter(s):David Fiorella, MD | |
12:20 PM - 12:30 PM | Case Presentations With Technical Issues For Discussion |
Presenter(s):David J. Altschul, MD | |
View Abstract | |
12:30 PM - 12:45 PM | Discussion: Led By Panel Of Experts |
Panelist(s): Walter Koroshetz, MD / Eugene S. Flamm, MD / Aman B. Patel, MD | |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
Thursday
SESSION 73:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 2
Moderators:Michael H. Wholey, MD, MBA / Thomas G. Brott, MD
|
|
x | |
73-A: CAROTID ARTERY REVASCULARIZATION - EYE OPENERS | |
12:45 PM - 12:54 PM | CREST 2 And Carotid Trials Update |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
12:55 PM - 1:04 PM | Can Patient Or Arterial Characteristics Guide The Choice To Carotid Angioplasty Or Endarterectomy |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
1:05 PM - 1:14 PM | Carotid Artery Revascularization: Why Do We Need More Trials? |
Presenter(s):Frank J. Veith, MD | |
View Abstract | |
1:15 PM - 1:24 PM | Introduction To Robotic Catheter Techniques |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
1:25 PM - 1:34 PM | Review Of The Latest Pertinent Carotid Literature |
Presenter(s):Michael H. Wholey, MD, MBA / Mark H. Wholey, MD | |
View Abstract | |
1:35 PM - 1:44 PM | Stroke Origins - The Carotid vs. The Intracranial Tree: Present Day Research |
Presenter(s):Raul G. Nogueira, MD | |
View Abstract | |
1:45 PM - 1:54 PM | Imaging And Implications For Plaque Inflammation: How Will It Affect Care? |
Presenter(s):Todd S. Miller, MD | |
View Abstract | |
SESSION 73-B: HEMORRHAGIC STROKE THERAPY | |
Moderator(s): David Gordon, MD / Daniel L. Labovitz, MD / Ajay K. Wakhloo, MD, PhD | |
1:55 PM - 2:04 PM | Classification Of AVMs |
Presenter(s):Lou R. Caplan, MD | |
View Abstract | |
2:05 PM - 2:14 PM | ARUBA Truths And Myths |
Presenter(s):Peter A. Rasmussen, MD | |
View Abstract | |
2:15 PM - 2:24 AM | ARUBA: A Surgeon’s Thoughts And Practice |
Presenter(s):Howard A. Riina, MD | |
View Abstract | |
2:25 PM - 2:34 PM | Embolization’s Key Role In AVM Therapy And Strategies For Cure |
Presenter(s):J. Mocco, MD, MS | |
View Abstract | |
2:35 PM - 2:44 PM | Convexity SAH And Other Causes Of Bleeds: My Advice |
Presenter(s):Howard A. Rowley, MD | |
View Abstract | |
2:45 PM - 2:54 PM | Anesthesia For INR Basic Concepts |
Presenter(s):Apolonia E. Abramowicz, MD | |
2:55 PM - 3:04 PM | Next Generation Of Aneurysm Therapy |
Presenter(s):Ajay K. Wakhloo, MD, PhD | |
View Abstract | |
3:05 PM - 3:14 PM | Flow Diversion Lessons Learned |
Presenter(s):Peter K. Nelson, MD | |
View Abstract | |
3:15 PM - 3:24 PM | Large Paraophthalmic Aneurysms: Surgical Skull Base Anatomy And Treatment Options |
Presenter(s):Aman B. Patel, MD | |
View Abstract | |
3:25 PM - 3:34 PM | Dural Sinus Stenosis And Venous Hypertension: My Paradigm |
Presenter(s):Sudhakar R. Satti, MD | |
View Abstract | |
3:35 PM - 3:45 PM | Panel Discussion |
3:45 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
73-C: BEST NEW STROKE REVASCULARIZATION DEVICES | |
Moderator(s): Aquilla S. Turk, DO / J. Mocco, MD, MS | |
4:00 PM - 4:09 PM | Ultrafast Door To Groin Puncture Times |
Presenter(s):Mayank Goyal, MD, FRCPC | |
View Abstract | |
4:10 PM - 4:19 PM | Pushing The Boundaries Of Acute Revascularization |
Presenter(s):J. Mocco, MD, MS | |
View Abstract | |
4:20 PM - 4:29 PM | ADAPT: This Sucks, But It Works |
Presenter(s):Aquilla S. Turk, DO | |
View Abstract | |
4:30 PM - 4:39 PM | Next Generation Stroke Devices |
Presenter(s):Osama O. Zaidat, MD | |
View Abstract | |
4:40 PM - 4:49 PM | Mobile Stroke Treatment Unit: A New System Of Stroke Care Delivery? |
Presenter(s):Peter A. Rasmussen, MD | |
View Abstract | |
4:50 PM - 4:59 PM | Balloon Guide Catheters And Other New Access Devices |
Presenter(s):Osama O. Zaidat, MD | |
View Abstract | |
5:00 PM - 5:09 PM | Trials Comparing Devices: SWIFT And TREVO 2 |
Presenter(s):Raul G. Nogueira, MD | |
View Abstract | |
5:10 PM - 5:19 PM | Is The Gold Standard Tarnished: Why A Randomized Controlled Study May Not Be The Best Study |
Presenter(s):Aaron L. Berez, MD | |
View Abstract | |
5:20 PM - 5:30 PM | Panel Discussion |
5:30 PM - 5:30 PM | Adjourn |
END OF SESSION 73 | |
Friday, November 21, 2014
Print Entire 2014 Program:
|
|
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
NEW OR IMPROVED TECHNIQUES OR TECHNOLOGIES; SOME HOT CAROTID AND VERTEBRAL TOPICS
|
|
x | |
6:45 AM - 6:50 AM | Cognitive And MRI Changes After Proximal TEVAR And TAVR Show The Need For Cerebral Protection During These Procedures: What Devices Are Available |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
6:51 AM - 6:56 AM | Use Of The VORTEC Technique: Another Method To Facilitate Hypogastric Revascularization During EVAR |
Presenter(s):Zoran Rancic, MD, PhD | |
View Abstract | |
6:57 AM - 7:02 AM | How To Make CEA Safer And Better In 2014 |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
7:03 AM - 7:08 AM | Optimal Evaluation And Surgical Approaches To Carotid Body Tumors In 2014 |
Presenter(s):John (Jeb) W. Hallett, MD | |
View Abstract | |
7:09 AM - 7:14 AM | What Is New In The Treatment Of Vertebro-Basilar Disease |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
7:15 AM - 7:20 AM | More Common Finding Of Thrombus Overlying A Carotid Plaque During CEA: What Is Its Significance Or Is It Related To The Earlier Performance Of CEA Currently Being Done In Symptomatic Patients |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) / Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
View Abstract | |
7:21 AM - 7:26 AM | Association Between Carotid Plaque Type And Internal Carotid Artery Occlusion: Therapeutic Implications |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
7:27 AM - 7:32 AM | How Can MRI Help To Select The Best And Personalized Treatment For A Given Carotid Patient: Can It Measure Plaque Size And Activity Accurately |
Presenter(s):Rachel E. Clough, MD, PhD | |
View Abstract | |
7:33 AM - 7:38 AM | What Can Duplex Ultrasonography Tell Us About Carotid Plaque Area And Juxtaluminal Black Area (JBA): How Do These Correlate With Stroke Risk And Do These Parameters And Stroke Risk Change With Statin Therapy |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD | |
View Abstract | |
7:39 AM - 7:44 AM | How Do Ultrasound And Microbubbles Help With Carotid Plaque Evaluation And Selection Of Asymptomatic Patients For CEA Or CAS |
Presenter(s):Chung S. Lim, MBBS, MRCS, PhD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
7:45 AM - 7:52 AM | Panel Discussion |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
MORE ABOUT THORACIC AND ABDOMINAL AORTIC DISEASE AND AORTIC DISSECTIONS; LARGE SHEATH ENDOVASCULAR ACCESS
Moderators:Ronald M. Fairman, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
7:52 AM - 7:57 AM | Alseal HQS Sheath To Minimize Blood Loss With Large Diameter Endovascular Devices |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
7:58 AM - 8:03 AM | DEBATE: Large Sheath Suture Closure Devices: Why Proglide Is Better: Tips And Tricks |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
8:04 AM - 8:09 AM | DEBATE: Large Sheath Suture Closure Devices: Why Prostar Is Better: Tips And Tricks |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
8:10 AM - 8:15 AM | Which Patients Should Not Be Treated By TEVAR For Aneurysms Or TBADs Because Their 3-Year Mortality Or Reintervention Rates Are So High |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
8:16 AM - 8:21 AM | Outcomes Of TEVAR For Complicated Acute TBADs Are Favorable: 1-Year Results From The US VALIANT (Medtronic) IDE Trial |
Presenter(s):Rodney A. White, MD / Joseph E. Bavaria, MD | |
View Abstract | |
8:22 AM - 8:27 AM | Multicenter 1-Year Favorable IDE Trial Results Of Conformable Gore C-TAG Device In TEVAR For Acute Complicated TBADs |
Presenter(s):Richard P. Cambria, MD | |
View Abstract | |
8:28 AM - 8:33 AM | Importance Of Biomechanical Factors For Ascending Aortic Endografts: What Can Be Done To Overcome These Factors |
Presenter(s):Rachel E. Clough, MD, PhD / Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
8:34 AM - 8:39 AM | Cerebral Embolic Injury Silent And Symptomatic During TEVAR: Incidence And Risk Factors: Significance Of Silent MRI Defects: What Can Be Done To Protect Against These Injuries |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Abstract | |
8:40 AM - 8:45 AM | Potential For Treating Type A Dissections With A Combined Transcatheter Aortic Valve Replacement And Ascending Aortic Stent-Graft: What Will And Will Not Be Possible |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
View Abstract | |
8:46 AM - 8:53 AM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
IN HONOR OF DAVID E. SUMNER, MD: CAROTID ARTERY AND SUPRA-AORTIC BRANCH TOPICS
Moderators:Jean-Baptiste Ricco, MD, PhD / Mark A. Adelman, MD
|
|
x | |
8:53 AM - 8:58 AM | How To Pick The Best Stent For CAS: It Is A Patient-Anatomy And Lesion Specific-Choice |
Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD | |
View Abstract | |
8:59 AM - 9:04 AM | How To Improve CAS Results With Better Approaches For Access, Mesh/Membrane Covered Stents (Roadsaver, C-Guard, Scaffold) And Better Embolic Protection: What Is The Evidence |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Abstract | |
9:05 AM - 9:10 AM | Will Robotic Assistance With The Magellan Robotic System Help To Navigate The Arch And Its Branches For CAS Less Traumatically |
Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD | |
View Abstract | |
9:11 AM - 9:16 AM | DEBATE: For Patients Who Are Undergoing CABG And Who Require Carotid Treatment CAS Is The Way To Go: Many Patients Need CAS |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
9:17 AM - 9:22 AM | DEBATE: Very Few Patients Need CAS Or CEA With Any Coronary Bypass Procedures |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
9:23 AM - 9:28 AM | Outcomes Of CAS For Radiation Induced Carotid Stenosis Are Equal To Those For Typical Arteriosclerotic Carotid Stenosis – Despite Increased Tortuosity Of Carotid Arteries: What Precautions Need To Be Taken |
Presenter(s):Peter L. Faries, MD, FACS | |
View Abstract | |
9:29 AM - 9:34 AM | Behavior Of Extracranial Carotid Aneurysms: How Should They Best Be Treated: Data From An International Registry |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
9:35 AM - 9:40 AM | Improved Treatment Of Iatrogenic Catheter Related Brachiocephalic Artery Injuries Using Endovascular Techniques: Tips And Tricks |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
9:41 AM - 9:46 AM | How Can Biochemical Markers CRP And BNP Be Helpful In Vascular Patient Management: Can CRP Levels Predict Progression Of Carotid Stenosis |
Presenter(s):Patrick A. Stone, MD | |
View Abstract | |
9:47 AM - 9:52 AM | Diaphragm Of The Cervical Carotid Arteries: An Underdiagnosed Cause Of Cerebral Infarcts: Diagnosis And Treatment |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
9:53 AM - 10:00 AM | Panel Discussion |
10:00 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
CAS Vs. CEA RELATED TOPICS: THE FUTURE FOR CAS IS BRIGHT
Moderators:Ross Naylor, MD, FRCS / Frank J. Veith, MD
|
|
x | |
10:10 AM - 10:15 AM | Despite Various Claims, What Is The Current Truth About The Effects Of CAS And CEA On Cognitive Function: Is There A Difference Between The Procedures |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Abstract | |
10:16 AM - 10:21 AM | Carotid Procedures (CEA Or CAS) For Acute Stroke: When Should They Be Done And How |
Presenter(s):Laura Capoccia, MD, PhD | |
View Abstract | |
10:22 AM - 10:27 AM | Outcome Of A High Risk Plaque Study In 6100 Americans: What Does It Tell Us |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
10:28 AM - 10:33 AM | The Truth About The High Risk Carotid Patient And Which Patients Should Be Enrolled In Future Carotid Trials |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
10:34 AM - 10:39 AM | Long-Term Stroke Risk After CEA Has Been Lower Than After CAS: Based On VQI And Medicare US Population-Wide Data |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
10:40 AM - 10:45 AM | DEBATE: CMS (Medicare) Should Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):William A. Gray, MD | |
View Abstract | |
10:46 AM - 10:51 AM | DEBATE: CMS Should Not Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
10:52 AM - 10:57 AM | Will Recent Improvements In Medical Therapy Lower Stroke Risk In Asymptomatic Carotid Stenosis Patients So Much That Further Treatment Will Be Unnecessary: Are The ACST And ACSRS Studies Now Obsolete And Will They Have To Be Done Again: Is There A High Risk Asymptomatic Patient Group That Will Benefit From CEA Or CAS |
Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD | |
View Abstract | |
10:58 AM - 11:05 AM | Panel Discussion |
THE FUTURE FOR CAS IS BRIGHT | |
Moderator(s): Thomas G. Brott, MD / Wesley S. Moore, MD | |
11:05 AM - 11:10 AM | Why CAS Will Have A Renaissance And What Studies Are Needed To Justify It: The Mesh Covered Scaffold Stent (Gore) Should Help |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
11:11 AM - 11:16 AM | How To Improve CAS And Prevent Post-Procedural Strokes After CAS: Clinical Experience With The Roadsaver Micromesh Carotid Stent: How Does The Micromesh Stent Compare To Other Mesh-Covered Stents Like The MicroNet (C-Guard) Stent From InspireMD And the Scaffold Stent From Gore |
Presenter(s):Max Amor, MD | |
View Abstract | |
11:17 AM - 11:22 AM | A New Development In CAS Which Will Improve Results: Is The Cervical Flow Reversal Device (Michi System) From Silk Road The Safest Way To Perform CAS: When Will We Know How Well It Works |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Abstract | |
11:23 AM - 11:28 AM | What Is The Pathological And Functional Significance Of Diffusion Weighted MRI (DW MRI) Defects After CEA And CAS: Are They Irrelevant Or A Bad Thing |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
INTENSIVE MEDICAL THERAPY WITH PROPER STATIN USAGE ETC. IS A DISRUPTIVE INFLUENCE | |
11:29 AM - 11:34 AM | Intensive Medical Therapy With Proper Statin Usage Etc. Is A Disruptive Influence |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
11:35 AM - 11:40 AM | The CREST Trial Did Not Optimize Medical Treatment And Risk Factor Control Especially In the CEA Treated Patients: What Are The Implications |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
11:41 AM - 11:46 AM | How Will ACST 2, SPACE 2 And CREST 2 Change The CAS vs. CEA Game |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Abstract | |
11:47 AM - 11:52 AM | What Will The ECST-2 Trial Tell Us About CEA, CAS And Medical Treatment: What Is The Significance Of White Matter And Other MRI Lesions |
Presenter(s):Martin M. Brown, MD | |
View Abstract | |
11:53 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
x | |
1:00 PM - 1:05 PM | What Were The Pathophysiological Mechanisms Leading To Intraprocedural Strokes In ICSS |
Presenter(s):Gerrit J. de Borst, MD | |
View Abstract | |
1:06 PM - 1:11 PM | How To Optimize Outcomes For CAS And CEA By Appropriate Patient Selection And Having Experts In Both Procedures On The Treating Service |
Presenter(s):Carlos Saadeh, MD, FRCSC, FACS | |
View Abstract | |
1:12 PM - 1:17 PM | Dual Antiplatelet Treatment And Tobacco Use May Increase The Rate Of Progression Of Asymptomatic Carotid Stenosis |
Presenter(s):Mahmoud B. Malas, MD, MHS / Bruce A. Perler, MD, MBA | |
View Abstract | |
1:18 PM - 1:23 PM | US National Trends In Utilization Of CAS For Carotid Bifurcation Disease: Effect Of CMS (Medicare) Decision And CREST Publications: Where Is CAS Going |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
View Abstract | |
1:24 PM - 1:29 PM | DEBATE: Treating Recently Symptomatic Carotid Stenosis Patients Rapidly By CEA Trumps All Interventions In Symptomatic Patients: CAS Should Not Be Used In This Setting |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Not So: Rapid CAS In Recently Symptomatic Carotid Stenosis Patients Can Be Done Safely With Results Equal To CEA |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Abstract | |
1:36 PM - 1:41 PM | What Is The Long-Term Fate Of The External Carotid Artery After CEA: Why It Matters |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Abstract | |
1:42 PM - 1:47 PM | Clinical And Imaging Strategies For Predicting Long-Term Stroke Risk In Asymptomatic Patients With Carotid Stenosis |
Presenter(s):Ross Naylor, MD, FRCS | |
View Abstract | |
1:48 PM - 1:54 PM | Tips And Techniques For Managing Intraprocedural Complications With CAS |
Presenter(s):Claudio J. Schonholz, MD | |
View Abstract | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
LATE BREAKING AND CONTROVERSIAL TOPICS
Moderators:Samuel R. Money, MD, MBA / Michael B. Silva, Jr., MD
|
|
x | |
2:00 PM - 2:05 PM | Management Of Secondary Hemorrhage From Vein Grafts In Military Extremity Wounds: In A War Setting PTFE Grafts May Be Better Than Vein Grafts |
Presenter(s):Charles J. Fox, MD, FACS | |
View Abstract | |
2:06 PM - 2:11 PM | Plaque Analysis After Lower Extremity Interventional Treatments And Its Impact On Outcomes |
Presenter(s):Hany Zayed, MD | |
View Abstract | |
2:12 PM - 2:17 PM | The Metabolic Syndrome And How Does It Lead To Bad Outcomes With Vascular Procedures Like EVAR And CEA |
Presenter(s):Alan Dardik, MD, PhD | |
View Abstract | |
2:18 PM - 2:23 PM | How Does The Ruby Coil System (From Penumbra) Facilitate Coil Embolization |
Presenter(s):Frank R. Arko, MD | |
View Abstract | |
2:24 PM - 2:29 PM | Intraluminal PTA Is Better In Diabetics With CLI: Tips To Stay Intraluminal |
Presenter(s):Marco G. Manzi, MD | |
View Abstract | |
2:30 PM - 2:35 PM | Renal Artery Stenting Is Still A Useful Procedure Despite The CORAL And ASTRAL Trials: When Is This So |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
2:36 PM - 2:41 PM | Pearls For The Vascular Surgeon/Specialist Managing Patients With Ehlers-Danlos Syndrome |
Presenter(s):James H. Black III, MD | |
View Abstract | |
2:42 PM - 2:47 PM | How To Treat Super Large AAAs 12-15 cm In Diameter: Is Open Or Endo Better |
Presenter(s):Jacques Busquet, MD | |
View Abstract | |
2:48 PM - 2:53 PM | Impact Of Selection Bias In RCTs Comparing EVAR To Open Repair For Ruptured AAAs: This Is A Major Flaw In The Recent Trials Including IMPROVE |
Presenter(s):Jonathan R. Boyle, MD, FRCS | |
View Abstract | |
2:54 PM - 2:59 PM | A Phantom Aorta: Use Of 3D Printer Technology To Facilitate Fenestrated EVAR |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
3:00 PM - 3:10 PM | Panel Discussion And Break Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
MORE LATE BREAKING INFORMATION AND UPDATES
Moderators:Mark A. Farber, MD / Gregg S. Landis, MD
|
|
x | |
3:11 PM - 3:16 PM | Endovascular Limb Salvage After Many Failed Open Bypasses And Open Surgical Limb Salvage After Many Failed Endovascular Procedures: Never Give Up |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
3:17 PM - 3:22 PM | Technique For Assessing Lower Extremity (Foot) Perfusion Beyond ABI, PVRs And Toe Pressures |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
3:23 PM - 3:28 PM | Hybrid Revascularization In CLI Patients: Still An Important And Useful Option: Tips And Tricks |
Presenter(s):Hany Zayed, MD | |
View Abstract | |
3:29 PM - 3:34 PM | Hybrid Revascularizatons For The “No Option” CLI Patient: What Are They And What Are The Results |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Abstract | |
3:35 PM - 3:40 PM | Optimal Techniques For Endovascular Management Of AAA Patients With Small Heavily Calcified Distal Aortic Necks And Common Iliac Arteries |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
3:41 PM - 3:46 PM | Ischemic Colitis After EVAR: What Is The Pathogenesis And Why Is The Incidence Decreasing |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
3:47 PM - 3:52 PM | Real Health Consequences To Interventionalists Of Radiation And Wearing Lead: It Is A Big Deal - Largely Unrecognized And What Can Be Done To Lessen These Consequences |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
3:53 PM - 3:58 PM | Weightless Lead Protection System For Busy Interventionalists: The Zero Gravity Radiation Protection System From CFI Medical Solutions: Advantages And Limitations |
Presenter(s):Mark A. Farber, MD | |
View Abstract | |
3:59 PM - 4:04 PM | At What Size Should Degenerative Femoral Aneurysms Be Repaired: Their Natural History Is Now Better Known And This Has Led To Changed Criteria For Repair |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
4:05 PM - 4:10 PM | Carotid Duplex Studies Can Be Terribly Misleading And Overestimate The Percent Stenosis: What Is The Mechanism: CEA vs. CAS Should Not Be Performed Without A Confirmatory Test |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT | |
View Abstract | |
4:11 PM - 4:16 PM | Carotid Duplex Studies Can Be Terribly Misleading And Miss Or Underestimate A High-Grade Carotid Stenosis: What Is The Mechanism |
Presenter(s):Glenn M. LaMuraglia, MD | |
View Abstract | |
4:17 PM - 4:24 PM | Panel Discussion |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
MORE LATE BREAKING INFORMATION AND UPDATES; ADDITIONAL VITAL NEW DATA ON RUPTURED AAAs
Moderators:James May, MD, MS, FRACS, FACS / John J. Ricotta, MD
|
|
x | |
4:24 PM - 4:29 PM | Is There Evidence In 2014 That Inferior Mesenteric Or Lumbar Artery Embolization Before EVAR Is Beneficial And Safe |
Presenter(s):Florian Dick, MD | |
View Abstract | |
4:30 PM - 4:35 PM | Interobserver Variability In Assigning TASC Or SVS Run-Off Scores: Neither Widely Quoted System Is Worth Much In Real World Usage |
Presenter(s):Steven G. Katz, MD | |
View Abstract | |
4:36 PM - 4:41 PM | AAA Patients With Highly Angulated Necks Can Be Treated Successfully If Certain Adjunctive Procedures Are Used: Tips And Tricks On How To Use Them |
Presenter(s):Boonprasit Kritpracha, MD | |
View Abstract | |
4:42 PM - 4:47 PM | Can Endograft Migration After EVAR Be Treated Successfully With Chimney Grafts |
Presenter(s):Ignacio Escotto, MD | |
4:48 PM - 4:54 PM | Panel Discussion |
VITAL NEW DATA ON RUPTURED AAAS AND THEIR TREATMENT | |
4:54 PM - 4:59 PM | How Often After EVAR For Ruptured AAAs Are Type 2 Endoleaks A Problem: How Can They Be Diagnosed And Treated |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Abstract | |
5:00 PM - 5:05 PM | How Do Type 2 Endoleaks Behave Differently After Elective EVAR And EVAR For Ruptured AAAs: Implications For Treatment |
Presenter(s):Manish Mehta, MD, MPH | |
View Abstract | |
5:06 PM - 5:11 PM | High Metabolic Activity By PET/CT Correlates With A High Rupture Risk In Patients With A Family History Of AAA: Such Patients Should Have A Lower Diameter Threshold For Repair Than 5.5 cm |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
View Abstract | |
5:12 PM - 5:17 PM | Institutional Transfer Of Ruptured AAA Patients Before Definitive Repair And Its Effect On Mortality: Tips And Tricks For Doing It Right |
Presenter(s):Matthew W. Mell, MD, MS / Ronald L. Dalman, MD | |
View Abstract | |
5:18 PM - 5:23 PM | Technique Of Aortic Balloon Control For Ruptured AAAs: The Technique Is Not Simple |
Presenter(s):Todd Berland, MD / Neal S. Cayne, MD / Frank J. Veith, MD | |
View Abstract | |
5:24 PM - 5:29 PM | Survival After AAA Rupture X3 In The Same Patient Over Many Years; What Is The Mechanism |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Abstract | |
5:30 PM - 5:35 PM | Onyx Can Be Used Successfully To Treat Some Ruptured AAAs, Ruptured Thoracic Aneurysms And Type I Endoleaks: Tips And Tricks In Its Use And When It Will Fail |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
5:36 PM - 5:45 PM | Panel Discussion End of Program J |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
ABDOMINAL AORTA AND ILIAC ARTERY RELATED TOPICS
Moderators:Kenneth Ouriel, MD, MBA / Ramon Berguer, MD, PhD
|
|
x | |
6:45 AM - 6:50 AM | Spontaneous Aortic Thrombus In The Absence Of Aortic Pathology: What Is Its Embolic Potential And How Should It Be Treated |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
6:51 AM - 6:56 AM | Renal Function Decline After EVAR: Is It Important And What Is The Etiology |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
View Abstract | |
6:57 AM - 7:02 AM | CO2 Angiography For EVAR In Patients Intolerant To Contrast: Tips, Tricks And Precautions For Its Use |
Presenter(s):Luigi Inglese, MD | |
View Abstract | |
7:03 AM - 7:08 AM | DEBATE: Current Stent-Grafts Will Allow Better Outcomes With EVAR Than Those Obtained In The RCTs: EVAR I, DREAM And OVER |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Abstract | |
7:09 AM - 7:14 AM | DEBATE: Not So: Current Outcomes For EVAR Will Be No Different From Those In The RCTs And The Conclusions Of These Trials Are Valid Today |
Presenter(s):Jan D. Blankensteijn, MD | |
View Abstract | |
7:15 AM - 7:20 AM | Long-Term Outcomes Of EVAR And Open Repair In A US Medicare Database: How Do These Compare With The RCT (EVAR 1, DREAM And OVER) Outcomes |
Presenter(s):Marc L. Schermerhorn, MD | |
View Abstract | |
7:21 AM - 7:26 AM | Outcomes And QOL Of EVAR In Octogenarians: The Procedure Is Worthwhile: Based On ENGAGE Registry Results |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Abstract | |
7:27 AM - 7:32 AM | Internal Iliac Aneurysms: Challenges And Techniques For Open And Endovascular Repair: At What Size (Diameter) Is Repair Indicated |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
7:33 AM - 7:38 AM | DEBATE: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Standard Endografts |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
7:39 AM - 7:44 AM | DEBATE: Not So: AAAs With Straight Short Necks (8-15 mm) Should Be Treated With Fenestrated Endografts |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Abstract | |
7:45 AM - 7:53 AM | Panel Discussion |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
MORE ABDOMINAL AORTA RELATED TOPICS
Moderators:Thomas C. Bower, MD / John B. Chang, MD
|
|
x | |
7:53 AM - 7:58 AM | Finite Element Analysis Is A Tool To Predict AAA Rupture Risk: How Can This Be Determined Easily And How Can It Be Combined With Other Risk Factor Data To Better Predict AAA Rupture Risk: What Is “Equivalent Diameter Rupture Risk” And The Vascops System |
Presenter(s):Dittmar Boeckler, MD / Natzi Sakalihasan, MD, PhD / | |
View Abstract | |
7:59 AM - 8:04 AM | How To Prevent Gutter Endoleaks With Parallel Grafts |
Presenter(s):Willem Wisselink, MD / Kak Khee Yeung, MD, PhD | |
View Abstract | |
8:05 AM - 9:10 AM | When Is AAA Repair Justified In Patients With Chronic Renal Insufficiency Or Connective Tissue Disease: By EVAR; By Open Repair |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
8:11 AM - 8:16 AM | Techniques And Strategies For Renal Protection During Open Pararenal And Thoracoabdominal Aneurysm Repair |
Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
8:17 AM - 8:22 AM | Why Are The Rates Of AAA Sac Regression So High And Of Type 2 Endoleak So Low With The Endologix AFX Grafts: Is It Related To An Extended Proximal Seal Or Other Factors |
Presenter(s):Zachary M. Arthurs, MD | |
View Abstract | |
8:23 AM - 8:28 AM | Errors In Endograft Sizing And How They Can Influence Outcomes: How To Prevent Them |
Presenter(s):Juan C. Parodi, MD | |
View Abstract | |
8:29 AM - 8:34 AM | Screening For AAAs Should Be More Selective As AAA Demographics Changes And Incidence Decreases |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
8:35 AM - 8:40 AM | There Is Little Glory In Achieving Access But Many Adverse Consequences Result: How To Do It Safely For EVAR And Other Procedures |
Presenter(s):Scott L. Stevens, MD | |
View Abstract | |
8:41 AM - 8:46 AM | Mural Thrombus Formation In The Endograft After EVAR: How Does It Relate To Complications And The Need For Surveillance: When Can Surveillance Protocols Be Relaxed |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Abstract | |
8:47 AM - 8:52 AM | Is There A Difference In Type 2 Endoleak Incidence Or Behavior Between Different Endografts: What Is The Reason |
Presenter(s):Marc L. Schermerhorn, MD | |
View Abstract | |
8:53 AM - 8:58 AM | Value Of Preloaded Catheters And Wires In Fenestrated Stent-Grafts: How Do They Work And How Helpful Are They |
Presenter(s):Konstantinos P. Donas, MD | |
View Abstract | |
8:59 AM - 9:04 AM | How To Predict, Prevent And Treat Iliac Limb Occlusion In EVAR |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
9:05 AM - 9:13 AM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
Moderators:Krassi Ivancev, MD, PhD / Marcelo Ferreira, MD
|
|
x | |
9:13 AM - 9:18 AM | Value And Need For Secondary Interventions After TEVAR: What Factors Predict An Increased Likelihood Of A Secondary Intervention |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
9:19 AM - 9:24 AM | Tips And Tricks To Avoid Complications And Improve TEVAR Results: How Well Do Branched Grafts Work In The Aortic Arch |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Newer Branched Endografts And Large Proximal Scallops For Aortic Arch Lesions |
Presenter(s):Mo S. Hamady, MD, FRCR, EBIR / Nicholas J.W. Cheshire, MD | |
View Abstract | |
9:31 AM - 9:36 AM | Does Endovascular Or Open Surgical Treatment Of TAAAs Yield A Survival Benefit |
Presenter(s):Florian Dick, MD | |
View Abstract | |
9:37 AM - 9:42 AM | With TBADs Secondary Interventions To Get Improved False Lumen Exclusion Is Important: How To Do It With Stents, Plugs, Coils: When Should They Be Done |
Presenter(s):Joseph V. Lombardi, MD | |
View Abstract | |
9:43 AM - 9:48 AM | Thoracoabdominal Aneurysm Sac Perfusion And Motor Evoked Potentials To Decrease Spinal Cord Ischemia With BEVAR Procedures: Tips And Tricks |
Presenter(s):Piotr M. Kasprzak, MD | |
View Abstract | |
9:49 AM - 9:54 AM | How To Protect A Left Internal Mammary Artery Coronary Bypass In Aortic Arch Interventions |
Presenter(s):Tilo Koelbel, MD, PhD | |
View Abstract | |
9:55 AM - 10:00 AM | How Durable Are Today’s TEVAR Devices: What Is The Need For Secondary Interventions To Fix Device Related Problems |
Presenter(s):Ronald M. Fairman, MD | |
View Abstract | |
10:01 AM - 10:10 AM | Panel Discussion |
10:10 AM - 10:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
MORE THORACIC AORTA AND ARCH BRANCH RELATED TOPICS
Moderators:Alan M. Dietzek, MD, RPVI, FACS / Dennis F. Bandyk, MD
|
|
x | |
10:30 AM - 10:35 AM | Endovascular Treatment Of Aortic And Branch Takayasu’s Disease: When Does It Work And When Does It Not: Based On An Asian Experience |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
10:36 AM - 10:41 AM | Endovascular Treatment Of Takayasu’s Disease: What Is Its Value: Based On A 10-Year South American Experience |
Presenter(s):Arno von Ristow, MD | |
View Abstract | |
10:42 AM - 10:47 AM | What Cardiac Surgeons Do Not Know About Acute Type A And Type B Aortic Dissections |
Presenter(s):Firas F. Mussa, MD | |
View Abstract | |
10:48 AM - 10:53 AM | Value Of Hepatorenal Bypass To Facilitate Treatment Of TBADs And Complex AAAs |
Presenter(s):Joseph S. Giglia, MD | |
View Abstract | |
10:54 AM - 10:59 AM | Retroperitoneal Access To Target Arteries: A Bailout Procedure When Prograde Branch Catheterization Does Not Work For F/B EVAR |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
11:00 AM - 11:05 AM | Treatment Of Distal Aortic Growth After TEVAR For TBADs |
Presenter(s):James H. Black III, MD | |
View Abstract | |
11:06 AM - 11:14 AM | Panel Discussion |
11:15 AM - 11:20 AM | What Is The Difference Between A Penetrating Aortic Ulcer And A Saccular Aneurysm: Why It Matters |
Presenter(s):Benjamin M. Jackson, MD | |
View Abstract | |
11:21 AM - 11:26 AM | Tips And Tricks For Open Repair After Failed TEVAR |
Presenter(s):Karl H. Orend, MD | |
View Abstract | |
11:27 AM - 11:32 AM | Open Surgical Adjuncts To Preserve Failing Infrarenal Endografts And Creative Non-Femoral Access Options |
Presenter(s):Martin R. Back, MD | |
View Abstract | |
11:33 AM - 11:38 AM | Chronic Aortic Aneurysms After TBADs: Incidence And Treatment Methods: Long-Term Outcomes Are Poor |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Abstract | |
11:39 AM - 11:44 AM | How Can Patients With An Aorto-Esophageal Fistula After TEVAR Be Salvaged |
Presenter(s):Jürg Schmidli, MD | |
View Abstract | |
11:45 AM - 11:50 AM | How To Identify Healthy Aorta For A Landing Zone In Endovascular Aneurysm Repairs: It May Not Always Be Possible |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
11:51 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
CAROTID RELATED TOPICS AND RECENT ADVANCES IN ACUTE STROKE TREATMENT
Moderators:Ali F. AbuRahma, MD / Anthony J. Comerota, MD, FACS, FACC
|
|
x | |
1:00 PM - 1:05 PM | Should Patients With Chronic Renal Insufficiency Undergo CAS Or CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Gender Specific Outcomes For CEA And CAS: Results From The SVS Registry Show That CEA Is Better In Both Men And Women |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Abstract | |
1:12 PM - 1:17 PM | CAS Is Still Not As Cost Effective As CEA: But That May Change |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Abstract | |
1:18 PM - 1:23 PM | With Symptomatic Carotid Stenosis Are The Results Of NASCET And ECST Obsolete In View Of Advances In Medical Therapy |
Presenter(s):Alison Halliday, MS, FRCS | |
View Abstract | |
1:24 PM - 1:29 PM | Which Asymptomatic Carotid Stenosis Patients Should Currently Be On Statins And Medical Therapy And Which Should Get This Treatment Plus CEA Or CAS: When Will We Know For Sure And What Should We Do Now |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
1:30 PM - 1:35 PM | How Common Are Carotid Stent Fractures After CAS And What Is Their Clinical Significance |
Presenter(s):Richard J. Powell, MD | |
View Abstract | |
1:36 PM - 1:42 PM | Panel Discussion |
RECENT PROGRESS IN ACUTE STROKE TREATMENT | |
Moderator(s): Klaus D. Mathias, MD / Mayank Goyal, MD, FRCPC | |
1:42 PM - 1:47 PM | Recent Improvements In Acute Stroke Management: Impact Of New Clot Aspiration Techniques And Stent-Clot Retrievers |
Presenter(s):Stefan Mueller-Hülsbeck, MD | |
View Abstract | |
1:48 PM - 1:53 PM | New Developments In Acute Stroke Endovascular Treatment: Value Of Stent-Clot Retriever Systems (Solitaire From Covidien) Coupled With Balloon Guide Catheters To Decrease Forward Arterial Flow |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
1:54 PM - 1:59 PM | New Developments In Acute Stroke Management And Endovascular Devices For Clot Removal And Managing Acute Carotid Occlusions: Success And Adverse Event Rates |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
2:00 PM - 2:11 PM | Panel Discussion |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
MORE CAROTID RELATED TOPICS
Moderators:R. Clement Darling III, MD / Cynthia K. Shortell, MD
|
|
x | |
2:11 PM - 2:16 PM | Inefficient Distal Embolic Filters A Cause Of Stroke With CAS: What Can Be Done To Offset This |
Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA | |
View Abstract | |
2:17 PM - 2:22 PM | How To Make CAS In Recently Symptomatic Carotid Stenosis Patients Safe: When Can CAS Compete With CEA In Such Patients |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Abstract | |
2:23 PM - 2:28 PM | CEA Under Local Anesthesia: Was The GALA Trial Misleading: How Can This Lower Costs In The ACA Era |
Presenter(s):Dipankar Mukherjee, MD | |
View Abstract | |
2:29 PM - 2:34 PM | How To Improve The Results Of Early CEA For Stroke |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
2:35 PM - 2:40 PM | How To Perform CAS Safely In Patients With A Non-Circumferential Severely Calcified Carotid Stenosis |
Presenter(s):Gioachino Coppi, MD | |
View Abstract | |
2:41 PM - 2:46 PM | The Game Is Finally Changing With Carotid Disease: When And How to Intervene Beyond Good Medical Therapy |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
View Abstract | |
2:47 PM - 2:52 PM | Tips And Tricks For Performing CAS With Difficult Arch Anatomy |
Presenter(s):Enrico M. Marone, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
2:53 PM - 2:58 PM | CEA In Women: Still Searching For Parity In Access To Treatment: Why Does This Occur And What Is Its Impact |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
2:59 PM - 3:04 PM | Which Specialty Gets The Best Outcomes With CEA; With CAS |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
3:05 PM - 3:10 PM | Clinical Volume Correlates With Outcomes For CAS: It Is Undeniable |
Presenter(s):Carlos H. Timaran, MD | |
View Abstract | |
3:11 PM - 3:17 PM | Panel Discussion |
3:17 PM - 3:24 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
LOWER EXTREMITY AND MISCELLANEOUS TOPICS
Moderators:Vivian Gahtan, MD / Calogero Presti, MD
|
|
x | |
3:24 PM - 3:29 PM | Gracilis Muscle Flap To Heal Groin Wounds With Infected Vascular Grafts: How To Do It And Results |
Presenter(s):John F. Eidt, MD | |
View Abstract | |
3:30 PM - 3:35 PM | Significance And Interpretation Of TLR (Target Lesion Revascularization) And Why TLR And Primary Patency Measures In Clinical Trials Can Be Misleading |
Presenter(s):John R. Laird, MD | |
View Abstract | |
3:36 PM - 3:41 PM | Why The TASC Classification Is No Longer Valid As A Treatment Guide |
Presenter(s):Klaus D. Mathias, MD | |
View Abstract | |
3:42 PM - 3:47 PM | Has The Increase In Lower Extremity Interventions Led To Lower Major Amputation Rates |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
3:48 PM - 3:53 PM | Tips And Tricks For OCT Guided Crossing Of Difficult SFA And Popliteal CTOs: A Way To Decrease Radiation Exposure |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
3:54 PM - 3:59 PM | Value And Limitations Of Subintimal PTA Of Aortic And Iliac Occlusive Lesions: Tips And Tricks |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
4:00 PM - 4:05 PM | Optimal Strategies For Dealing With Heavily Calcified SFA Lesions |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
4:06 PM - 4:11 PM | Endovascular Treatment Of Arterial Complications Of Pancreatitis: Tips And Tricks |
Presenter(s):Maria Antonella Ruffino, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Importance Of Distal Embolization After SFA Interventions And How To Prevent And Treat It |
Presenter(s):Nicholas J. Morrissey, MD | |
View Abstract | |
4:18 PM - 4:23 PM | Hybrid Procedures In The Lower Extremity: Are They Effective And Which Are The Factors That Determine Durability |
Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS | |
View Abstract | |
4:24 PM - 4:31 PM | Panel Discussion |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
MORE LOWER EXTREMITY AND MISCELLANEOUS TOPICS
Moderators:Kenneth Ouriel, MD, MBA / Peter A. Schneider, MD
|
|
x | |
4:31 PM - 4:36 PM | Do Anti-MRSA Agents Prophylactically Prevent Groin Infection After Vascular Procedures: A RCT: What Regimen Should We Use |
Presenter(s):Patrick A. Stone, MD | |
View Abstract | |
4:37 PM - 4:42 PM | Key Technical Tips For Preventing Groin Incision Infections And Decreasing Readmissions And Hospital Costs |
Presenter(s):Peter Henke, MD | |
View Abstract | |
4:43 PM - 4:48 PM | In Hemodialysis Diabetic Patients With CLI And Gangrene: When Is A Primary Amputation The Right Treatment Option And When Should Revascularization Be Attempted |
Presenter(s):Mark G. Davies, MD | |
View Abstract | |
4:49 PM - 4:54 PM | How IVUS Can Be Helpful In Treating Lower Extremity Ischemia And The Lesions Causing It |
Presenter(s):Fabrizio Fanelli, MD, EBIR | |
View Abstract | |
4:55 PM - 5:00 PM | A Special New Technique For Spinal Artery Mapping To Aid In Preservation Of Its Flow And Decrease Cord Ischemia With Thoracic Aortic Procedures |
Presenter(s):Jeffrey Indes, MD | |
View Abstract | |
5:01 PM - 5:06 PM | Tips And Tricks For Performing Optimal And Adequate Debridements Of Diabetic Foot Infections |
Presenter(s):Giustino Marcucci, MD | |
View Abstract | |
5:07 PM - 5:12 PM | How Should Lower Extremity Post PTA Dissections Be Managed And Why Do “Bail Out Stenting” Rates Vary So Much |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
5:13 PM - 5:18 PM | Tips And Tricks To Make CFA Stenting Successful: When Is It Indicated |
Presenter(s):George H. Meier III, MD | |
View Abstract | |
5:19 PM - 5:24 PM | Tips And Tricks To Make A Radial Artery Approach Applicable To Most Endovascular Interventions |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
5:25 PM - 5:30 PM | Spiral Flow Prosthetic Grafts In Lower Extremity Bypasses: 1-Year Results And Beyond |
Presenter(s):Nick J. Shaper, FRCS | |
View Abstract | |
5:31 PM - 5:36 PM | Results And Cost Effectiveness Of Carbon Dioxide As Contrast Media For Revascularization Of TAXD A And B Femoro-Popliteal Lesions: A Prospective RCT |
Presenter(s):Mariana Krutman, MD | |
View Abstract | |
5:37 PM - 5:43 PM | Duplex Guided Angioplasty And Stenting vs. Conventional Endovascular Technique In Femoro-Popliteal Occlusive Disease: Comparative Results |
Presenter(s):Eduardo F. Rocha, MD | |
View Abstract | |
5:43 PM - 5:53 PM | Panel Discussion End of Program K |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
MORE STRATEGIC METHODS TO DEAL WITH SAPHENOUS INCOMPETENCE AND VARICOSE VEINS
Moderators:Lowell S. Kabnick, MD, RPhS, FACS, FACPh
|
|
x | |
6:49 AM - 6:54 AM | RCT Comparing Open Surgery, Radiofrequency, Laser Or Foam Sclerotherapy For Varicose Veins |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
6:55 AM - 7:00 AM | Why Is The SVS-VQI Venous Registry Critical |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
7:01 AM - 7:06 AM | Thermal Ablation On Anticoagulated Patients: Is It Durable And Effective |
Presenter(s):Glenn Jacobowitz, MD | |
View Abstract | |
7:07 AM - 7:12 AM | When LEED Isn’t Enough: The Distribution Of Thermal Energy In The Vein Wall After Endovenous Thermal Ablation |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
7:13 AM - 7:18 AM | Investigating The Effects Of Sclerotherapy And MOCA With Histology And Immunocytochemistry |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
7:19 AM - 7:24 AM | Extreme C6 Cases And Endovenous Solutions |
Presenter(s):Ignacio Escotto, MD | |
View Abstract | |
7:25 AM - 7:30 AM | Do The Economic Benefits Of Earlier Surgery Trump The Current Conservative Non-Operative Approach To The Healing Of Venous Ulcers |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
7:31 AM - 7:36 AM | Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
7:37 AM - 7:42 AM | Partial Crossectomy With Branch Preservation And Venoplasty Of Saphenous Bulb |
Presenter(s):Gioachino Coppi, MD | |
7:43 AM - 7:48 AM | Use Of Mechanical Chemical Ablation In Non Saphenous Veins |
Presenter(s):Julianne Stoughton, MD, FACS | |
View Abstract | |
7:49 AM - 7:54 AM | Step By Step Use Of Cyanoacrylate For Saphenous Ablation |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
7:55 AM - 8:00 AM | Neurological Complications Of Sclerotherapy For Varicose Veins |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
8:01 AM - 8:06 AM | Radiofrequency Treatment Of Perforating Veins For Recalcitrant Venous Ulcers: How To Do It And Does It Help |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
8:07 AM - 8:12 AM | Superficial Vein Thrombophlebitis: To Treat Or Not To Treat |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
8:13 AM - 8:18 AM | Saphenous Ablation Of Complex Anatomy: Tips And Tricks |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
8:19 AM - 8:24 AM | The Role Of Truncal Ablation In Venous Ulceration: Is Timing Key |
Presenter(s):Manj S. Gohel, MD, FRCS | |
View Abstract | |
8:25 AM - 8:30 AM | Panel Discussion |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
MORE STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION
|
|
x | |
8:31 AM - 8:36 AM | Surgical Reconstruction Of The Deep Veins |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
8:37 AM - 8:42 AM | Neo-Valve Reconstruction In The Post-Thrombotic Syndrome |
Presenter(s):Marzia Lugli, MD | |
8:43 AM - 8:48 AM | What Is Worse: Obstruction Or Reflux? |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
8:55 AM - 9:00 AM | What Comprises The Chronic Venous Obstruction Of Post -Thrombotic Syndrome? |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
9:01 AM - 9:06 AM | Reduction Internal Valvuloplasty (RIVAL) - A New Technique For Deep Vein Valve Reconstruction: Early Results |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
9:07 AM - 9:12 AM | Panel Discussion |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
OTHER MISCELLANEOUS VENOUS CONDITIONS
Moderators:Thomas F. O'Donnell, Jr., MD / Joann Lohr, MD
|
|
x | |
9:13 AM - 9:18 AM | Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
9:19 AM - 9:24 AM | Anomalous Features Of Iliac Vein Stenosis That Impact Diagnosis And Treatment |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Quality Of Life Assessment After Iliac Vein Stenting For DVT From May-Thurner Syndrome |
Presenter(s):Todd Berland, MD | |
View Abstract | |
9:31 AM - 9:36 AM | Optimal Management Of Isolated Gastrocnemius Or Soleal Vein Thrombosis (ISGVT) |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
9:37 AM - 9:42 AM | Non-Venous Vascular Complications Of Pregnancy |
Presenter(s):Joann Lohr, MD | |
View Abstract | |
9:43 AM - 9:48 AM | Knowns And Unknowns About Popliteal Venous Aneurysms |
Presenter(s):Ido Weinberg, MD, MSc | |
View Abstract | |
9:49 AM - 9:54 AM | What Is Short-Stretch Compression And Why Is That Important For Vascular Surgeons? |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
9:55 AM - 10:00 AM | Lymphedema In Cancer Patients Is Usually Due To Venous Obstructions And Therefore Treatable |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
10:01 AM - 10:06 AM | PAVA – More Understanding Of Peri-Adventitial Venous Abnormalities |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
10:07 AM - 10:12 AM | Venous Embryology |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
View Abstract | |
10:13 AM - 10:18 AM | RCT Demonstrating The Efficacy And Benefits Of Sulodexide Treatment In Patients With Venous Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
10:19 AM - 10:24 AM | AVM And VM Are As Different As Apple And Orange |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
10:25 AM - 10:30 AM | Is There A Role For Percutaneous Suture Mediated Closure Systems In Venous Interventions: Tips And Tricks |
Presenter(s):Brian G. DeRubertis, MD | |
View Abstract | |
10:31 AM - 10:36 AM | Update On Caprini DVT Risk Assessment Score |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
10:37 AM - 10:42 AM | How To Properly Design And Interpret Clinical Trials |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
10:43 AM - 10:48 AM | Panel Discussion |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
PELVIC INCOMPETENCE AND ITS CONSEQUENCES
|
|
x | |
10:49 AM - 10:54 AM | Diagnosis And Treatment Paradigm For Patients With Pelvic Venous Congestion Syndrome |
Presenter(s):Melvin Rosenblatt, MD | |
View Abstract | |
10:55 AM - 11:00 AM | Pelvic Congestion Syndrome: Current Principles Of Diagnostic Duplex Imaging |
Presenter(s):Melvin Rosenblatt, MD | |
View Abstract | |
11:01 AM - 11:06 AM | Pelvic Congestion Syndrome: Current Principles Of Diagnostic Cross-Sectional Imaging |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
View Abstract | |
11:07 AM - 11:12 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein? |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
11:13 AM - 11:18 AM | Embolization Has A Major Role In The Treatment Of Varicocele And Pelvic Congestion Syndrome |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
11:19 AM - 11:24 AM | Pelvic Vein Reflux – Are Hemorrhoids The Next Target? |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
11:25 AM - 11:30 AM | The Safety Of Coil Embolization Of Pelvic Veins And Subsequent Pregnancy |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
11:31 AM - 11:36 AM | Ovarian Vein, Hypogastric Vein Incompetence Or Compression Syndrome: Coil, Stent, Both, Neither? |
Presenter(s):Constantino Pena, MD | |
View Abstract | |
11:37 AM - 11:42 AM | Left Renal Vein Stenting Pitfalls |
Presenter(s):Constantino Pena, MD | |
View Abstract | |
11:43 AM - 11:48 AM | How To Treat Vulvar Veins Before Or After Pelvic Embolization |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Abstract | |
11:49 AM - 11:54 AM | Acute Or Chronic Ovarian Vein Thrombosis: What To Do? |
Presenter(s):Mikel Sadek, MD | |
View Abstract | |
11:55 AM - 12:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
MORE STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO-SUBCLAVIAN SYSTEM
Moderators:Thomas W. Wakefield, MD / Gregory L. Moneta, MD
|
|
x | |
1:00 PM - 1:05 PM | Endovascular Management Of Ilio-Femoral DVT With Percutaneous Thrombectomy And Thrombolysis: Indications, Techniques And Results |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:06 PM - 1:11 PM | Pharmacomechanical Thrombolysis Of Large Volume (Extensive) DVT Using The Rapid Lysis Technique Minimizing The Need For Catheter Directed Lysis |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Methods Of Aging Of Deep Vein Thrombosis |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
1:18 PM - 1:23 PM | Rheolytic Thrombectomy For Deep Vein Thrombosis: Final Report Of A Prospective Multi-Center Registry |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:24 PM - 1:29 PM | Appropriate Use Of D-Dimer Testing Can Minimize Over-Utilization Of Venous Duplex Ultrasound In A Contemporary High-Volume Hospital |
Presenter(s):Albeir Y. Mousa, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Portal Vein Thrombosis: Techniques For Treating And Recanalizing |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
1:36 PM - 1:41 PM | What’s New In Thoracic Outlet Syndrome Treatment And Reporting Standards: When If Ever Should Neurologic TOS Be Treated? |
Presenter(s):Karl A. Illig, MD | |
View Abstract | |
1:42 PM - 1:48 PM | DEBATE: Warfarin Is Still The Treatment Of Choice For VTE: The Noacs Are Not Ready For Prime Time |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
1:49 PM - 1:54 PM | DEBATE: Warfarin Is NOT Still The Treatment Of Choice For VTE: The Noacs Are Ready For Prime Time |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
1:55 PM - 2:00 PM | The Value Of Non-Invasive Diagnosis Of Venous Obstruction At The Thoracic Outlet |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:01 PM - 2:06 PM | Incidence Of Upper Extremity DVT After Central Venous Catheterization And What To Do About It |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
2:07 PM - 2:12 PM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting? |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:13 PM - 2:18 PM | Panel Discussion |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS
Moderators:Peter Gloviczki, MD / William J. Quinones-Baldrich, MD
|
|
x | |
2:19 PM - 2:24 PM | IVC Replacement For Malignancy: How To Do It And What Is The Best Graft |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
2:25 PM - 2:30 PM | Endovascular Reconstruction Techniques For Chronic IVC Occlusions |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
2:31 PM - 2:36 PM | Role Of Z-Stent In Iliocaval And Caval Stenting |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
2:37 PM - 2:42 PM | IVC Agenesis: Is This A Real Entity |
Presenter(s):David M. Williams, MD | |
View Abstract | |
2:43 PM - 2:48 PM | Management Of Tumor Thrombus From Renal Cell Carcinoma Extending Into Supra Hepatic IVC And Right Heart |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
2:49 PM - 2:54 PM | Patient Selection For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
2:55 PM - 3:00 PM | Exposure And Techniques For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
3:01 PM - 3:06 PM | Conduit Choices For In-Line Caval Reconstruction |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
3:07 PM - 3:12 PM | Caval Tumors |
Presenter(s):William A. Marston, MD | |
View Abstract | |
3:13 PM - 3:18 PM | Catheter-Based Interventions For Caval Thrombosis: Which Is The Best |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
3:19 PM - 3:24 PM | Panel Discussion |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
Moderators:Paul J. Foley III, MD / Ramesh K. Tripathi, MD, FRCS, FRACS
|
|
x | |
VENA CAVA FILTRATION | |
3:25 PM - 3:30 PM | IVC Filters In Acute DVT: Necessary Or Expensive Luxury? |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
3:31 PM - 3:36 PM | Update On The PRESERVE Vena Cava Filter Study |
Presenter(s):David L. Gillespie, MD | |
View Abstract | |
3:37 PM - 3:42 PM | Remove Tilted IVC Filters Immediately: Complications Are Inevitable |
Presenter(s):Werner Lang, MD | |
View Abstract | |
3:43 PM - 3:48 PM | Indications For IVC Filters – Are They Being Observed? |
Presenter(s):John E. Rectenwald, MD, MS | |
View Abstract | |
3:49 PM - 3:54 PM | Successful Techniques For Challenging IVC Filter Retrieval (Permanent And Temporary IVC Filters) |
Presenter(s):Paul J. Foley III, MD | |
View Abstract | |
3:55 PM - 4:00 PM | Why Aren’t Retrievable IVC Filters Retrieved? |
Presenter(s):Ronald L. Dalman, MD | |
View Abstract | |
4:01 PM - 4:06 PM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
4:07 PM - 4:12 PM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Abstract | |
4:13 PM - 4:18 PM | What Evidence Is There That IVC Filters Save Lives? |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
4:19 PM - 4:24 PM | The Prepic Trial – Fact Or Fiction? |
Presenter(s):John E. Rectenwald, MD, MS | |
View Abstract | |
4:25 PM - 4:30 PM | Panel Discussion |
MORE ON STENTS | |
4:31 PM - 4:36 PM | First Experiences With The Veniti And Zilver Vena Stents |
Presenter(s):Stephen A. Black , MD | |
View Abstract | |
4:37 PM - 4:42 PM | Nitinol Versus Wall Stents For Iliac Vein Stenting For Lower Limb Outflow Obstruction: Does It Really Matter? What Is An Ideal Venous Stent? |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
4:43 PM - 4:48 PM | VIVO Venous Stent IDE Trial Design |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
4:49 PM - 4:54 PM | Pregnancy After Stenting For Ilio-Femoral DVT: Outcome And Complications |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
4:55 PM - 5:00 PM | What Is The Nature Of In-Stent Stenosis After Venous Stenting? |
Presenter(s):David M. Williams, MD | |
View Abstract | |
5:01 PM - 5:10 PM | Panel Discussion End of Program M |
END OF SESSION 96 | |
Saturday, November 22, 2014
Print Entire 2014 Program:
|
|
SESSION 97 SCHEDULE | |
Saturday
SESSION 97:
BASICS OF SUPERFICIAL VENOUS DISEASE
|
|
x | |
8:00 AM - 8:05 AM | Welcome: Tour Of C1 - C6 Venous Disease |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
8:06 AM - 8:11 AM | Venous Valvular Physiology |
Presenter(s):Fedor Lurie, MD, PhD | |
8:12 AM - 8:17 AM | Venous Embryology: Part 1 |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
8:18 AM - 8:23 AM | Venous Embryology: Part 2 |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
8:24 AM - 8:29 AM | Important Superficial Venous Anatomy |
Presenter(s):Jean Francois Uhl, MD, FACPh | |
8:30 AM - 8:35 AM | Venous Mapping: How Detailed Should This Be |
Presenter(s):Neil M. Khilnani, MD | |
View Abstract | |
8:36 AM - 8:41 AM | Evolution Of Superficial Venous Insufficiency: Ascending Or Descending Theory |
Presenter(s):Sylvain Chastanet, MD | |
View Abstract | |
8:42 AM - 8:47 AM | Is It The Weakened Venous Wall Or The Valve That Causes Varicose Veins |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
8:48 AM - 8:53 AM | Venous Disease Pathophysiology: Which Patients Progress To Tissue Damage At The Ankle |
Presenter(s):Peter J. Pappas, MD | |
View Abstract | |
8:54 AM - 9:00 AM | Panel Discussion |
END OF SESSION 97 | |
SESSION 98 SCHEDULE | |
Saturday
SESSION 98:
EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 1
|
|
x | |
9:01 AM - 9:06 AM | How To Use CEAP And VCSS Properly |
Presenter(s):William A. Marston, MD | |
View Abstract | |
9:07 AM - 9:12 AM | What Determines The Clinical Severity Of Superficial Venous Disease |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
9:13 AM - 9:18 AM | What Kind Of Duplex Image Should We Expect After Endovenous Ablation |
Presenter(s):Jean Luc Gerard, MD | |
View Abstract | |
9:19 AM - 9:24 AM | Clinical Findings Do Not Match The Ultrasound: What Do You Do |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Investigating The Effects Of Sclerotherapy And MOCA With Histology And Immunocytochemisty |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
9:31 AM - 9:36 AM | Step By Step Use Of 1470nm Laser To Ablate Perforators And Indications |
Presenter(s):Mark A. Adelman, MD | |
9:37 AM - 9:42 AM | Step By Step Use Of Mechanical-Chemical Ablation In Non-Saphenous Veins |
Presenter(s):Julianne Stoughton, MD, FACS | |
View Abstract | |
9:43 AM - 9:48 AM | Step By Step Use Of Proprietary Foam For Saphenous Ablation And Indications |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
9:49 AM - 9:54 AM | Step By Step Treatment Of Recurrent Veins Following Endovenous Thermal Ablation, Incidence And Causes |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
9:55 AM - 10:00 AM | Panel Discussion |
END OF SESSION 98 | |
SESSION 99 SCHEDULE | |
Saturday
SESSION 99:
EVALUATION AND MANAGEMENT OF SUPERFICIAL VENOUS DISEASE - PART 2
|
|
x | |
10:01 AM - 10:06 AM | Step By Step Use Of Sclerotherapy For Large Varicose Tributaries And Why |
Presenter(s):Neil M. Khilnani, MD | |
View Abstract | |
10:07 AM - 10:12 AM | Step By Step Use Of Ambulatory Phlebectomy For Large Varicose Tributaries And Why |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
10:13 AM - 10:18 AM | Efficacy Of Powered Phlebectomy For Large Symptomatic Varicosites |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
10:19 AM - 10:24 AM | Steps To Treat The Small Saphenous Cranial Extension |
Presenter(s):Randolph Todd C. Jones, MD | |
View Abstract | |
10:25 AM - 10:30 AM | Steps To Avoid Endothermal Heat Induced Thrombosis |
Presenter(s):Mikel Sadek, MD | |
View Abstract | |
10:31 AM - 10:36 AM | Steps To Avoid Complications Of Foam And Liquid Sclerotherapy |
Presenter(s):Edward G. Mackay, MD | |
View Abstract | |
10:37 AM - 10:42 AM | Steps To Avoid Thermal Ablation Complications |
Presenter(s):David J. Dexter, MD | |
View Abstract | |
10:43 AM - 10:48 AM | Steps To Avoid Nerve Damage |
Presenter(s):Jean Luc Gerard, MD | |
View Abstract | |
10:49 AM - 10:54 AM | Steps To Avoid Thermal Skin Damage |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
10:55 AM - 11:00 AM | Panel Discussion |
END OF SESSION 99 | |
SESSION 100 SCHEDULE | |
Saturday
SESSION 100:
FUTURE OF VENOUS DISEASE
|
|
x | |
11:01 AM - 11:06 AM | Who Will Treat Varicose Veins And Who Will Pay For The Treatment In The Future |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
11:07 AM - 11:12 AM | What Do The Quality Measures (QM) Measure: Analysis Of PQRS (Physician Quality Reporting System) For Venous Disease |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
11:13 AM - 11:18 AM | Future Of Venous Reimbursement: Pressures From CMS |
Presenter(s):Glenn Jacobowitz, MD | |
View Abstract | |
11:19 AM - 11:24 AM | Update: Intersocietal Accreditation Commission – Vein Center |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
11:25 AM - 11:30 AM | A One Stop Vein Clinic: The Ideal Option |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) | |
View Abstract | |
11:31 AM - 11:36 AM | A Plea For A National Coverage Determination Policy |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
11:37 AM - 11:42 AM | Why Is The SVS-VQI Venous Registry Critical |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
11:43 AM - 11:48 AM | Update On The Management Of Lymphedema |
Presenter(s):Raghu Kolluri, MD | |
View Abstract | |
11:49 AM - 11:54 AM | Partial Crossectomy With “Branch” Preservation And Venoplasty Of Saphenous Bulb |
Presenter(s):Gioachino Coppi, MD | |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 3rd Floor Foyer and Promenade Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 100 | |
SESSION 101 SCHEDULE | |
Saturday
SESSION 101:
EVIDENCE AND RESEARCH NEEDED FOR ENDOVENOUS TREATMENT
|
|
x | |
1:00 PM - 1:05 PM | Endovenous Thermal Ablation RCTs: Do We Know Enough |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | Should The UK Nice Guidelines Be The Same As The SVS/AVF |
Presenter(s):Chung S. Lim, MBBS, MRCS, PhD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
1:12 PM - 1:17 PM | How Should Society Allocate Resources For Venous Disease |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
1:18 PM - 1:23 PM | Venous Ulcers - An Algorithm For Management |
Presenter(s):Peter F. Lawrence, MD | |
View Abstract | |
1:24 PM - 1:29 PM | DEBATE: Ultrasound Is Mandatory After Saphenous Ablation |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Ultrasound Is Not Mandantory After Saphenous Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
1:36 PM - 1:41 PM | Extreme C6 Cases And Endovenous Solutions |
Presenter(s):Ignacio Escotto, MD | |
View Abstract | |
1:42 PM - 1:47 PM | Not All Skin Ulcers Are Venous |
Presenter(s):Raghu Kolluri, MD | |
View Abstract | |
1:48 PM - 1:53 PM | Thermal Ablation On Anticoagulated Patients: Is It Durable And Effective |
Presenter(s):Glenn Jacobowitz, MD | |
View Abstract | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 101 | |
SESSION 102 SCHEDULE | |
Saturday
SESSION 102:
MORE TOPICS REGARDING TRUNCAL REFLUX, CLUSTERS AND SPIDER TELANGIECTASIA
|
|
x | |
2:01 PM - 2:06 PM | A Prospective Observational Study Comparing 810nm And 1470nm Wavelength For Great Saphenous Laser Ablation |
Presenter(s):Ian C. Chetter, MD, FRCS | |
View Abstract | |
2:07 PM - 2:12 PM | Is 1920nm Wavelength The Future Of Venous Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
2:13 PM - 2:18 PM | Primary CVD: Which Patients Should You Intervene On Early (GSV Ablation Correct Hemodynamics) And If You Intervene Will It Reduce Or Prevent The Progression To Higher Clinical Class |
Presenter(s):Joseph D. Raffetto, MD | |
View Abstract | |
2:19 PM - 2:24 PM | Homemade Foam Versus FDA Approved Manufactured Foam: Risks And Rewards |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
2:25 PM - 2:30 PM | 5-Year Results Of A Randomized Clinical Trial Comparing Concomitant And Sequential Phlebectomy Following Endovenous Laser Ablation |
Presenter(s):Ian C. Chetter, MD, FRCS | |
View Abstract | |
2:31 PM - 2:36 PM | How Real Are Venous Thromboembolic Complications With Endovenous Thermal Ablation: Paradox Between RCTs, Large Observational Case Series, And Registry Data |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
2:37 PM - 2:42 PM | Radiofrequency Ablation Treatment Pearls |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Abstract | |
2:43 PM - 2:48 PM | Laser Ablation Treatment Pearls |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Abstract | |
2:49 PM - 2:54 PM | Sclerotherapy Pearls |
Presenter(s):Julianne Stoughton, MD, FACS | |
View Abstract | |
2:55 PM - 3:00 PM | Cutaneous Laser Pearls: When And How To Use For Spider Veins |
Presenter(s):Ian J. Franklin, MS, FRCS (Gen Surg) | |
View Abstract | |
3:01 PM - 3:06 PM | Mechanico-Chemical Ablation Pearls |
Presenter(s):Steve Elias, MD | |
View Abstract | |
3:13 PM - 3:18 PM | Panel Discussion |
END OF SESSION 102 | |
SESSION 103 SCHEDULE | |
Saturday
SESSION 103:
ENDOVENOUS CASE PRESENTATION, PRE-RECORDED VIDEO, EVIDENCE AND MORE
|
|
x | |
3:19 PM - 3:29 PM | Saphenous Ablation |
Presenter(s):Jose I. Almeida, MD, RPVI, RVT, FACS | |
View Abstract | |
3:29 PM - 3:33 PM | Discussion/Q&A |
3:34 PM - 3:44 PM | Pelvic Congestion Syndrome |
Presenter(s):Neil M. Khilnani, MD | |
View Abstract | |
3:44 PM - 3:48 PM | Discussion/Q&A |
3:49 PM - 3:59 PM | Predictive Value Of A Preoperative Test For The Reversibility Of The Reflux After Phlebectomy With Preservation Of The Great Saphenous Vein |
Presenter(s):Sylvain Chastanet, MD | |
3:59 PM - 4:03 PM | Discussion/Q&A |
4:04 PM - 4:14 PM | A New Look At Venous Hemodynamics: Importance Of Measuring Both Reflux And Venous Outflow Obstruction |
Presenter(s):Andrew N. Nicolaides, MS | |
4:14 PM - 4:18 PM | Discussion/Q&A |
4:19 PM - 4:29 PM | How To Treat Exotic Veins – Hand, Foot, And Vulvar Veins |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Abstract | |
4:29 PM - 4:33 PM | Discussion/Q&A |
4:34 PM - 4:44 PM | Phlebectomy: How, When, And Why |
Presenter(s):Paul Pittaluga, MD | |
View Abstract | |
4:44 PM - 4:48 PM | Discussion/Q&A |
4:49 PM - 4:59 PM | Proper Application Of Bandages –Short Stretch And Why Is That Important For Vascular Surgeons |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
4:59 PM - 5:03 PM | Discussion/Q&A |
5:04 PM - 5:15 PM | Panel Discussion End of Program N |
END OF SESSION 103 | |
SESSION 104 SCHEDULE | |
Saturday
SESSION 104:
PREOPERATIVE PLANNING FOR HEMODIALYSIS ACCESS
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
8:00 AM - 8:07 AM | Review Of The SVS Guidelines For Hemodialysis Access |
Presenter(s):Robyn A. Macsata, MD | |
View Abstract | |
8:08 AM - 8:15 AM | Predialysis Planning To Optimize The Management Of The Patient With CKD |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
View Abstract | |
8:16 AM - 8:23 AM | Update On The Fistula First/Catheter Last Initiative |
Presenter(s):Lawrence M. Spergel, MD | |
View Abstract | |
8:24 AM - 8:31 AM | Algorithms To Avoid Central Venous Catheters At Dialysis Initiation |
Presenter(s):Charmaine Lok, MD | |
View Abstract | |
8:32 AM - 8:39 AM | Quality Benchmarks Of A Vascular Access Program |
Presenter(s):David L. Cull, MD, FACS | |
View Abstract | |
8:40 AM - 8:50 AM | Panel Discussion |
8:51 AM - 8:58 AM | Use Of The Noninvasive Vascular Laboratory In Dialysis Access |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Abstract | |
8:59 AM - 9:06 AM | Impact Of Transvenous Cardiac Devices On Vascular Access Placement And Patency |
Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN | |
View Abstract | |
9:07 AM - 9:14 AM | The Implications Of Transradial Approach For Cardiovascular Interventions On Hemodialysis Access |
Presenter(s):Theodore F. Saad, MD | |
View Abstract | |
9:15 AM - 9:22 AM | Anesthesia For Office Based Vascular Access Interventions |
Presenter(s):David Fox, MD, FACS | |
View Abstract | |
9:23 AM - 9:30 AM | Dialysis Access Cannulation: A Lost Art? |
Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
View Abstract | |
9:31 AM - 9:41 AM | Panel Discussion |
9:42 AM - 10:00 AM | Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 104 | |
SESSION 105 SCHEDULE | |
Saturday
SESSION 105:
OPTIMIZING OUTCOMES IN HEMODIALYSIS ACCESS
|
|
x | |
10:00 AM - 10:07 AM | Optimization Of Risk Factors To Maximize Vascular Access Patency |
Presenter(s):Charmaine Lok, MD | |
View Abstract | |
10:08 AM - 10:15 AM | How Do Cell Biology And Hemodynamics Impact AV Access Outcomes |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
View Abstract | |
10:16 AM - 10:23 AM | Medical Factors Affecting Patency Of AV Access Procedures |
Presenter(s):Robyn A. Macsata, MD | |
View Abstract | |
10:24 AM - 10:31 AM | Management Of Hypercoagulable States In Patients With End Stage Renal Disease |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Abstract | |
10:32 AM - 10:39 AM | Role Of Surveillance And Preemptive Intervention In Optimizing Hemodialysis Access Outcomes |
Presenter(s):Jack Work, MD | |
View Abstract | |
10:40 AM - 10:47 AM | The Role Of BAM In Autogenous Access Maturation |
Presenter(s):Gregg A. Miller, MD | |
View Abstract | |
10:48 AM - 10:58 AM | Panel Discussion |
10:59 AM - 11:06 AM | Challenges Of Vascular Access In The Elderly Patient |
Presenter(s):David L. Cull, MD, FACS | |
View Abstract | |
11:07 AM - 11:14 AM | Challenges Of Vascular Access In The Obese Patient |
Presenter(s):William Jennings, MD | |
View Abstract | |
11:15 AM - 11:22 AM | Challenges Of Vascular Access In The Patient With Lupus |
Presenter(s):Mitchell L. Henry, MD | |
View Abstract | |
11:23 AM - 11:30 AM | Update On The Results Of The REVISE, RESCUE And RENOVA Trials |
Presenter(s):John E. Aruny, MD | |
View Abstract | |
11:31 AM - 11:38 AM | Management Of Complications In An Office Based Practice |
Presenter(s):Gregg A. Miller, MD | |
View Abstract | |
11:39 AM - 11:49 AM | Panel Discussion |
11:50 AM - 12:30 PM | Lunch Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 105 | |
SESSION 106 SCHEDULE | |
Saturday
SESSION 106:
POLITICAL, ETHICAL AND LEGAL ISSUES IN HEMODIALYSIS
Moderators:John E. Aruny, MD / Mitchell L. Henry, MD
|
|
x | |
12:30 PM - 12:40 PM | Challenges And Opportunities In Hemodialysis Access In The Current Economic Climate |
Presenter(s):Robert Provenzano, MD | |
12:41 PM - 12:48 PM | The Affordable Care Act, Capitation, And Other Factors That Affect Our Hemodialysis Access Practice |
Presenter(s):Robert M. Zwolak, MD, PhD | |
12:49 PM - 12:56 PM | Medicolegal Risk Reduction In Hemodialysis Access Surgery |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
12:57 PM - 1:04 PM | Ethical Issues In Hemodialysis Access |
Presenter(s):James W. Jones, MD, PhD, MHA | |
1:05 PM - 1:12 PM | Coding For Hemodialysis Access Procedures: What’s New And What Lies Ahead |
Presenter(s):Sean P. Roddy, MD | |
1:13 PM - 1:20 PM | How The FDA Is Working To Improve The Quality Of Vascular Access For Dialysis Patients |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD | |
1:21 PM - 1:28 PM | Office Based Access Centers And Financial Impact On Practice |
Presenter(s):Clifford M. Sales, MD, MBA | |
1:29 PM - 1:39 PM | Panel Discussion |
END OF SESSION 106 | |
SESSION 107 SCHEDULE | |
Saturday
SESSION 107:
NEW TECHNOLOGIES AND CONCEPTS IN HEMODIALYSIS ACCESS
Moderators:Clifford M. Sales, MD, MBA / Eric Chemla, MD
|
|
x | |
1:40 PM - 1:47 PM | Endoluminal Anastomosis: Results With The Gore Hybrid Graft |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Abstract | |
1:48 PM - 1:55 PM | VWingTM Vascular Needle Guide For Improved AV Fistula Access |
Presenter(s):Marc H. Glickman, MD | |
View Abstract | |
1:56 PM - 2:03 PM | Clinical Experience With Tissue Engineered Grafts In Hemodialysis Access |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Abstract | |
2:04 PM - 2:11 PM | Spiral Laminar Flow Grafts In Hemodialysis Access |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
2:12 PM - 2:19 PM | OptiflowTM Device For Percutaneous AV Fistula Anastomosis |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
View Abstract | |
2:20 PM - 2:27 PM | NexSiteTM Catheter For Hemodialysis Access |
2:28 PM - 2:44 PM | Panel Discussion |
2:45 PM - 3:10 PM | Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 107 | |
SESSION 108 SCHEDULE | |
Saturday
SESSION 108:
UPDATE ON CLINICAL ISSUES IN HEMODIALYSIS ACCESS
Moderators:A. Frederick Schild, MD / Marc H. Glickman, MD
|
|
x | |
3:10 PM - 3:17 PM | The Role Of Peritoneal Dialysis In Patients With Difficult Hemodialysis Access |
Presenter(s):Jack Work, MD | |
View Abstract | |
3:18 PM - 3:25 PM | Current Status Of Biologic Grafts In Hemodialysis Access |
Presenter(s):Matthew J. Dougherty, MD | |
View Abstract | |
3:26 PM - 3:33 PM | Strategies For Use Of Early Access Grafts For Hemodialysis Access |
Presenter(s):Eric Chemla, MD | |
View Abstract | |
3:34 PM - 3:41 PM | Basilic Vein Transposition Using One Stage Or Two Stage Techniques |
Presenter(s):Mitchell L. Henry, MD | |
View Abstract | |
3:42 PM - 3:49 PM | Management Of The Massively Dilated AV Fistula |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Abstract | |
3:50 PM - 4:00 PM | Panel Discussion |
4:01 PM - 4:08 PM | Use Of Stent Grafts To Treat Cephalic Arch Stenosis |
Presenter(s):David Shemesh, MD, RVT | |
View Abstract | |
4:09 PM - 4:16 PM | Innovative Approaches To Treatment Of Central Venous Stenosis |
Presenter(s):Karl A. Illig, MD | |
View Abstract | |
4:17 PM - 4:24 PM | Role Of The HeRo Graft In Hemodialysis Access |
Presenter(s):Marc H. Glickman, MD | |
View Abstract | |
4:25 PM - 4:32 PM | An Individualized Approach To The Management Of Hand Ischemia Associated With Dialysis Access |
Presenter(s):Lawrence M. Spergel, MD | |
View Abstract | |
4:33 PM - 4:40 PM | Creating Access In A Patient With A History Of Steal Syndrome |
Presenter(s):William Jennings, MD | |
View Abstract | |
4:41 PM - 4:50 PM | Panel Discussion End of Program O |
END OF SESSION 108 | |
SESSION 109 SCHEDULE | |
Saturday
SESSION 109:
CLASSIFICATION, IMAGING, AND EMBOLIC AGENTS FOR VASCULAR ANOMALIES
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
8:00 AM - 8:10 AM | Current Classification And Nomenclature Of Vascular Malformations |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
View Abstract | |
8:10 AM - 8:20 AM | Vascular Tumors Confused With Vascular Malformations: Pediatric Hemangioma, RICH, NICH, KPH Of Liver, KPH Of Trunk With Kassabach-Merritt Syndrome |
Presenter(s):Francine Blei, MD, MBA | |
View Abstract | |
8:20 AM - 8:30 AM | New Imaging Modalities Essential For Accurate Diagnosis Of Vascular Malformations |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
8:30 AM - 8:40 AM | 2014 ISSVA Classification Of Vascular Anomalies: Update |
Presenter(s):Francine Blei, MD, MBA | |
View Abstract | |
8:40 AM - 8:50 AM | Techniques For Treating Vascular Malformations Of The Extremities |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
8:50 AM - 9:00 PM | Old Things About Arterio-Venous Lesions And Personal Classification |
Presenter(s):Emmanuel M. Houdart, MD | |
View Abstract | |
9:00 AM - 9:10 AM | The Houdart AVM Classification, The Cho-Do AVM Classification, And The Yakes AVM Classification And Its Therapeutic Implications |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
9:10 AM - 9:20 AM | Use Of Polymerizing Agents In The Endovascular Treatments Of AVMs |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
9:20 AM - 9:30 AM | Onyx AVM Embolotherapy: The Histologic Tissue Changes, The Tissue Inflammatory Response, And The Fluoroscopy Issues With Its Use |
Presenter(s):Mollie Meek, MD | |
View Abstract | |
9:30 AM - 9:40 AM | Sclerogel: A New Ethanol Based Embolic Agent To Treat Low-Flow Vascular Malformations |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
9:40 AM - 10:00 AM | Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 109 | |
SESSION 110 SCHEDULE | |
Saturday
SESSION 110:
MANAGEMENT OF HEAD AND NECK VASCULAR ANOMALIES
|
|
x | |
10:00 AM - 10:10 AM | The Role Of Medical Therapies For Hemangiomas And Vascular Malformations |
Presenter(s):Francine Blei, MD, MBA | |
View Abstract | |
10:10 AM - 10:20 AM | Surgical Management Of Head And Neck Pediatric Hemangioma |
Presenter(s):Milton Waner, MD | |
View Abstract | |
10:20 AM - 10:30 AM | Dangerous Arterial Corrections In The Head And Neck: Avoiding Neurological Complications And The Judicious Use Of Embolic Agents |
Presenter(s):Guilherme Dabus, MD | |
View Abstract | |
10:30 AM - 10:40 AM | Surgical Options In Head And Neck Vascular Malformation Management |
Presenter(s):Milton Waner, MD | |
View Abstract | |
10:40 AM - 10:50 AM | Head And Neck Vascular Malformation Management: UAMS Experience |
Presenter(s):Mollie Meek, MD | |
View Abstract | |
10:50 AM - 11:00 AM | Liquid Embolic Agents In The Treatment Of Cranio-Facial AVMs and AVFs: Techniques And Results |
Presenter(s):Guilherme Dabus, MD | |
View Abstract | |
11:00 AM - 11:10 AM | Curative Endovascular Management Of Complex Multiple High-Flow Vascular Malformations Of The Head And Neck |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
11:10 AM - 11:20 AM | Endovascular Treatment Of Yakes Type IV AVMs |
Presenter(s):Krassi Ivancev, MD, PhD | |
11:20 AM - 11:30 AM | Intra-Arterial Chemotherapy For Retinoblastoma: Lessons Learned After 1000 Infusions |
Presenter(s):Pierre Gobin, MD | |
View Abstract | |
11:30 AM - 11:40 AM | Ethanol Endovascular Management Of Low-Flow Venous And Lymphatic Vascular Malformations Of The Head, Neck, And Tongue |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
END OF SESSION 110 | |
SESSION 111 SCHEDULE | |
Saturday
SESSION 111:
UPPER AND LOWER EXTREMITY VASCULAR MALFORMATION MANAGEMENT – PART 1
|
|
x | |
11:40 AM - 11:50 AM | Surgical Approaches To Vascular Malformation Management: Triumphs And Pitfalls |
Presenter(s):Christopher J. Morin , MD | |
View Abstract | |
11:50 AM - 12:00 PM | Step Table Venography In Venous Malformation Of The Lower Extremities |
Presenter(s):Patricia E. Burrows, MD | |
View Abstract | |
12:00 PM - 12:10 PM | Surgical Concepts To Treat The Lateral Marginal Vein Of The Servelle Of The Lower Extremity |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
12:10 PM - 1:15 PM | Lunch Break – Visit Exhibits (3rd Floor Foyer and Promenade) |
END OF SESSION 111 | |
SESSION 112 SCHEDULE | |
Saturday
SESSION 112:
UPPER AND LOWER EXTREMITY VASCULAR MALFORMATION MANAGEMENT – PART 2
|
|
x | |
1:15 PM - 1:25 PM | Common Femoral And Iliac Arterial Sparing Endovascular Techniques In Neonates |
Presenter(s):Patricia E. Burrows, MD | |
View Abstract | |
1:25 PM - 1:35 PM | Treatment Of Intramuscular Venous Malformations Of The Extremities |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
1:35 PM - 1:45 PM | Treatment Of AVMs Of The Upper And Lower Extremities |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
1:45 PM - 1:55 PM | Long-Term Outcomes For The Treatment Of Vascular Malformations: The Northwestern Experience |
Presenter(s):Robert L. Vogelzang, MD | |
1:55 PM - 2:05 PM | Endovascular Curative Management Of AVMs Of Bone |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
END OF SESSION 112 | |
SESSION 113 SCHEDULE | |
Saturday
SESSION 113:
CHEST, ABDOMEN, PELVIS AND BUTTOCK VASCULAR MALFORMATIONS
|
|
x | |
2:05 PM - 2:15 PM | Ethanol Ablation Of Venous Malformations Of The Chest, Abdomen And Buttocks |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
2:15 PM - 2:25 PM | Endovascular Management Of Mesenteric, Small Bowel, Hepatic, And Colo-Rectal High Flow And Low Flow Vascular Malformations |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
2:25 PM - 2:35 PM | Staged Management Of Pelvic AVMs With nBCA |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
2:35 PM - 2:45 PM | Management Of Malformations Of The Vulva And External Genitalia |
Presenter(s):George Hamilton, MD; FRCS | |
2:45 PM - 2:55 PM | Endovascular Management Of Strategies For Inoperable Thoracic And Shoulder AVMs |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
2:55 PM - 3:05 PM | Large Complex Pelvic AVMs: The Retrograde Vein Approach For Curative Treatment |
Presenter(s):Robert L. Vogelzang, MD | |
3:05 PM - 3:15 PM | Combined Antegrade Arterial And Retrograde Vein Approaches To Cure Complex AVMs Of The Chest, Abdomen, Paraspinal And Spinal Areas |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
3:15 PM - 3:15 PM | End of Program P |
END OF SESSION 113 | |
SESSION 114 SCHEDULE | |
Saturday
SESSION 114:
UPDATES AND NEW CONCEPTS IN WOUND CARE
|
|
x | |
8:30 AM - 8:40 AM | Opening Remarks |
Presenter(s):Dieter O. Mayer, MD | |
8:40 AM - 8:50 AM | Systematic Management Approach To Chronic Wounds – “DOMINATE The Wounds” System |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
8:50 AM - 8:55 AM | Discussion |
8:55 AM - 9:05 AM | Pharmacological Agents In Promoting Leg Ulcer Healing |
Presenter(s):Chung S. Lim, MBBS, MRCS, PhD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
9:05 AM - 9:10 AM | Discussion |
9:10 AM - 9:20 AM | The Role Of TNF Alfa Inhibitors In Lower Leg Ulcers |
Presenter(s):Marco Romanelli, MD, PhD | |
View Abstract | |
9:20 AM - 9:25 AM | Discussion |
9:25 AM - 9:35 AM | PluroGel PN (Double Antibiotic) Phase II Results |
Presenter(s):David G. Armstrong, DPM, MD, PhD | |
9:35 AM - 9:40 AM | Discussion |
9:40 AM - 10:00 AM | Break – Visit Exhibits (South Corridor, 2nd Floor) |
END OF SESSION 114 | |
SESSION 115 SCHEDULE | |
x | |
10:00 AM - 10:07 AM | Dermal Substitutes Outperform Split Skin Grafts In Chronic Wounds: Pro |
Presenter(s):Lee C. Rogers, DPM | |
10:07 AM - 10:14 AM | Dermal Substitutes Outperform Split Skin Grafts In Chronic Wounds: Con |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Abstract | |
10:14 AM - 10:20 AM | Discussion |
10:20 AM - 10:27 AM | Dermagraft Or Apligraf: That’s The Question |
Presenter(s):Wayne J. Caputo, DPM | |
View Abstract | |
10:27 AM - 10:30 AM | Discussion |
10:30 AM - 10:37 AM | Skin Substitutes May Be Nice, But Flaps Are The Only Way To Go: Pro |
Presenter(s):Peter A. Blume, DPM, FACS | |
View Abstract | |
10:37 AM - 10:44 AM | Skin Substitutes May Be Nice, But Flaps Are The Only Way To Go: Con |
Presenter(s):Gary W. Gibbons, MD | |
View Abstract | |
10:44 AM - 10:50 PM | Discussion |
END OF SESSION 115 | |
SESSION 116 SCHEDULE | |
x | |
10:50 AM - 11:00 AM | An Evidence-Based And Interdisciplinary Guideline For Acute Wound Care |
Presenter(s):Hester Vermeulen, PhD | |
View Abstract | |
11:00 AM - 11:05 AM | Discussion |
11:05 AM - 11:15 AM | Predicting Complex Acute Wound Healing In Patients From A Wound Expertise Center |
Presenter(s):Anne M. Eskes, RN, PhD | |
View Abstract | |
11:15 AM - 11:20 AM | Discussion |
11:20 AM - 11:25 AM | A Prospective Study On Demographic Characteristics, Genetic Pattern And Association Of Lipidema |
Presenter(s):Afsaneh Alavi, MD, FRCPC | |
View Abstract | |
11:25 AM - 11:30 PM | Discussion |
11:30 AM - 11:40 AM | Prospective Randomized Study Evaluating Polymen And Negative Wound Pressure Therapy (NWPT) With NWPT Alone |
Presenter(s):Afshin Assadian, MD | |
View Abstract | |
11:40 AM - 11:45 AM | Discussion |
11:45 AM - 12:30 PM | Lunch Break – Visit Exhibits (South Corridor, 2nd Floor) |
END OF SESSION 116 | |
SESSION 117 SCHEDULE | |
x | |
12:30 PM - 12:45 PM | Screening For The High Risk Diabetic Foot: What Is The Return On Investment |
Presenter(s):R. Gary Sibbald, MD | |
View Abstract | |
12:45 PM - 12:55 PM | Discussion |
12:55 PM - 1:05 PM | How To Improve Compliance For Offloading In Diabetic Patients |
Presenter(s):Thomas Boeni, MD | |
1:05 PM - 1:15 PM | Discussion |
1:15 PM - 1:25 PM | Is There A Major Fungal Component Within Diabetic Neurotrophic Ulcerations |
Presenter(s):Marc A. Brenner, DPM, FASPD | |
View Abstract | |
1:25 PM - 1:35 PM | Discussion |
1:35 PM - 1:45 PM | Predictors Of Poor Outcome In Non-Revascularized Patients With A Diabetic Foot Ulcer And Peripheral Arterial Disease |
Presenter(s):Robert J. Hinchliffe, MD | |
View Abstract | |
1:45 PM - 1:55 PM | Break – Visit Exhibits (South Corridor, 2nd Floor) |
END OF SESSION 117 | |
SESSION 118 SCHEDULE | |
x | |
1:55 PM - 2:05 PM | LEAN Principles And Their Application To Vascular Healthcare: What Can Toyota Teach Us In Vascular Healthcare |
Presenter(s):Tej M. Singh, MD, MBA | |
View Abstract | |
2:05 PM - 2:15 PM | Discussion |
2:15 PM - 2:25 PM | PTA First For Critical Ischemia And Wound Healing: A Success Story Started 40-Year Ago By Andreas Gruentzig At The University Hospital Of Zurich |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Abstract | |
2:25 PM - 2:35 PM | Discussion |
2:35 PM - 2:45 PM | Evaluation Of Feasibility Of Ankle Pressure And Foot Oximetry Values For The Detection Of Critical Limb Ischemia In Diabetic Patients |
Presenter(s):Giacomo Clerici, MD | |
2:45 PM - 2:55 PM | Discussion |
2:55 PM - 3:05 PM | Perfusion Guided Revascularization Using Tissue Implanted Oxygen Sensors |
Presenter(s):Miguel F. Montero-Baker , MD | |
3:05 PM - 3:15 PM | Discussion |
3:15 PM - 3:25 PM | New And Better Ways Of Measuring Perfusion: An Unmet Need |
Presenter(s):Joseph L. Mills, MD | |
View Abstract | |
3:25 PM - 3:35 PM | Discussion |
3:35 PM - 3:40 PM | Closing Remarks |
Presenter(s):Dieter O. Mayer, MD | |
3:40 PM - 3:40 PM | End of Program Q |
END OF SESSION 118 | |